<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:56dec8fe-bb4b-4711-9c82-c533c008edd6,g:2a065e27-cccc-4ae9-a029-5c29f5f60184,d:c89f06320f9c4f57b19c511822f36cac--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:abbv="http://www.abbvie.com/20220331" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>abbv-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180L2ZyYWc6YzNhM2I4ZWVhZmUyNDNlY2FjNGEyZmMyYTBiZWNkMGYvdGFibGU6NjZjZjk5YTQ2MmI4NGU2YTk3ZWZlNGQ3MzRkMjQ2MmQvdGFibGVyYW5nZTo2NmNmOTlhNDYyYjg0ZTZhOTdlZmU0ZDczNGQyNDYyZF8xLTEtMS0xLTczMjUz_2f32b1bd-3255-4f21-a632-9c8af16b1cf4">0001551152</ix:nonNumeric><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180L2ZyYWc6YzNhM2I4ZWVhZmUyNDNlY2FjNGEyZmMyYTBiZWNkMGYvdGFibGU6NjZjZjk5YTQ2MmI4NGU2YTk3ZWZlNGQ3MzRkMjQ2MmQvdGFibGVyYW5nZTo2NmNmOTlhNDYyYjg0ZTZhOTdlZmU0ZDczNGQyNDYyZF8yLTEtMS0xLTczMjUz_1461bdcd-f1c7-45fd-a42c-603d57d93ae0">false</ix:nonNumeric><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180L2ZyYWc6YzNhM2I4ZWVhZmUyNDNlY2FjNGEyZmMyYTBiZWNkMGYvdGFibGU6NjZjZjk5YTQ2MmI4NGU2YTk3ZWZlNGQ3MzRkMjQ2MmQvdGFibGVyYW5nZTo2NmNmOTlhNDYyYjg0ZTZhOTdlZmU0ZDczNGQyNDYyZF8zLTEtMS0xLTczMjUz_07749f03-cee0-4cdd-a30c-81226c3a085e">December 31</ix:nonNumeric><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180L2ZyYWc6YzNhM2I4ZWVhZmUyNDNlY2FjNGEyZmMyYTBiZWNkMGYvdGFibGU6NjZjZjk5YTQ2MmI4NGU2YTk3ZWZlNGQ3MzRkMjQ2MmQvdGFibGVyYW5nZTo2NmNmOTlhNDYyYjg0ZTZhOTdlZmU0ZDczNGQyNDYyZF80LTEtMS0xLTczMjUz_ea03aef9-dfb4-4d97-be0d-dd7c0773f7bc">2022</ix:nonNumeric><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180L2ZyYWc6YzNhM2I4ZWVhZmUyNDNlY2FjNGEyZmMyYTBiZWNkMGYvdGFibGU6NjZjZjk5YTQ2MmI4NGU2YTk3ZWZlNGQ3MzRkMjQ2MmQvdGFibGVyYW5nZTo2NmNmOTlhNDYyYjg0ZTZhOTdlZmU0ZDczNGQyNDYyZF81LTEtMS0xLTczMjUz_0f12976d-b790-4ec4-b2c7-788c50809639">Q1</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xMDAvZnJhZzo1YzRmMGUwYjA3Yzk0MDdkOGFiMzkwMmJjYzlhNWFlMi90YWJsZTo2NWY5YmZiNDZiN2U0OGE3YWI1MTY0NDVjOTExOTQwNi90YWJsZXJhbmdlOjY1ZjliZmI0NmI3ZTQ4YTdhYjUxNjQ0NWM5MTE5NDA2XzEtMS0xLTEtNzMyNTM_32e6e38e-d1ab-4169-aa14-6727c2fdc9d1">1</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="abbv-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="icf2f690357b3411ab045058c62c6b838_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7b03101ef58492ca9192ba750dbd681_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffe012c9dbd240048d813949942fdca1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80b5d238bb8e41cca471222ecd0792da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:Sec1500SeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d28e73ff9804c2ba49fd0a53b2e8e80_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:Sec1.375SeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib20f829371cc40dabd2a3c59b1f1a0fb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:Sec1250SeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21ebb248bd964f8fa03fbfc9e37742b5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:Sec0.750SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec6ad1bebd34f3bb53e7507c29a99ae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:Sec2.125SeniorNotesdue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib84804f5ed9046c8ad2c59ea3175685c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:Sec2625SeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1583bfe6b33a4f04a6bafb359ac40353_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:Sec2125SeniorNotesDue2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13386ec6dca24c72873db6a581548a42_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:Sec1.250SeniorNotesdue2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a62f89becf43099721dde7ba0ee70e_I20220427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ee167f36562471dab7b2f232caad9ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a942c6b68a54ff3b7a44fe6b3def08c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cb1995fa5b74df58173afb77b7e467f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66fe2db515c241c0bb28d212b85279e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6e8e05625504d9a944f9bade3f3867c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf1feacb1a194c1d9816daa1d27870c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia427e86aee794ddda12fc9e121da41f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6accb844205d4e909ea7d6f406d2b865_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bd6e7e0203e48078669ad3bde0d5c7d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d02525654584e2f9f785b90b9913777_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i063a456449f745c98a09be163769f332_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0872c55f62b455494f25c4d7b92ca72_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i022758431fdb43f8b4df8421bb21711f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c3f47fb5c714936a77899d22ef47d49_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5cf8db55503473d9dd1af8c0d20c48d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6e9540820e34b43b3e6ec3daddaa1fc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f9dace7c91d4297a7aa7f308de3f768_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a3023971ae049339d5747605ef52a7c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i980dca056e914f6385bbf2d1f0a5c20b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab26cb86a14c46ba9fa64e4b951dfaea_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cf70c299b6747128fa4a148bd06c306_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide7dd1b7a2964e66b89583f5e940f748_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03d21af462c442b5beb00d3ba5c34925_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a07265e199d4b30a14e9e6383620f9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1929ee5ab0f4e8c9347283529630a9c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e9ff1d5c2f242d3acc07bc91dffb247_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa789cc1b9f041559e83b047a68991b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i029e4a4f41224ff9bf2006f28fa206ae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie21ccd46654948208d4f049707193b17_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31fbe96bedc549d2b2b83439135cb5b0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eb84aa68550418ebde877bd62bbcda0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76fbe238f3894a0eb179d09b47890654_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1baefcb501194b7fb536593a1a2bd9ea_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87b37cb73f2d4eacace3c00d60098061_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i207acaa2165d403396ea05f332f5d280_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib201ee2f6aa040aa994d36824861b99b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95c2a9dc2507491cbed7bcc6382ac0bd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedf65e4946d940d7b337ee6ad83e0838_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i613f449aeb814d5eb9f9f5433bf45c4b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72db22a233c742cb9fdaf4ec7205f2f1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:SyndesiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb3553129a064588b861cbad2e2e642e_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:SyndesiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20abf2418b52449bbcdcb69db0df0b34_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:JanssenBiotechIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e7da2bc9100421a9871b5285fd9fa10_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:JanssenBiotechIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9fe4ce1afbad40ee8b142ccdca3cbdf7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:JanssenBiotechIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i757157a6b1f24339a6987f24f728b796_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:JanssenBiotechIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c90b03e0a9d4b959d426288837a1ac9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:JanssenBiotechIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f9f25b9cf5e4ee0bbe7e382b04feba9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:JanssenBiotechIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1248f479629473abbdb6ed040285ccc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:JanssenBiotechIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7189bfa6119440549f13eb789b20c623_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:JanssenBiotechIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i503b434bb2cd4949ab32e3eea0c0a13b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:JanssenBiotechIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e417e1f49424cb4b129ec6ce7c723da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:GenentechInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if70fdebf15534416b657e3efc08cb7de_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:GenentechInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b131031330347efae33d3283c798c08_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:GenentechInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia91bb22b751b4f769a3ed871c1a8e163_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:GenentechInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6409d59d48544dd3b57e4e907e0daf25_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abbv:GenentechInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6d0443c07a5417ca515d44ddc962b47_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d4ad2d90a3249b7ab95933f6531b3bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85d7032a627d4586b0df7536454a2953_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6abf8b13366e446b8e4d345e553af9c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id13caefd7d5a471aa354ceb296f2d670_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2fa833e1b5a4350b5373871f1e0b8db_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dbf40f3d8814b2cb5a231dbbd3418e6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc654c5b431f4e2c81e6d3dc971bbfce_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac0e02057646439c9b219a540ab6bba4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d31e315887b49cf9383108785d5b7a2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b0ea0dc41fe4934b7afc79df8635743_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie28ae11319ad4812a556b3a24a0d7eb8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4b089c0fc324d5b82b75e000f5fe9cd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c6435c30e6b40489560149b0efd5c0b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2be7d9eaa6f4f369f0de369cbb043f8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7f0edb319054698965e395df2f44e5f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b13ed86da2945de8f2c44a2373537a6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56e369611bfc4546bf3c8e89fd8a3f48_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b7593516564b7588f173a9d381ac8a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77324bf397cc41f7a15e4eef24ecff2d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e5e0d98c3744bdb9096abdccc0ad91a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92f1ab36dc934e39ae4bfefcbe05705e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i714dfb429c6f451eb83c696c0379c6ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5007646043540a1b0e932caf506c8b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae8327b6e3b446c39bc4154fdcab2095_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id430b90a4b4b4e00accb2dafe2190824_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:AllerganIntegrationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35524fcc0d8743e3af6573cf03287f13_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:OtherRestructuringPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f4c4b3745f349e198629a93da34561b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:OtherRestructuringPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6e8c16288ca4a859ec70b21f89ef7a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:OtherRestructuringPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a368d5034e44f028f602236d3ab8057_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">abbv:OtherRestructuringPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d0578582acc4184bae1fe1a5d03842e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64d7cd1d96fd463d81f7b441a15f7907_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85e773fb160f4868b7b34f01835f244e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4dcf7772a434cca8535434fc724868d_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7c27a6d499a4374bb62731e6ee3c5ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ea6c9f4ab71401f8e112e105b0a87ea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14c87abe9559493098137ef93eb16897_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56fd5370a66349abb5a708fcca3df153_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e5c418235f74f58be5d142972173da3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i1440f6810115464aaba75d7ad2e205fa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e04d5b1b77e42338343cb7a394365ac_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida1c9540265a40ae89ed8e5bac26055b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0695b54b4eee4244ad7f53879aaf2b88_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3023f47a89be437a8979714fa7aeb5ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae50d2fb61c84091860a38b122dcec5e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3896b7812d9c4f458a6ee1c222fdc5d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf844e180d3a469caf77cbfd640ee06a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i278c392732fe405ca9790ebca84a2b5a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2759b8249f9b4c0abfb4b6e0d5d1f19a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21ebd92b09814dbd9c34016fbe056f80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37efff4161cb4c0493595e73c1b6c251_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42302eafa7c143eea1f93c5698a3de9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45a96d28015b45949c078f6766332529_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8fe28e93231442a879e677d581e007a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21f5ff90441c477985db4a043e94ba99_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i081e9eccbec84d14b3e5e990418ead24_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2762b41ed6f34461bfde8f1333fdf996_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d6c7748fb844f8387515876c985d86a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i435b30592ac747d989c50678808fe1d0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47e7a78e77c640c0978087e1e5aa5365_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic20d6c5cd9154d11b748fba274562228_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec68c25a887f49d4b34b8179ed6dda01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24765f81c1fb4287a6f15e1f08b37561_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84610d1bd2b740fb98e00437e286d300_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i099396de57cc428db3ba3fa6496e9806_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bb723c8d7d94576a2e267ad0bde0d6a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84f403b6217414e9c4727bdaddefefa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i993003f0c8794563b176024ce0433091_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf6856ef91ba4d929d656629013d3068_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie282fe45ad5d4fabb47f2e2e934d4440_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i621e08f15f004824aefad73ab5851795_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i179bb4a086e74b04bc986f5bbbb847c6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ed7b475bcdf40e59be351b723196753_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0ba58f0b4804781a450e1eafe670429_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73a0138eece144c7b6d7536ce561b961_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6e338b61d1141f5b8c13e661709f6b5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a7bd97603484ae1802843d027d4882c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1681dbbb7fe645d6853c751bdc56bbad_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaed8d036846c41e7ae1fd8954a4b4f77_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52f7ce3635354a61a150bfdfc38169f5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id741975d93ce432ca3360bc759262c9c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib000460db5074562808f7f1eb5c6419e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9f6fa4fbbe04394a9fe1a7d581eaec0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib64b83983f224c629b47278996994efe_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47ba7efcd0f44228bd851a9cfd907eca_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if79203b4f0e042919ad95c75b6c9ed1d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3338f9b94ba644cdb8a5bfb1a5c29358_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib576612385b34159a385efbbb44ac312_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa2ab8d0faba462a8cdae1d115c9ac72_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i859211caa6b54eaa83b28f597db71274_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia38e263f9b26407aad657967962464cc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab718c63b5884ec79c89e37caa022504_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d51b5f39b30417591b468b9cc37d240_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdce0bbf0ade46c2bcb9b28658b93b26_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9a1275578fd4eab9c1a98a3a69b8994_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i547378d779a94424afb2f81c95c765e8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifced2c43ef9a4921b504c12eeb7b2ef1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied0d7604169c4be790295c65966d9417_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ad1758bd2446cea957f2ad4754f617_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e694d0a849640f2baad8365a826d153_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfa6a41f682746a8ace32ddbe43016b7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2af1965f163b48ea903e4c8e2f20baed_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i626df6b5d80b4e98b0edeaa02ad00831_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if649f364c260430e996cc0e7faf77825_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f48fccb6a964533ad0a2bc9fa1b69d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida5d7c1351314f0aa35ce7a44c4a1460_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b425e8bb2fc4bf98f7703e322eb47ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e2a58ae48e34c639ba8dc2259cc6bf8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib99530b1ca1f4637a531747b189b68e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75b92c917f6c46e8bec270fac1ab97be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87ad90d3c5e24243a4f6eb626050ecbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1c1d4df013d43b6a59943a73db0d1fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e05944c5ce844a18dea78c42fefb97f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2306289346ba4f6eac115558f89ffb15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if76fd003b44e4e00b01dd0219527e8f6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3316afc52f864995939b74f4200c4d5d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie41be7ae9a7746e29ab56e1c3957336c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaaf5c1772824540821269f5a7d5d060_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e6a0250795b4caeb9007fccb2fb25e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7064869e3d004e11826a6f8e545956e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0e23bbc802e473d941d50ddec1eac96_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforUnachievedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc34b4f0b824400cb3e06c112446fd78_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforUnachievedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa6c770a5e4e43219c664f8eeaebc92b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforUnachievedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeca827be1174ca8b3b26a2dd3170414_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforUnachievedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c6e00071bb14c0f9134687f14d184c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforUnachievedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40f7d8e61c394c11942ca3d90870ce76_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforUnachievedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36a5db71b7bc44afa79f34197c0d50c0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b7bbcb6f78a486c9aaaf2cc66ad620a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a58f36c0a0f455fb16aee3fddf5e537_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c4ab8ef49f6437ea3dc95bf05981bfc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i088dd727214a49e5bdaa60f93779a823_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3155754d608b4eb491cdd36b45bcc5de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86308a2e6f2a4ecfba5255d3af29d432_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProjectedYearofPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9678c4caaf349ba8006f44b404b1b82_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProjectedYearofPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d2bc0b8db334803be5cea99172bad7f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProjectedYearofPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdc8ba9e255b47fbb82c3c726dd8508a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProjectedYearofPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1455f288cfc245b69c8e6fa1ee29a92c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProjectedYearofPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i653e387441bf474ba40509d89d957072_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProjectedYearofPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01d4a0312e1a42c1bbb49eebf6fb2dbc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f0399851154ccb8d747ab261a55ff7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e22014612a6456496ade50c3c0e598b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6150f60c782f4bbe93e9e862b343af55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">abbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044a3d7ac50441e494f6a05e1c9a61b5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if42be951e40b4522978f85dbcf5c6c5f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i077c77a1980b4f8fb626087d04f359c2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c0cf7b896574cd48467e517534d6c7e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f1f25b805ee48a38221900a8f4ec23b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a0fb1ead0c4427aa4a771f260c12ddb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6c49899324342418b3c03ecab096e69_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c93bb319518438dacf0fb870fcabe09_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3079fe6a94b4043bd136bd42880f7e2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaafb386815a84014b6e79d88e23df483_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i683f0aac0c634dfca6b9b368ab20372a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb19f61a177a44cc83608f369fc35200_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95aad88173d14db798e85a935c24c68b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="wholesaler"><xbrli:measure>abbv:wholesaler</xbrli:measure></xbrli:unit><xbrli:context id="i6a1415a76d304bdd903790a631d4b562_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abbv:PrincipalUSCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5fd10e4797b4759b2ad9ee884eb18fb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abbv:PrincipalUSCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb70f3e9a3064175beb5a4288f9555cf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:HUMIRAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i598f780a95a34397b93cc33d29482fbf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:HUMIRAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if319dff6fb6d4c9b9e70b7590afec644_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abbv:SeniorNotesDue2022At3.450PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id24046754e794d98901ac09a9a57728a_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abbv:SeniorNotesDue2022At3.450PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia646a389a6944ee39075a400a0260d9f_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abbv:FloatingRateTermLoanTrancheDueMay2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedf4aed6ce494fb0b76f1715e4bc5fdb_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abbv:FloatingRateTermLoanTrancheDueMay2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d290b478df340cb86cfefef5344e881_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abbv:FloatingRateTermLoanTrancheDueMay2025RefinancedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5efb5d06f0c4acd9a7f96ddd5917965_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3cf0076169046e2a8a90c274b32e1a5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8f119ab76784686b6ca0d67fd748f1b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i336829d47f964430a3f3ec676b1093ab_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79841cf14ea346c48bdbc856f1e4b860_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88ba3758b6c416da9c9db84a7ca5778_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26f9a43336ae4b0da381254b468ae09c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7badfe6657634d348d22e9be1faa35ea_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54988d2c4f2f40c2933727e2b8be27ff_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3001aef538c54c44b5812a99e4845adc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8391b17f0e1049f9be08ea7161a2487c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbf3ce65514c443c8ef37159d35d4a69_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e56837ed6bd423c89d802b44906df17_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">abbv:RestrictedStockUnitsAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic438b74601344b28a5a621e09638dfa5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">abbv:RestrictedStockUnitsAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bcd77a684aa4ecf8e6a62f0794f8418_D20220217-20220217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-17</xbrli:startDate><xbrli:endDate>2022-02-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e438a1448d44f418e9b8f452ccf2783_D20211029-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-29</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2670f469a2ac4a459ccecfc909f364ee_D20210910-20210910"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-10</xbrli:startDate><xbrli:endDate>2021-09-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72db19201e77427a944de55507b7fe80_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i300fb3fc7b084fe1ae13da9f57c82d71_D20210218-20210218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-18</xbrli:startDate><xbrli:endDate>2021-02-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib694cd894894414da5c46138d815dd90_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">abbv:December2018StockRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bcc50f777fb4122a035380de5a8418a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">abbv:December2018StockRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30d113b6de524e999e45640992e7d5f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic307ce6fcfdb4b95a357b18194e6695a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied4482ed129142548aa3b7aba9e6e05f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b80412b07c14765b60765c6863daf16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i305d5315aa3249959cf54167f51117a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ef7519873594295b569d2ed9d013d3b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5c66dc788a1430581c272b0c716b06a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19158d14e728497cbede5b260b0904be_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i222f710050af4ecca660d0fd445ff9ef_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6c2e6b413dd4c95ae4cc6fd40f6a699_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38cbefbb7640470d8912c518f4d612c4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d0749feb42e4416b8b7650f417a1131_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a8127b3ac3548c3890da55bf63f1701_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice36e374d1fe41cd885017f660510ca7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00bc0c90f91f4af0a5a3a88ab5477eaa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idba4be4766064887868cd838db3129a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13ba96e9d518432f846efbdefd0568c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfa61ba6e74c4671b7c09c21de67bea5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85f7baaa43f94988beb4cab455519ed9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ef17bd343cf45f4a0064de2b7b25559_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fde8fe6a5d44d7083e9b20d383298c0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f16ffe755c541c08daeb711d76a9eed_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab1455b44d7b4ad7ae2afb21e3bdb861_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacecdda3bbc54ee1b9906ba01da77d2e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0d08aebc5e649d9a475213ebb8a10ef_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32fccc997a0749b1bb81108be62eb6e8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i157ad54cc34c4b9e9f5f62ce15e5c956_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcc473aa8ebe448e985aa0a29dcd7e8c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ce7636b82d0488790d551ca1286a964_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe0c4dc2984f481b92d6852e941b91b9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28e53bf29aba4d48b3d569bcdcfec9ec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i156ab7fa7ed04946b0d67a6660158361_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i115d67da01e8464594d5f3097915285d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d2a39cd4e914c2baf4e3f7f78e0e037_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia93484cb8e084701be386a098217dd41_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac58012cb8394749b3da275880c656bf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f8aa0c8a5684d66952c25dc6e509fe7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5ce39b3335d40a193f5da7859d3e742_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18c8e4e34cdc418dadb3f7f36b8d5041_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2761b85b027474db273e8bb0d34f65a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfd179fad6a84747bceee1f796370db1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">abbv:NiaspanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>abbv:lawsuit</xbrli:measure></xbrli:unit><xbrli:unit id="class_action"><xbrli:measure>abbv:class_action</xbrli:measure></xbrli:unit><xbrli:unit id="direct_purchaser"><xbrli:measure>abbv:direct_purchaser</xbrli:measure></xbrli:unit><xbrli:unit id="end_payor_purchaser"><xbrli:measure>abbv:end_payor_purchaser</xbrli:measure></xbrli:unit><xbrli:context id="ie9849c3641274f60b03fcb8763315cdc_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">abbv:AndroGelAntitrustLitigationKingDrugCoOfFlorenceIncEtAlVAbbVieIncEtAlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="company"><xbrli:measure>abbv:company</xbrli:measure></xbrli:unit><xbrli:context id="i2876ad381a314d1492fed65c7ba60831_D20190301-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">abbv:HumiraAntitrustLitigationInReHumiraAdalimumabAntitrustLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i061f6899a2e64d8b9f6710d2ffdaa440_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">abbv:BystolicAntitrustLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b950ca2895a442093c6358346b89e00_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">abbv:PrescriptionDrugAbuseLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>abbv:claim</xbrli:measure></xbrli:unit><xbrli:context id="i0d6b8a8607154239bab327083f4f2a16_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">abbv:PrescriptionDrugAbuseLitigationInStateCourtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c041511930545c890fb52c2cac408df_D20160601-20160630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">abbv:ElliottAssociatesL.P.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-06-01</xbrli:startDate><xbrli:endDate>2016-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="investment_fund"><xbrli:measure>abbv:investment_fund</xbrli:measure></xbrli:unit><xbrli:context id="id8b1a9f1c7674ab7b5a46fc570730aa0_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">abbv:ElliottAssociatesL.P.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie49c8cbd1c924c69b51d6bd1f5088886_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">abbv:ElliottAssociatesL.P.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3d814e2470641b7adca70c8dfd22826_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:HUMIRAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d8cd18e85b4007971cea988abe2864_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:HUMIRAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86efe50966f24c74849d1de4249000b9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:HUMIRAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf1053eda3554c3bb53ea7f9f667809a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:HUMIRAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d8620bf3edb45e497398d57317e67ab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:HUMIRAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i151f76a6bb394b0e8dc33fbdabffeef4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:HUMIRAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9dcf0e2a5bc4237a3420a8ed35591ab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:SKYRIZIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a121fb3a1a74d08bb6b193989e4706a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:SKYRIZIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief7e3bfd63234b9987cf846478a441fd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:SKYRIZIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8267ed584474c71a1ee8dbc54f58ef8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:SKYRIZIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f415caa04a941a3b6c40335ad6d10f0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:SKYRIZIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f1c4e6bb026457da1f4cdf7df42c5f6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:SKYRIZIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia38c669542ad4085a09a271f057f90d9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RINVOQMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0dfe507ba24433988668a7d003a378c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RINVOQMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia89a047a7f15451fae62f0586e4244bb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RINVOQMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa4d1ef4d3c3472f8587646493588ca3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RINVOQMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06547d54c7744ec59245e1aabe7bb4a9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RINVOQMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68fecb4ba92b444e8e7c4082e3cacd88_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RINVOQMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63c7fad38a034510aef4faf293e98042_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:ImbruvicaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2609235fb4a14a5fa8a9ae2ce41de85d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:ImbruvicaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83dd8a4923b14d1e9444794bdc3c9fa3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:ImbruvicaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i839ac535845b43fe8878c6e026ae540d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:ImbruvicaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88dc4f478b445c989df2931bf4129de_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:ImbruvicaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8b31104dd4f4b588d5964c0a59fc7d9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:ImbruvicaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa0a5001dda54d03b17d99d99907ef72_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:VENCLEXTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc2f01f0a3bc4965baed776f9c1ee2ee_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:VENCLEXTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd7e7447fe34c6287942f568429ef69_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:VENCLEXTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffd103eaea8d4b81b307a47031308a2b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:VENCLEXTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia21887679ab4450e9854e11b52987fd2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:VENCLEXTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ca3b9d904a042d1be012441bfbfbbbc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:VENCLEXTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:HematologicOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i646b3499eac046a9a4d0c7b552528647_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxCosmeticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d51184fb925493e90b9ff271b8ba444_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxCosmeticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cf374b782644e749678d1f567eb3bc1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxCosmeticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i231632e602304cbcbf663af9260ff447_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxCosmeticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d97cd1c204d47a0894f071baccfb3dc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxCosmeticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i485c4f314f4d4d4887041a01bca64c2b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxCosmeticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia81395f4f3fa48e8826d79041d865c17_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:JuvedermCollectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5523e96c483e4a5a83a81a78cfdec571_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:JuvedermCollectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2bf9f5d90ff4778afcba822173f993c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:JuvedermCollectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8ccf536e0504054b9c01fbb9c17051f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:JuvedermCollectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68379647466f42ac98da932e0ae7ba56_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:JuvedermCollectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b9a74c5d27b427db7df5b72e0ef9e71_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:JuvedermCollectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9886797304fd44789c0dae1792702122_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1192611baa7144ae9f6aa9bd6469b73f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f45042ba49947aea027157aa3e5005e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6297715bc8540428f641904958468e5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i274365a0958a49bb88080cb48c332ccd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aeec465d3b44d6d836a7f5d22f41e34_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:AestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic117a05f0ad047458c3dfdf3d563d985_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxTherapeuticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0aa0c6e5e8e4e86be8c148b66aedbb6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxTherapeuticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0f1b5410e4a4e8fb9abfa2219b13d78_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxTherapeuticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic78f3e2ee61c499ba7cc0746a2385d47_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxTherapeuticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdbacd087ccb4b378166217f2e6bac38_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxTherapeuticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2b0f54b6f66490ea61e7105a06bbd5f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:BotoxTherapeuticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ff614778cc44cd498c6a9c8964075c2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:VraylarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f19775fa7fb4454916890a2d18f7368_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:VraylarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3125d8c421f84befbfdc8c98d0f12733_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:DuodopaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1c196d5476444949e789bed861f1aa6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:DuodopaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d5f22d6d24942c5974fd185d2251f6a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:DuodopaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdf4bed28ef04a34be1be2775ace098f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:DuodopaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia72f22aa56674f6ea95b38deaf7d7ef0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:DuodopaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i639f02ea2ac340d384b27444a35f86c5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:DuodopaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0f9dd7d8685493e9094a8411dc69ba7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:UbrelvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb5cc0c791ad4deb82c1071bb2540517_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:UbrelvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3d3e94281d14e1ead6013f512d2ba56_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:QuliptaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18fd6150a38a4e9b9bd77ea967639212_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:QuliptaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i512cec6652ce4f19be4c4e4462feb4e8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b4fe39a35de44ecaa3535608505ded0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeabc0e9b646406e88ddb1c5e1f12518_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia12ead842eee42f59b1937c152fb8415_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia67b003e0c9d489a93fc432063b0605d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a38522757a47f08bcaaed26cc95890_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherNeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0b09878f9324ebc81010863a7bb2312_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LumiganGanfortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67b43137ee1c4af9956280587d60c83c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LumiganGanfortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae85b406a18e40d7b2917cf2e17d0b83_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LumiganGanfortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i741797da087c4ef6a3b16e0b40c35175_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LumiganGanfortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic34cab53f8594ff4979a946f5a3fc1f9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LumiganGanfortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85cd48264009438ca440c693ab0cf2f1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LumiganGanfortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fc8282031784d8caeb6a4ef809f2f50_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:AlphaganCombiganMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a85e57b458b4094a0c62505b2a9799e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:AlphaganCombiganMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50fb763a0f1c482a9572f571170e440e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:AlphaganCombiganMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93307eafe6504d879af164c82b04eda8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:AlphaganCombiganMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia46e3aeb263045cfbb0acf95c88c121b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:AlphaganCombiganMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a77a42b923942bfaff4dc08627c3225_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:AlphaganCombiganMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief85b551045345879ed1be64c67a8b4b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RestasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cf3d5f2dfb344e59a6c9efc465d8f5b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RestasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic62a015e1747449791ed3c131fc6f351_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RestasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bf8ded17cba43f7b08f7d24f7aed016_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RestasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea2c9be5775d49e7af0a83f0b14fce7f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RestasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ddf6b053a5d4cf1b48234a1c15b6c1a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:RestasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i882c0ed4b6454d5db18fd823a31bcb88_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherEyeCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf25850c2d1c4ceb840ecd9bfee2891c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherEyeCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife17341a39044007bd37eb3dcabab9af_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherEyeCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i379b152b16b1407985df7a9d9e3ad633_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherEyeCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6df2de6a1db84a14bc36698e3dbcbf51_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherEyeCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58a92b2ecc5f4aaf9d8351f86caf7be5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherEyeCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:EyeCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e933b76f7264c7cb306a5779cb4d526_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:MAVYRETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9bf38d011cc4cfd9351b1938594689b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:MAVYRETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e746d238af04e0fba57b391911704b6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:MAVYRETMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59295dec623542dba93f26a4df9b7bf3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:MAVYRETMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieefe0806b5ac487fb58df139e942b4bf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:MAVYRETMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic251b48766744736852af8a750fb5fa6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:MAVYRETMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife9748feec04436daefd70ed8fde5035_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:CreonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ca6bfcb2a742d2a419a770b28a65e2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:CreonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2ecf09fad83434f8b75838cf1459dde_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LinzessConstellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6fb7ab9f9404aa4800b094182ef46f5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LinzessConstellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9915235f3a844da69814226e5774c2d7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LinzessConstellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4538d383a2c14cac819e3ce9bc8a27c4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LinzessConstellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i531f3349e8c348c39ad330ddd7567561_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LinzessConstellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a8b6f17bd484927bdf4246fdc7d2e83_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="abbv:KeyProductPortfolioAxis">abbv:OtherKeyProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:LinzessConstellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i092297541dd04ee2b04cfdcfbb71eef1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i143c59ef117840e5b84f10e564ee91c4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">abbv:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>abbv:segment</xbrli:measure></xbrli:unit><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0yLTEtMS03MzI1My90ZXh0cmVnaW9uOjMzNzFjODljMzFkYjQ3NGI5MTdlYjI1N2E0ZmI2OTcxXzI3NDg3NzkwNjk0NDQ_af625595-0582-4b93-a179-0e2dd45ed242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMDY_84d7cab9-93ac-4fc8-a39f-7622c4e8652b" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0yLTEtMS03MzI1My90ZXh0cmVnaW9uOjMzNzFjODljMzFkYjQ3NGI5MTdlYjI1N2E0ZmI2OTcxXzI3NDg3NzkwNjk0NDQ_af625595-0582-4b93-a179-0e2dd45ed242" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMTQ_721db4ae-4305-482d-b373-ec8b16aa1b8a" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0yLTEtMS04MTA4MC90ZXh0cmVnaW9uOjZiMTY3ZWQzNGFiYjRkNDdiMTA0MzIyMDkyZTJlNGZjXzI3NDg3NzkwNjk0NTA_9cccc2a8-86e2-48fe-9f89-53bbf7e6c0f0" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMDY_84d7cab9-93ac-4fc8-a39f-7622c4e8652b" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0yLTEtMS04MTA4MC90ZXh0cmVnaW9uOjZiMTY3ZWQzNGFiYjRkNDdiMTA0MzIyMDkyZTJlNGZjXzI3NDg3NzkwNjk0NTA_9cccc2a8-86e2-48fe-9f89-53bbf7e6c0f0" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMTQ_721db4ae-4305-482d-b373-ec8b16aa1b8a" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjc0ODc3OTA5NTI1OA_5d256177-b7e1-4915-a8f0-e491dbb9f298 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0xLTEtMS03MzI1My90ZXh0cmVnaW9uOjM0NmYyMzM1ZDVmNDRhYWU5ZGJiNzc3ZDA4MTVlMTEzXzI3NDg3NzkwNjk0NTA_04ada94e-64b7-459a-a5dd-adeb4f6ea353 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0xLTEtMS04MTA3OC90ZXh0cmVnaW9uOjhhOTdiMzJiNzRjNDQ3YjM5NDlmMWQ2MzEzNGY2ZTk5XzI3NDg3NzkwNjk0NTg_1139f260-ebf0-4997-a8bf-8e3e9c1797b3 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0xLTEtMS04MTA3OC90ZXh0cmVnaW9uOjhhOTdiMzJiNzRjNDQ3YjM5NDlmMWQ2MzEzNGY2ZTk5XzI3NDg3NzkwNjk0NjY_34203fed-736d-478f-9829-5ad6abaa8128 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0xLTEtMS03MzI1My90ZXh0cmVnaW9uOjM0NmYyMzM1ZDVmNDRhYWU5ZGJiNzc3ZDA4MTVlMTEzXzI3NDg3NzkwNjk0NDQ_7949dad9-89a4-41ee-b66a-7fc7207216bb id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjc0ODc3OTA5NTI1Mg_2255b661-58b9-448c-a8da-5793bd88bc4d" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMDY_84d7cab9-93ac-4fc8-a39f-7622c4e8652b" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTEtNy0xLTEtNzMyNTM_da5e13a0-ba04-43e2-9ccc-697be415ecf8 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTEtNS0xLTEtNzMyNTM_c3509005-a607-426a-a140-90bfa6a40cdb" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjk2Ng_339b42bb-9e96-46ac-89bc-283f924a8cbd" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfNy03LTEtMS03MzI1Mw_e0b01168-ad34-434d-9854-14c860bb3278 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfNy01LTEtMS03MzI1Mw_5de29469-8128-4032-a9fe-d194d6935866" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMzAwOA_4e00e857-6c03-4577-bf53-0941bd05ee5f" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMy01LTEtMS03MzI1Mw_dcbb1f13-4991-4b76-b758-f7b88b8d660e id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTItNS0xLTEtNzMyNTM_5e757465-320d-4d59-890d-c8493a2521aa id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMy03LTEtMS03MzI1Mw_a9d9e243-873f-4eef-b19e-5939933a8100 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTMtNy0xLTEtNzMyNTM_9dfa7b53-a718-428a-84f0-a2b6048d47ca id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTMtNS0xLTEtNzMyNTM_f5d8bf1d-c1fd-4481-bde9-f036b794d7e1 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTItNy0xLTEtNzMyNTM_d33aba04-37d9-4799-8851-d1a29a61115b" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjk5NQ_4f394a68-56b5-40ba-85ee-31ba8f0a7a22" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMi0yLTEtMS03MzI1My90ZXh0cmVnaW9uOmQ0MGEzNmJlOGMxYzRjM2RhOTE4ZWYwODI5MTZiYTcwXzI3NDg3NzkwNjk0NDQ_22cd617e-882f-4a62-a3a0-f377e022ebfd id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMS0yLTEtMS03MzI1My90ZXh0cmVnaW9uOjgzM2JmZTkxZDBkZDQyMWE5NDI5NmQxMjEyNGE3M2MzXzI3NDg3NzkwNjk0NDQ_274ad924-0f34-4f79-977f-36dc21f67545 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNC0yLTEtMS04MTA4MC90ZXh0cmVnaW9uOmMzYzcyMDAxZGQyNTQzNTRhYjBjZGRmMzEwOTkxMzQ0XzI3NDg3NzkwNjk0NTA_f621a23b-df7f-4771-a959-3f4a432c6de1 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNy0yLTEtMS04MTA4MC90ZXh0cmVnaW9uOjc2MzFmNTcxMzBkZTQyZjE4NmQ5MmEwNjk4ODM5MGM1XzI3NDg3NzkwNjk0NTA_6fba84dd-6dc2-4522-a73d-12e386424d43 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0yLTEtMS03MzI1Mw_1e8fbd73-3e85-44c5-8cfb-b0e0822a4975 id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0yLTEtMS04MTA4MC90ZXh0cmVnaW9uOmI2ODBhMDkwNGJjZTQ2ZmViMjljYmVjY2Y1NGIzYzMyXzI3NDg3NzkwNjk0NTA_cef10409-9e56-4640-b348-5c474e51230b" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMTQ_721db4ae-4305-482d-b373-ec8b16aa1b8a" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ic89f06320f9c4f57b19c511822f36cac_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTQw_98c684f0-5d68-4c05-9fb4-d482d42099b2">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTUw_b366d782-728e-42cb-a4dd-33c8c4e5b86b">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMjU_e363e7d6-7ae6-44ba-aad3-0a44f7d01a96">March 31, 2022</ix:nonNumeric></span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OR</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTUx_40be19cc-9daa-420e-a506-194298569fe4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;to </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number:&#160;<ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTQx_9cb39a2b-a4dd-4e3d-b534-5907338cba66">001-35565</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><img src="abbv-20220331_g1.jpg" alt="abbv-20220331_g1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:164px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTQ0_824631c1-637a-47b6-bd18-d6973a27daa7">AbbVie Inc.</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.861%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6ZjBiNmQ0MWIyNjQ2NGRmZjhhY2U2YTE1NjJkNTlmMWUvdGFibGVyYW5nZTpmMGI2ZDQxYjI2NDY0ZGZmOGFjZTZhMTU2MmQ1OWYxZV8xLTAtMS0xLTczMjUz_ff788997-1dd9-48c4-be55-361072a46e57">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6ZjBiNmQ0MWIyNjQ2NGRmZjhhY2U2YTE1NjJkNTlmMWUvdGFibGVyYW5nZTpmMGI2ZDQxYjI2NDY0ZGZmOGFjZTZhMTU2MmQ1OWYxZV8xLTItMS0xLTczMjUz_c8deb2a9-f8fe-46d5-80d3-1f891bffafb9">32-0375147</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. employer identification number)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></div></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTQ3_9f65a209-5ed8-4087-9578-b2a2ce7fb52a">1 North Waukegan Road</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTQ1_436136ae-d57a-4cb3-960e-170bbdab9a3c">North Chicago</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTUy_f7d2f17b-93c8-4b18-a52e-9a67c370a9f5">Illinois</ix:nonNumeric> <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTUz_08defa2b-89ee-484d-88c6-6136da3fe129">60064-6400</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Telephone: </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTQy_b864d910-1a7e-4f2e-bfd2-28e68e1c6a7b">847</ix:nonNumeric>) <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTQ4_a6b77ef1-98b3-4290-b63f-bd3f37e2219e">932-7900</ix:nonNumeric> </span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTQz_e646689c-75b4-4a58-a619-6e7d39aa8e96">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTU0_ab44d58b-fcd9-468c-8b0d-23dda50eec46">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6Y2FkYWY5Mzg1ZWY0NGUxYjg4YzI5OGNkMjYxYmIxMDIvdGFibGVyYW5nZTpjYWRhZjkzODVlZjQ0ZTFiODhjMjk4Y2QyNjFiYjEwMl8wLTAtMS0xLTczMjUz_1472dc24-8c02-4dc4-82e0-43c7951e8f41">Large Accelerated Filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6Y2FkYWY5Mzg1ZWY0NGUxYjg4YzI5OGNkMjYxYmIxMDIvdGFibGVyYW5nZTpjYWRhZjkzODVlZjQ0ZTFiODhjMjk4Y2QyNjFiYjEwMl8xLTMtMS0xLTczMjUz_2395a486-8d1b-454f-acb4-83fcc17cc999">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6Y2FkYWY5Mzg1ZWY0NGUxYjg4YzI5OGNkMjYxYmIxMDIvdGFibGVyYW5nZTpjYWRhZjkzODVlZjQ0ZTFiODhjMjk4Y2QyNjFiYjEwMl8yLTMtMS0xLTczMjUz_7f3accdc-4642-4aaa-beb7-90423b739706">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMTQ5_85120a9e-eb6e-47d4-a780-763d5d45c07f">&#9746;</ix:nonNumeric></span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.822%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.762%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.628%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic7b03101ef58492ca9192ba750dbd681_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8xLTAtMS0xLTczMjUz_024a3240-fef7-46c3-99b5-93815b5a9dfd"><ix:nonNumeric contextRef="iffe012c9dbd240048d813949942fdca1_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8xLTAtMS0xLTczMjUz_a0cead0a-8657-4a4e-ac0b-e3e38f1eef99">Common Stock, par value $0.01 per share</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic7b03101ef58492ca9192ba750dbd681_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8xLTItMS0xLTczMjUz_ce10e4c9-4b43-4d4b-972a-579877d6376f"><ix:nonNumeric contextRef="iffe012c9dbd240048d813949942fdca1_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8xLTItMS0xLTczMjUz_dcf6c143-0703-4fe3-b749-3502e796a150">ABBV</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iffe012c9dbd240048d813949942fdca1_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8xLTQtMS0xLTczMjUz_6cf3ab2b-ffa4-481b-9e75-3baf482bd6ff">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic7b03101ef58492ca9192ba750dbd681_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8yLTQtMS0xLTczMjUz_c51a9dd8-49ef-4029-8b7d-b2fdf836a524">Chicago Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i80b5d238bb8e41cca471222ecd0792da_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8zLTAtMS0xLTczMjUz_8de0921d-610c-4c7e-9a2a-112814189a93">1.500% Senior Notes due 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i80b5d238bb8e41cca471222ecd0792da_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8zLTItMS0xLTczMjUz_da6c4f5b-b837-41db-a0f4-aea2fce3238f">ABBV23B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i80b5d238bb8e41cca471222ecd0792da_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8zLTQtMS0xLTczMjUz_bff6c4cf-81a9-43ec-bb7e-19224d30c9cb">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2d28e73ff9804c2ba49fd0a53b2e8e80_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl80LTAtMS0xLTczMjUz_8131ca33-47fe-494c-9dd0-b458c5417925">1.375% Senior Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2d28e73ff9804c2ba49fd0a53b2e8e80_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl80LTItMS0xLTczMjUz_ca54a00f-dd10-4a63-8741-39d1adb8f637">ABBV24</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2d28e73ff9804c2ba49fd0a53b2e8e80_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl80LTQtMS0xLTczMjUz_82de2794-2685-4dd3-93a4-647e5b1c3dcc">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib20f829371cc40dabd2a3c59b1f1a0fb_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl81LTAtMS0xLTczMjUz_213ff2ac-b01f-4fb1-9025-9f3f83af2f83">1.250% Senior Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib20f829371cc40dabd2a3c59b1f1a0fb_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl81LTItMS0xLTczMjUz_64ed4422-c691-45fe-8c9a-71f5367447e7">ABBV24B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib20f829371cc40dabd2a3c59b1f1a0fb_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl81LTQtMS0xLTczMjUz_c48e3414-883d-4e24-9690-4a4b57faeb61">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i21ebb248bd964f8fa03fbfc9e37742b5_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl82LTAtMS0xLTczMjUz_9cf0fe32-2215-484a-8317-d769db189b0b">0.750% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i21ebb248bd964f8fa03fbfc9e37742b5_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl82LTItMS0xLTczMjUz_619359a6-93f0-4d17-bbe3-f84029ea30ba">ABBV27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i21ebb248bd964f8fa03fbfc9e37742b5_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl82LTQtMS0xLTczMjUz_bdebec32-8eab-4ee2-aa2a-cec048d323a5">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8ec6ad1bebd34f3bb53e7507c29a99ae_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl83LTAtMS0xLTczMjUz_919d488a-ae2e-4c1e-94a4-c11350aa190d">2.125% Senior Notes due 2028</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8ec6ad1bebd34f3bb53e7507c29a99ae_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl83LTItMS0xLTczMjUz_fe87b0e7-0f62-4283-961b-00bdff043806">ABBV28</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8ec6ad1bebd34f3bb53e7507c29a99ae_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl83LTQtMS0xLTczMjUz_8e45cd2a-fc10-4f95-a19e-ef4735dfc807">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib84804f5ed9046c8ad2c59ea3175685c_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl84LTAtMS0xLTczMjUz_146c0083-638a-4962-b54f-8ff5203159f6">2.625% Senior Notes due 2028</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib84804f5ed9046c8ad2c59ea3175685c_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl84LTItMS0xLTczMjUz_fcf2e39d-3e49-4ce8-ad44-b260b02e1d42">ABBV28B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib84804f5ed9046c8ad2c59ea3175685c_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl84LTQtMS0xLTczMjUz_90478eb0-5495-4252-9116-4b31e712942e">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1583bfe6b33a4f04a6bafb359ac40353_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl85LTAtMS0xLTczMjUz_9a8281ff-10a3-4631-bee7-aafc3580815d">2.125% Senior Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1583bfe6b33a4f04a6bafb359ac40353_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl85LTItMS0xLTczMjUz_c87b8e02-a187-4a84-abf4-f763d8cb058a">ABBV29</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1583bfe6b33a4f04a6bafb359ac40353_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl85LTQtMS0xLTczMjUz_1d29d022-9105-40a6-9e10-1e57abb51a2e">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i13386ec6dca24c72873db6a581548a42_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8xMC0wLTEtMS03MzI1Mw_a479ec9e-a50f-40e9-a501-6ff6e3482b17">1.250% Senior Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i13386ec6dca24c72873db6a581548a42_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8xMC0yLTEtMS03MzI1Mw_bfb06978-daf0-431b-92c3-00a83b360f8c">ABBV31</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i13386ec6dca24c72873db6a581548a42_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGFibGU6MzM0N2JlMTdmYjcyNDI4NGE0NWNhNGViMmI5Y2M0YmIvdGFibGVyYW5nZTozMzQ3YmUxN2ZiNzI0Mjg0YTQ1Y2E0ZWIyYjljYzRiYl8xMC00LTEtMS03MzI1Mw_3e9f3fc9-c1b6-41d1-8abe-43faa975c980">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of April&#160;27, 2022, AbbVie Inc. had <ix:nonFraction unitRef="shares" contextRef="id0a62f89becf43099721dde7ba0ee70e_I20220427" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xL2ZyYWc6OGQwMjM0NjQ1ZWYzNDliZTliMDI3MDZmMzQzZGMxOGIvdGV4dHJlZ2lvbjo4ZDAyMzQ2NDVlZjM0OWJlOWIwMjcwNmYzNDNkYzE4Yl8yMDgy_b1d1ec92-c720-478f-9682-29ac6fd3428e">1,767,110,083</ix:nonFraction> shares of common stock at $0.01 par value outstanding.</span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_7"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AbbVie Inc. and Subsidiaries</span></div><div><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_10">PART&#160;I.</a></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_10">FINANCIAL INFORMATION</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_13">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_103">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_103">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_103">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_139">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_139">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_139">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_142">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_142">CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_142">34</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_145">PART&#160;II.</a></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_145">OTHER INFORMATION</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_148">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_148">LEGAL PROCEEDINGS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_148">35</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_154">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_154">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_154">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_157">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_157">EXHIBITS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic89f06320f9c4f57b19c511822f36cac_157">36</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><span><br/></span></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_10"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART&#160;I. FINANCIAL INFORMATION </span></div><div id="ic89f06320f9c4f57b19c511822f36cac_13"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 1.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div id="ic89f06320f9c4f57b19c511822f36cac_16"></div><div style="margin-top:3pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AbbVie Inc. and Subsidiaries</span></div><div><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Earnings (unaudited)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions,&#160;except&#160;per&#160;share&#160;data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMi02LTEtMS03MzI1Mw_1ea9b709-5d26-4b28-acff-0aa6a9ec0628">13,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMi04LTEtMS03MzI1Mw_4b97deba-9eb0-4c71-8642-87fe56902709">13,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfNC02LTEtMS03MzI1Mw_0e3cfa95-64c9-439f-833c-cee6ffe28ec1">4,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfNC04LTEtMS03MzI1Mw_f90c9b7c-8f49-4be2-8337-df4f9ad32195">4,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfNS02LTEtMS03MzI1Mw_0b4d8aeb-9abd-4b12-83aa-1f89fa80e23e">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfNS04LTEtMS03MzI1Mw_d2afea1c-2201-46c3-a71a-00af4157276f">2,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfNi02LTEtMS03MzI1Mw_1c6c7d79-ce85-42b0-ad22-b6d4f55bbc85">1,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfNi04LTEtMS03MzI1Mw_6f254e22-5077-4d46-99bc-6b2911d3f57e">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D and milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfNy02LTEtMS03MzI1Mw_d3a0d7fb-9152-4301-8443-63aaed03d1ad">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfNy04LTEtMS03MzI1Mw_7e528561-c68f-4dbe-901a-09717b6f8c00">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfOS02LTEtMS03MzI1Mw_b185af68-cdaa-4261-8c55-ee3a21ed6fcf">8,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfOS04LTEtMS03MzI1Mw_734845ad-3a60-4f5b-a735-53e2ddcdc639">8,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating earnings</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTAtNi0xLTEtNzMyNTM_1467b817-8a34-4c97-9d87-ca0e047b728b">4,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTAtOC0xLTEtNzMyNTM_e99e3278-993c-4ba8-b2e3-cfadb4935232">4,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTItNi0xLTEtNzMyNTM_6a7c802a-901b-4f40-abd8-43b850233992">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTItOC0xLTEtNzMyNTM_36520dd3-e193-4c95-a8ce-659eb6daadd7">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTMtNi0xLTEtNzMyNTM_c1f21e38-4ecf-47e9-874a-76d7d501bb15">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTMtOC0xLTEtNzMyNTM_0b60e52f-5e8a-4321-9e1c-3888166fa973">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTQtNi0xLTEtNzMyNTM_acc7a249-eb75-4719-a75a-c0ae616fb3a3">776</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTQtOC0xLTEtNzMyNTM_7e5b3a10-db2f-4675-941b-00eb2f86a320">395</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income tax expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTUtNi0xLTEtNzMyNTM_1f521ff4-023e-4eaf-bded-3fcdafd7ede9">4,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTUtOC0xLTEtNzMyNTM_8c73c419-b9bc-4dd2-853e-339e6de88808">3,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTYtNi0xLTEtNzMyNTM_b0f5ba17-1a9e-4ef1-87fa-0db943e2d278">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTYtOC0xLTEtNzMyNTM_7ae07da7-50da-4855-afbe-2180b417c635">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTctNi0xLTEtNzMyNTM_239139ca-22f5-433c-b154-acc1dc0bded7">4,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTctOC0xLTEtNzMyNTM_854a3453-e970-46c1-9e52-95b62ecc8d09">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTgtNi0xLTEtNzMyNTM_77571f51-7e99-4d81-9fdc-560a71c96392">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTgtOC0xLTEtNzMyNTM_70c73fe4-9bc3-408d-b6bd-d7ddf7505ce8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to AbbVie Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTktNi0xLTEtNzMyNTM_bfb43cdf-32f7-4e0d-b63e-47171420bef6">4,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMTktOC0xLTEtNzMyNTM_6c4acd5e-e989-4f09-a749-38b57b07efda">3,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per share data</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share attributable to AbbVie Inc.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMjItNi0xLTEtNzMyNTM_ab857fc3-1ff9-491c-8ca9-a8060de0b2e9">2.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMjItOC0xLTEtNzMyNTM_d28524c5-9263-460f-af48-6d9ae0a7c9bf">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share attributable to AbbVie Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMjMtNi0xLTEtNzMyNTM_16ff6acc-146c-4494-a4fc-4d3c84b333ff">2.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMjMtOC0xLTEtNzMyNTM_e0961706-c156-4b2f-b7ec-d9f9251858cf">1.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average basic shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMjUtNi0xLTEtNzMyNTM_687c5be5-79f3-497f-b91e-8e74a7c7c243">1,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMjUtOC0xLTEtNzMyNTM_8f078004-9a5f-4e3d-8f18-d13777b8ec11">1,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMjYtNi0xLTEtNzMyNTM_76fe9945-2acd-4f1a-ab58-3983957c3817">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xNi9mcmFnOjcyNzlmNmY4NGY5ZTQ4MmQ4NGFjMDk3NmYxZmIzNjQxL3RhYmxlOjA5MjQ1YjFhYTJlNzQwMThiYmE3MjlkMzE1ZDVjODg4L3RhYmxlcmFuZ2U6MDkyNDViMWFhMmU3NDAxOGJiYTcyOWQzMTVkNWM4ODhfMjYtOC0xLTEtNzMyNTM_c8689ae3-d5b2-405a-8476-08cfe2b24e06">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_19"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AbbVie Inc. and Subsidiaries <br/>Condensed Consolidated Statements of Comprehensive Income (unaudited)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.705%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfMi01LTEtMS03MzI1Mw_e5b2c256-f167-4f33-8e95-738b438d0570">4,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfMi03LTEtMS03MzI1Mw_be1af1e2-9883-4581-8b8a-f1a0da6396a5">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net of tax expense (benefit) of $(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNC0wLTEtMS03MzI1My90ZXh0cmVnaW9uOmY0ZjEzNDc2NGFjODRhNDY4MjVlYzM1Y2YzOTFkNDI5XzEwNw_0e846dd7-274a-4089-b863-d31d8f2c98aa">7</ix:nonFraction>) for the three months ended March 31, 2022 and $(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNC0wLTEtMS03MzI1My90ZXh0cmVnaW9uOmY0ZjEzNDc2NGFjODRhNDY4MjVlYzM1Y2YzOTFkNDI5XzE1Mw_e8cd5ec1-ebb7-4209-b2a8-99533efcf9bd">25</ix:nonFraction>) for the three months ended March 31, 2021</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNC01LTEtMS03MzI1Mw_70dc080a-cb1a-4be7-9da4-db67f848d276">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNC03LTEtMS03MzI1Mw_798de2e0-3719-4de0-9729-188832c55c4a">677</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedging activities, net of tax expense (benefit) of $<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="abbv:OtherComprehensiveIncomeLossNetInvestmentHedgeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNS0wLTEtMS03MzI1My90ZXh0cmVnaW9uOjc5NjA2MjQ4MWI1YjRiZTZiMDk4ZGY5MDNjZDRlYjBhXzk5_28b7d043-e650-41c7-abdc-8b87a4805830">37</ix:nonFraction> for the three months ended March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="abbv:OtherComprehensiveIncomeLossNetInvestmentHedgeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNS0wLTEtMS03MzI1My90ZXh0cmVnaW9uOjc5NjA2MjQ4MWI1YjRiZTZiMDk4ZGY5MDNjZDRlYjBhXzE0NQ_253583b1-c5bc-4253-9944-f64f2fdadb62">103</ix:nonFraction> for the three months ended March 31, 2021</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="abbv:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNS01LTEtMS03MzI1Mw_c28da181-5d2e-45a2-a8f1-0f25b9addd76">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="abbv:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNS03LTEtMS03MzI1Mw_460fa9c3-1937-4b51-bece-7d37d6569a4f">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and post-employment benefits, net of tax expense (benefit) of $<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNi0wLTEtMS03MzI1My90ZXh0cmVnaW9uOjBlYWRjMTdhNDExZjRmZTRiZjZiNGVkNWJmYWRlMGY4XzEwMg_b19e5138-7c00-4cbb-8bd5-261772be5129">10</ix:nonFraction> for the three months ended March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNi0wLTEtMS03MzI1My90ZXh0cmVnaW9uOjBlYWRjMTdhNDExZjRmZTRiZjZiNGVkNWJmYWRlMGY4XzE0OA_db083b78-e7b9-49d8-9922-8a67833437eb">19</ix:nonFraction> for the three months ended March 31, 2021</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNi01LTEtMS03MzI1Mw_0852afd1-ccfe-4252-9886-14736fcf8976">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfNi03LTEtMS03MzI1Mw_839e17bd-127f-45a0-95fd-bbf7094e3538">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedging activities, net of tax expense (benefit) of $(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfOC0wLTEtMS03MzI1My90ZXh0cmVnaW9uOjEyNTBlM2JlOTgxMzQ0NTRhZjZjYTMxOWY2NWNlYzZmXzk0_6a2f6c77-0238-427b-9d8b-d5577af7ac13">2</ix:nonFraction>) for the three months ended March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfOC0wLTEtMS03MzI1My90ZXh0cmVnaW9uOjEyNTBlM2JlOTgxMzQ0NTRhZjZjYTMxOWY2NWNlYzZmXzE0MA_a462e94e-e424-4670-b7fc-45d84569ddbf">3</ix:nonFraction> for the three months ended March 31, 2021</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfOC01LTEtMS03MzI1Mw_6a820093-efec-4899-828f-7fdd15f24551">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfOC03LTEtMS03MzI1Mw_935e7c51-bdde-4e95-83c0-c0146f465222">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfOS01LTEtMS03MzI1Mw_f6dcfc62-adad-4f8f-bcb6-3558f628f51a">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfOS03LTEtMS03MzI1Mw_feeeda83-1948-4a60-a8f9-36a6f0c79d29">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfMTAtNS0xLTEtNzMyNTM_24157632-c44b-4631-a557-d11439da975b">4,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfMTAtNy0xLTEtNzMyNTM_1a462c34-1e24-47d9-850d-2a2e6989b44a">3,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interest</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfMTEtNS0xLTEtNzMyNTM_5dce1ca9-b8d9-4882-b4f3-2605b8f24aff">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfMTEtNy0xLTEtNzMyNTM_3d3580d7-a0d5-40b6-8dbe-42311da99687">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to AbbVie Inc.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfMTItNS0xLTEtNzMyNTM_6e5ca759-4a06-45f5-bbd1-fa1646c07d62">4,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18xOS9mcmFnOmNlMTMyMzJhOTk3YTQ0ZGVhODgzNzY5NWQwMDQxZGYwL3RhYmxlOjNlOWQ3ZTkzYzJjNTRlNDJiYWVhMTEwZDllNjRiNjgwL3RhYmxlcmFuZ2U6M2U5ZDdlOTNjMmM1NGU0MmJhZWExMTBkOWU2NGI2ODBfMTItNy0xLTEtNzMyNTM_e9617d3d-9f0f-4fdf-8f35-6c8ef4799dda">3,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">2</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_25"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AbbVie Inc. and Subsidiaries <br/>Condensed Consolidated Balance Sheets</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions,&#160;except&#160;share&#160;data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, <br/>2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfNC0xLTEtMS03MzI1Mw_8316afbd-0055-4c3d-99a5-e010155aaa37">6,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfNC0zLTEtMS03MzI1Mw_c7bb1c16-dc87-4952-9e92-c2f45e4bb6b5">9,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfNS0xLTEtMS03MzI1Mw_f55401f6-4fa9-4e98-95df-89f3e3bc83a8">1,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfNS0zLTEtMS03MzI1Mw_5e828f2a-87f0-469d-9c13-91fd018493e5">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfNi0xLTEtMS03MzI1Mw_2bcfeecf-3789-4e26-a973-9c6c2658a108">10,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfNi0zLTEtMS03MzI1Mw_2b4ce90d-70d7-4989-afc3-4f90e371fbdc">9,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfNy0xLTEtMS03MzI1Mw_29b4a77b-473e-465a-b0c9-081b0a4eba6e">3,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfNy0zLTEtMS03MzI1Mw_336e1585-f647-4135-aa66-bb15a4e0bbdf">3,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfOC0xLTEtMS03MzI1Mw_ff7bcbee-26af-419d-8d26-baa81fbde169">4,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfOC0zLTEtMS03MzI1Mw_ee90aee1-a3ae-4e46-823a-3c06a7f3ca20">4,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfOS0xLTEtMS03MzI1Mw_fb6d43af-a2f0-4a67-9884-633a821be8e8">26,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfOS0zLTEtMS03MzI1Mw_6fd61afb-3843-4a12-943e-1d756adf94c0">27,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTEtMS0xLTEtNzMyNTM_577f6504-c098-48c1-84aa-a9f1f8969df4">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTEtMy0xLTEtNzMyNTM_f9a6a77b-8b60-4c52-a7a3-5b0ae0f7f11e">277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTItMS0xLTEtNzMyNTM_9aa46c53-8aeb-4d3f-afab-9b3add98115e">5,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTItMy0xLTEtNzMyNTM_3f320dc6-b648-4487-87a5-01d6dc5a90b8">5,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTMtMS0xLTEtNzMyNTM_12f3abf4-3aa8-4001-9ffb-9fc27ef4d9a9">73,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTMtMy0xLTEtNzMyNTM_b02db59f-6e3a-4556-b9ff-d2b09ac647ba">75,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTQtMS0xLTEtNzMyNTM_2a97da31-2b0d-46d9-996f-0104083b6bf8">32,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTQtMy0xLTEtNzMyNTM_ad014b88-7067-4de3-ad88-f10d9adaf706">32,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTUtMS0xLTEtNzMyNTM_7276a1d9-fd14-4b76-8dc5-85ec01985fe7">5,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTUtMy0xLTEtNzMyNTM_c7b38354-52cd-4db4-9907-709933592e41">4,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTYtMS0xLTEtNzMyNTM_f6a09ef9-8206-4732-bedd-3d809ab7963e">143,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMTYtMy0xLTEtNzMyNTM_a001d42f-4558-4178-9c9e-d90d688e63bd">146,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjAtMS0xLTEtNzMyNTM_cdb0d5e4-dd17-41c6-a5fe-1e442f01b801">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjAtMy0xLTEtNzMyNTM_e5948576-9323-4dd7-9f12-b48d5f81ecd9">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjEtMS0xLTEtNzMyNTM_bf7b5f59-e58f-4f6b-b883-f4d8aba42b9d">9,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjEtMy0xLTEtNzMyNTM_debd17ca-d32f-4d74-85c0-ccc529b81577">12,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjItMS0xLTEtNzMyNTM_40d9b68d-fdc6-4b5c-bbdc-46cac91adbbe">22,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjItMy0xLTEtNzMyNTM_0af3c78a-bbf1-4a62-a0c3-5713db4ed2d9">22,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjMtMS0xLTEtNzMyNTM_7ffdfa42-c4a5-4704-96d2-83b25cc0903b">32,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjMtMy0xLTEtNzMyNTM_5a3708a9-f49b-4e0a-9b2e-d08efb2a8ca5">35,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjUtMS0xLTEtNzMyNTM_9c4c2dd7-5762-44e2-89ad-08b575e671e3">63,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjUtMy0xLTEtNzMyNTM_c7c9256b-c501-4435-a50e-0f395bcfd1a5">64,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjYtMS0xLTEtNzMyNTM_3f2284c9-a0db-4395-bfcc-cf81b1ded318">2,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjYtMy0xLTEtNzMyNTM_4d94ecc1-56f6-44ed-ad7c-a72d0eb78f55">3,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjctMS0xLTEtNzMyNTM_7da6ae52-9067-4f9a-87e5-4bcdf39b3427">28,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjctMy0xLTEtNzMyNTM_f0acfb25-cd5d-4f26-80d5-430906517810">28,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjktMS0xLTEtNzMyNTM_b7cc857a-2e48-437e-8700-e89c51f10679"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMjktMy0xLTEtNzMyNTM_46d390b3-d484-40ff-8706-02a079aeb14e"></ix:nonFraction></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzItMC0xLTEtNzMyNTMvdGV4dHJlZ2lvbjoyZDAxYzUwMTQ5NWU0N2EwOTMxMzhhNGQ3ZDMyZGEyMF8xOA_4192cf9d-b0c4-4622-9745-11eae8ef4759"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzItMC0xLTEtNzMyNTMvdGV4dHJlZ2lvbjoyZDAxYzUwMTQ5NWU0N2EwOTMxMzhhNGQ3ZDMyZGEyMF8xOA_4e098e9d-d53d-40c8-b76b-dd94c11fbf57">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzItMC0xLTEtNzMyNTMvdGV4dHJlZ2lvbjoyZDAxYzUwMTQ5NWU0N2EwOTMxMzhhNGQ3ZDMyZGEyMF8zMg_b9ab60b0-d780-4de6-ada4-7f93ab3321ae"><ix:nonFraction unitRef="shares" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzItMC0xLTEtNzMyNTMvdGV4dHJlZ2lvbjoyZDAxYzUwMTQ5NWU0N2EwOTMxMzhhNGQ3ZDMyZGEyMF8zMg_ef34f7b1-6918-4e43-a813-143bb323a9f8">4,000,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzItMC0xLTEtNzMyNTMvdGV4dHJlZ2lvbjoyZDAxYzUwMTQ5NWU0N2EwOTMxMzhhNGQ3ZDMyZGEyMF81NA_c9fda24d-a086-40d8-9a30-97b9fe940fbc">1,811,430,573</ix:nonFraction> shares issued as of March 31, 2022 and <ix:nonFraction unitRef="shares" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzItMC0xLTEtNzMyNTMvdGV4dHJlZ2lvbjoyZDAxYzUwMTQ5NWU0N2EwOTMxMzhhNGQ3ZDMyZGEyMF84NA_43126ee0-8b34-4cb1-97d7-700f5f566268">1,803,195,293</ix:nonFraction> as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzItMS0xLTEtNzMyNTM_30decaaa-1042-458c-9472-71972581017c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzItMy0xLTEtNzMyNTM_fd93f7a8-8003-493a-a5c0-8d78f9a74f6f">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in treasury, at cost, <ix:nonFraction unitRef="shares" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzMtMC0xLTEtNzMyNTMvdGV4dHJlZ2lvbjo3NDRjY2QyZDExZmM0YzZiODhjZTY4YmZmZWNjNmM3M180NA_a7af0163-b2bc-45b7-987e-761a2c523fc0">44,557,588</ix:nonFraction> shares as of March 31, 2022 and <ix:nonFraction unitRef="shares" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzMtMC0xLTEtNzMyNTMvdGV4dHJlZ2lvbjo3NDRjY2QyZDExZmM0YzZiODhjZTY4YmZmZWNjNmM3M182Nw_fdb31461-60c4-4d48-8d8f-3564908ff517">34,857,597</ix:nonFraction> as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzMtMS0xLTEtNzMyNTM_16c9c040-13b4-4a58-91c9-c1ff7a491b1a">4,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzMtMy0xLTEtNzMyNTM_675da50a-8420-45f7-9dad-49681f47988c">3,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzQtMS0xLTEtNzMyNTM_feef771f-e97c-4ff1-9232-a04e8ece4d2b">18,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzQtMy0xLTEtNzMyNTM_9a64322d-f228-4983-a3f6-58f39b449338">18,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzUtMS0xLTEtNzMyNTM_bd1f6aaa-99ca-4378-a659-cd8daa2ee3bf">5,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzUtMy0xLTEtNzMyNTM_7c896c57-af7c-47cf-80b5-5272dfbe65ee">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzYtMS0xLTEtNzMyNTM_5e9510fd-55ea-4f18-afb9-9c3249690d69">2,984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzYtMy0xLTEtNzMyNTM_2e995146-6538-4980-b3e7-fd84bde81ff7">2,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzctMS0xLTEtNzMyNTM_158bc989-3081-4f29-aa6f-ff9d8e724f49">16,283</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzctMy0xLTEtNzMyNTM_00c22fde-92b6-44d3-b824-f0e8d2d79272">15,408</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzgtMS0xLTEtNzMyNTM_0d003326-ecad-4636-97ed-54f47ff09c9e">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzgtMy0xLTEtNzMyNTM_8fbcae41-80fc-47dc-8a87-8e504966dcc5">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzktMS0xLTEtNzMyNTM_a3831806-59a8-46d4-aff1-d4f97354fd48">16,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfMzktMy0xLTEtNzMyNTM_08e93e0d-2e5d-40d3-9a8a-e74aa115c9e9">15,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfNDEtMS0xLTEtNzMyNTM_be55db18-1083-4f82-9356-f7f1dc2ca093">143,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yNS9mcmFnOjc2MjJlNGFlYjUzNjRhZGU5NTI4NjgwMmRkYTdkNzM2L3RhYmxlOjEzMWEyOTMyMWFmYjRiNGI4MjNiYjI5ZWEyODMyYjI5L3RhYmxlcmFuZ2U6MTMxYTI5MzIxYWZiNGI0YjgyM2JiMjllYTI4MzJiMjlfNDEtMy0xLTEtNzMyNTM_882253d4-b2f6-479f-93b7-d31f76b08de1">146,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">3</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_28"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AbbVie Inc. and Subsidiaries <br/>Condensed Consolidated Statements of Equity (unaudited)</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.129%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common shares outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a942c6b68a54ff3b7a44fe6b3def08c_I20201231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMS0xLTEtMS03MzI1Mw_a4e678fd-0fad-4b0a-8413-cfd8c6824a79">1,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a942c6b68a54ff3b7a44fe6b3def08c_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMS0zLTEtMS03MzI1Mw_eade0620-819d-497f-8b8b-235d0827cf4b">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cb1995fa5b74df58173afb77b7e467f_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMS01LTEtMS03MzI1Mw_a1531eaf-73dd-42f3-9899-c939dc89889a">2,264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66fe2db515c241c0bb28d212b85279e9_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMS03LTEtMS03MzI1Mw_c66359e6-ed8b-4687-a8a9-6b6a164e9639">17,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6e8e05625504d9a944f9bade3f3867c_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMS05LTEtMS03MzI1Mw_8f125517-2455-4832-886c-9c99082220dc">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf1feacb1a194c1d9816daa1d27870c0_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMS0xMS0xLTEtNzMyNTM_06f3d593-702a-4709-bd16-4a9d64b3ceb5">3,117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia427e86aee794ddda12fc9e121da41f0_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMS0xMy0xLTEtNzMyNTM_25a73e1d-0ab5-4acb-bc6f-15796538cc3c">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6accb844205d4e909ea7d6f406d2b865_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMS0xNS0xLTEtNzMyNTM_f4db4082-b34c-490d-9bfa-e37c4162a515">13,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to AbbVie Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd6e7e0203e48078669ad3bde0d5c7d_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMy0zLTEtMS03MzI1Mw_e3ca5fc4-33e6-43ee-8694-f3b00c8c9248">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d02525654584e2f9f785b90b9913777_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMy01LTEtMS03MzI1Mw_c2c84dbb-ec30-4696-b32a-899d1ec4a593">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063a456449f745c98a09be163769f332_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMy03LTEtMS03MzI1Mw_0ab4ac65-6821-4db5-8beb-11159ec2440a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0872c55f62b455494f25c4d7b92ca72_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMy05LTEtMS03MzI1Mw_e62b6e3f-af5b-4abe-90ae-f8d39ba88c01">3,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022758431fdb43f8b4df8421bb21711f_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMy0xMS0xLTEtNzMyNTM_03d8de3b-6caf-4de8-bcf8-9c33389075c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3f47fb5c714936a77899d22ef47d49_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMy0xMy0xLTEtNzMyNTM_9718d6c0-7f11-406d-94b0-d01b4e84ce92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMy0xNS0xLTEtNzMyNTM_d4b21536-dc85-46e8-b4e9-9a7359cb3dfb">3,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd6e7e0203e48078669ad3bde0d5c7d_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNC0zLTEtMS03MzI1Mw_d106b131-32ad-4b49-a371-66d433850860">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d02525654584e2f9f785b90b9913777_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNC01LTEtMS03MzI1Mw_3803510e-9c05-4f25-98a5-932e352babdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063a456449f745c98a09be163769f332_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNC03LTEtMS03MzI1Mw_6aa53c1e-97ad-486e-a6bc-d5e8c975cb45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0872c55f62b455494f25c4d7b92ca72_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNC05LTEtMS03MzI1Mw_9d551ec7-48d1-4c32-a2f6-5f21be130c09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i022758431fdb43f8b4df8421bb21711f_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNC0xMS0xLTEtNzMyNTM_9cff0b71-47c8-4067-ad5f-53443a4474a9">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3f47fb5c714936a77899d22ef47d49_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNC0xMy0xLTEtNzMyNTM_80afaaa9-da24-445a-91e5-39658f42dcb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNC0xNS0xLTEtNzMyNTM_ce54ce16-b4b1-4bc2-ac41-ea5e7e6a8a38">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd6e7e0203e48078669ad3bde0d5c7d_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNS0zLTEtMS03MzI1Mw_7fc90b72-38c2-41a8-a7d6-3019859cdb2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d02525654584e2f9f785b90b9913777_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNS01LTEtMS03MzI1Mw_d346eda7-92e2-4c48-b301-6067081462da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063a456449f745c98a09be163769f332_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNS03LTEtMS03MzI1Mw_7467ac60-2df8-4f16-a27f-9caa994a1a65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0872c55f62b455494f25c4d7b92ca72_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNS05LTEtMS03MzI1Mw_f190210a-0aff-4be3-a9f2-1d201350851c">2,316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022758431fdb43f8b4df8421bb21711f_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNS0xMS0xLTEtNzMyNTM_a6d63676-8397-4e0c-8eb1-68cfe500b5de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3f47fb5c714936a77899d22ef47d49_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNS0xMy0xLTEtNzMyNTM_e34905a4-6ef4-44f6-8794-cc9e9baa5cd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNS0xNS0xLTEtNzMyNTM_746de55a-9e98-4f32-ad84-b9e432db5f1a">2,316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0bd6e7e0203e48078669ad3bde0d5c7d_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNy0xLTEtMS03MzI1Mw_15b11053-6051-4d37-a47e-95a213c3ceac">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd6e7e0203e48078669ad3bde0d5c7d_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNy0zLTEtMS03MzI1Mw_b3942fac-0ca4-4fb0-b005-aca875bc62f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d02525654584e2f9f785b90b9913777_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNy01LTEtMS03MzI1Mw_f9009a91-65c6-4b4d-b61b-c4180f4f2f89">787</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063a456449f745c98a09be163769f332_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNy03LTEtMS03MzI1Mw_efceb515-9162-4059-958e-9fc4c8e99056">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0872c55f62b455494f25c4d7b92ca72_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNy05LTEtMS03MzI1Mw_65bf7f11-6ed7-4ef5-90ba-dc439addaec7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022758431fdb43f8b4df8421bb21711f_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNy0xMS0xLTEtNzMyNTM_c6aff273-6307-475a-9f96-434511770e6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3f47fb5c714936a77899d22ef47d49_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNy0xMy0xLTEtNzMyNTM_96824b9a-cd23-4835-ab9b-011195a2b95b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfNy0xNS0xLTEtNzMyNTM_7c69a985-9883-4612-88d1-816f05834349">787</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation plans and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bd6e7e0203e48078669ad3bde0d5c7d_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOC0xLTEtMS03MzI1Mw_a0136286-474e-4081-a5ab-badd1abfba22">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd6e7e0203e48078669ad3bde0d5c7d_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOC0zLTEtMS03MzI1Mw_2ccc3523-3b6f-4741-8b6e-211a231fc25f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d02525654584e2f9f785b90b9913777_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOC01LTEtMS03MzI1Mw_d7f1e694-e3ad-4ad8-be59-36f054648aba">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063a456449f745c98a09be163769f332_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOC03LTEtMS03MzI1Mw_409986ed-d574-406d-8fe2-a02fc5f386bb">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0872c55f62b455494f25c4d7b92ca72_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOC05LTEtMS03MzI1Mw_25aa6a27-c9fa-44b4-aa39-8e84a54243a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022758431fdb43f8b4df8421bb21711f_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOC0xMS0xLTEtNzMyNTM_5849e305-8e2e-4e19-9552-f01262642d18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3f47fb5c714936a77899d22ef47d49_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOC0xMy0xLTEtNzMyNTM_82799e9e-4c0a-4550-a4cf-adcef910e6ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOC0xNS0xLTEtNzMyNTM_cf38aadc-e321-40e7-ba16-7f79839d01d4">362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd6e7e0203e48078669ad3bde0d5c7d_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOS0zLTEtMS03MzI1Mw_322023ed-466c-4034-bc7c-6c1f0c4e820c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d02525654584e2f9f785b90b9913777_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOS01LTEtMS03MzI1Mw_f7adb831-1985-49dc-b801-868806d48470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063a456449f745c98a09be163769f332_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOS03LTEtMS03MzI1Mw_c702255e-291f-417b-bc1c-b0d32612a5a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0872c55f62b455494f25c4d7b92ca72_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOS05LTEtMS03MzI1Mw_f188eeea-96eb-4b51-88be-d2b90889ea8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022758431fdb43f8b4df8421bb21711f_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOS0xMS0xLTEtNzMyNTM_2ca9d987-0ba0-48cb-9a58-3dcfa880a9e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3f47fb5c714936a77899d22ef47d49_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOS0xMy0xLTEtNzMyNTM_c90411aa-2729-48ea-b68a-3b3bf2aef917">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfOS0xNS0xLTEtNzMyNTM_f1636c9c-b96c-46b3-92f6-6693e9416e01">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id5cf8db55503473d9dd1af8c0d20c48d_I20210331" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTAtMS0xLTEtNzMyNTM_d48e582b-efd4-4d6b-b9f1-a458b77ab3e5">1,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5cf8db55503473d9dd1af8c0d20c48d_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTAtMy0xLTEtNzMyNTM_b61e1786-bc17-43be-82dd-b94aa55dc2aa">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6e9540820e34b43b3e6ec3daddaa1fc_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTAtNS0xLTEtNzMyNTM_25baf1e2-16ae-4cad-be54-7eed037f54ac">3,017</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f9dace7c91d4297a7aa7f308de3f768_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTAtNy0xLTEtNzMyNTM_328c177d-be71-4be0-afbe-8cbb50b4ee5e">17,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a3023971ae049339d5747605ef52a7c_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTAtOS0xLTEtNzMyNTM_fb922321-bb0d-4206-a01a-1662090d3849">2,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i980dca056e914f6385bbf2d1f0a5c20b_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTAtMTEtMS0xLTczMjUz_0d7e6e64-3966-40bc-b196-44d53724420f">3,295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab26cb86a14c46ba9fa64e4b951dfaea_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTAtMTMtMS0xLTczMjUz_696629ae-f3dc-4c3a-a835-b810e51ca727">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf70c299b6747128fa4a148bd06c306_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTAtMTUtMS0xLTczMjUz_5c057a5d-ba73-470e-97c4-2607fd9837fc">13,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide7dd1b7a2964e66b89583f5e940f748_I20211231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTItMS0xLTEtNzMyNTM_da3a1010-a611-4017-bbb8-623c94357ade">1,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7dd1b7a2964e66b89583f5e940f748_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTItMy0xLTEtNzMyNTM_51afcea6-ff15-4089-bcee-25b2537c5745">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d21af462c442b5beb00d3ba5c34925_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTItNS0xLTEtNzMyNTM_bfd49c81-dceb-4158-9311-b35ca26d7b27">3,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a07265e199d4b30a14e9e6383620f9f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTItNy0xLTEtNzMyNTM_538f06fa-3050-4356-808e-888038c7394c">18,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1929ee5ab0f4e8c9347283529630a9c_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTItOS0xLTEtNzMyNTM_62ceaf8b-4cea-4d16-b7b3-f11e149f71e6">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e9ff1d5c2f242d3acc07bc91dffb247_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTItMTEtMS0xLTczMjUz_9b0e8bbd-2b5b-4bfe-aec5-14145f58bada">2,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa789cc1b9f041559e83b047a68991b0_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTItMTMtMS0xLTczMjUz_9f17bc8d-9316-4059-9bda-768cda811235">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTItMTUtMS0xLTczMjUz_865bc644-144b-48d7-99ff-fb4fb572d3e7">15,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to AbbVie Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029e4a4f41224ff9bf2006f28fa206ae_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTQtMy0xLTEtNzMyNTM_273ced71-9467-46de-86c8-e2fab61a9d76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21ccd46654948208d4f049707193b17_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTQtNS0xLTEtNzMyNTM_9ebae2e7-d981-4dd9-bb4e-ab3c751d8a41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31fbe96bedc549d2b2b83439135cb5b0_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTQtNy0xLTEtNzMyNTM_67e12320-2564-43a4-939d-c4faf061373c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb84aa68550418ebde877bd62bbcda0_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTQtOS0xLTEtNzMyNTM_fe2a59e8-2a83-4f77-a06b-211ffcb2b53d">4,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbe238f3894a0eb179d09b47890654_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTQtMTEtMS0xLTczMjUz_f6864b29-4af3-4328-b714-c92a37f32812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1baefcb501194b7fb536593a1a2bd9ea_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTQtMTMtMS0xLTczMjUz_327c0758-ecd0-441d-93ed-270cb4d2f2b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTQtMTUtMS0xLTczMjUz_baf6d876-3005-431b-8879-5a5b177e16da">4,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029e4a4f41224ff9bf2006f28fa206ae_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTUtMy0xLTEtNzMyNTM_175f1a05-7523-48dc-b7bf-4a6bcb3bc39d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21ccd46654948208d4f049707193b17_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTUtNS0xLTEtNzMyNTM_ac137a3f-510e-4042-97b5-79f74940dc32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31fbe96bedc549d2b2b83439135cb5b0_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTUtNy0xLTEtNzMyNTM_66a804aa-7f33-4065-9ebb-a20e9508b300">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb84aa68550418ebde877bd62bbcda0_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTUtOS0xLTEtNzMyNTM_a6bfc348-841a-47c7-b05a-1f9bfe166245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76fbe238f3894a0eb179d09b47890654_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTUtMTEtMS0xLTczMjUz_ebe5b4bc-c79b-442c-b8d6-2f0e9eefe083">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1baefcb501194b7fb536593a1a2bd9ea_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTUtMTMtMS0xLTczMjUz_29706705-791a-40cb-9dba-ed39b3526bd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTUtMTUtMS0xLTczMjUz_459a3c18-a423-4bbc-8efb-de606714fd9a">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029e4a4f41224ff9bf2006f28fa206ae_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTYtMy0xLTEtNzMyNTM_d35498b5-f165-4c9d-b295-4c3f30a3167e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21ccd46654948208d4f049707193b17_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTYtNS0xLTEtNzMyNTM_1bef22c7-0bc7-4673-8bc6-85580b812d86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31fbe96bedc549d2b2b83439135cb5b0_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTYtNy0xLTEtNzMyNTM_5358e67f-e6b7-473b-b66f-955be4bc964a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4eb84aa68550418ebde877bd62bbcda0_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTYtOS0xLTEtNzMyNTM_ecdbcdc3-64a4-497b-b222-bc257030ed12">2,514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbe238f3894a0eb179d09b47890654_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTYtMTEtMS0xLTczMjUz_6374ec5f-a03d-4f9f-9af8-14437b675659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1baefcb501194b7fb536593a1a2bd9ea_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTYtMTMtMS0xLTczMjUz_f5f5f25a-9def-42ee-920e-b57309c416b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTYtMTUtMS0xLTczMjUz_5d14d7e8-343b-4e31-8a26-7abd7c5ba276">2,514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i029e4a4f41224ff9bf2006f28fa206ae_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTgtMS0xLTEtNzMyNTM_c9c9f3f9-cdab-4428-86cf-a913664654da">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029e4a4f41224ff9bf2006f28fa206ae_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTgtMy0xLTEtNzMyNTM_37bc470c-91a5-45c8-8a5e-50be070efdb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie21ccd46654948208d4f049707193b17_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTgtNS0xLTEtNzMyNTM_69cba8ce-8a54-4196-bca9-0bdd605c3a4c">1,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31fbe96bedc549d2b2b83439135cb5b0_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTgtNy0xLTEtNzMyNTM_206ae1ec-81ef-40eb-8700-5b8a4bd78a1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb84aa68550418ebde877bd62bbcda0_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTgtOS0xLTEtNzMyNTM_5fdb6129-d991-4f98-956a-e48ff8c9dc35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbe238f3894a0eb179d09b47890654_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTgtMTEtMS0xLTczMjUz_edec7525-92d0-4218-813c-fd0422d33a5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1baefcb501194b7fb536593a1a2bd9ea_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTgtMTMtMS0xLTczMjUz_c2c8a2c7-65a7-4c4a-9a4a-c1574f0e3937">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTgtMTUtMS0xLTczMjUz_0e503333-a9e0-4e27-9c88-b200ba646777">1,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation plans and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i029e4a4f41224ff9bf2006f28fa206ae_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTktMS0xLTEtNzMyNTM_053f23d8-32e5-4ac3-99bd-0529b34ebf41">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029e4a4f41224ff9bf2006f28fa206ae_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTktMy0xLTEtNzMyNTM_8cc64268-f982-4e60-a8f7-fad4732574da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21ccd46654948208d4f049707193b17_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTktNS0xLTEtNzMyNTM_66ab5441-b1da-467e-8e06-ec7487282db8">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31fbe96bedc549d2b2b83439135cb5b0_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTktNy0xLTEtNzMyNTM_a90a8739-2ed1-4ab1-bb96-00e721bcd277">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb84aa68550418ebde877bd62bbcda0_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTktOS0xLTEtNzMyNTM_866ddb76-ccdb-46b8-ae27-b1ed350ae68d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbe238f3894a0eb179d09b47890654_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTktMTEtMS0xLTczMjUz_8cce41e4-0f7c-4c57-8875-e314714860dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1baefcb501194b7fb536593a1a2bd9ea_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTktMTMtMS0xLTczMjUz_dbedeb4e-1d69-4915-a355-eb5c1b123888">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMTktMTUtMS0xLTczMjUz_326f6111-0cb8-474e-9c7a-e53cff81fcc1">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029e4a4f41224ff9bf2006f28fa206ae_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjAtMy0xLTEtNzMyNTM_71c072a2-a059-454c-b5ea-f71cbb6d68be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21ccd46654948208d4f049707193b17_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjAtNS0xLTEtNzMyNTM_264d7459-698b-4fcf-ab18-75684d5d0036">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31fbe96bedc549d2b2b83439135cb5b0_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjAtNy0xLTEtNzMyNTM_b940dc32-e641-4d8d-9088-b89b96ee8324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb84aa68550418ebde877bd62bbcda0_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjAtOS0xLTEtNzMyNTM_8b531163-b2b3-4fa4-bce4-98bb7a3d379a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbe238f3894a0eb179d09b47890654_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjAtMTEtMS0xLTczMjUz_ecd0b491-8b9d-4a99-b6c2-608aaf4da37d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1baefcb501194b7fb536593a1a2bd9ea_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjAtMTMtMS0xLTczMjUz_7a79126a-5533-4d55-9ab8-975a5d1313cd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjAtMTUtMS0xLTczMjUz_283d44e7-60fd-4e7e-b4d4-15c33c1c1307">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i87b37cb73f2d4eacace3c00d60098061_I20220331" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjEtMS0xLTEtNzMyNTM_cc613c29-90c3-4464-b4bd-73c7f5f5e140">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b37cb73f2d4eacace3c00d60098061_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjEtMy0xLTEtNzMyNTM_b8e6e5a4-bdc9-4405-bca3-3533e34f4f42">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207acaa2165d403396ea05f332f5d280_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjEtNS0xLTEtNzMyNTM_fe3686c5-8730-4487-9368-d30720928570">4,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib201ee2f6aa040aa994d36824861b99b_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjEtNy0xLTEtNzMyNTM_4cbf1be5-b2f4-42f1-bd07-22401cd197a2">18,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c2a9dc2507491cbed7bcc6382ac0bd_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjEtOS0xLTEtNzMyNTM_97872696-f488-45d0-ba00-6b4ad7175a43">5,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedf65e4946d940d7b337ee6ad83e0838_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjEtMTEtMS0xLTczMjUz_fc9e702b-f530-4dcb-9206-48159e14a476">2,984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613f449aeb814d5eb9f9f5433bf45c4b_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjEtMTMtMS0xLTczMjUz_9ac8621b-1b99-4b62-a123-8063eee1ce10">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18yOC9mcmFnOjAwYzE2ZWNlNjBjYTQ3OTU4YmI2NjEzM2JiOTUxMWViL3RhYmxlOjVlMjIxODc1ZDgyMTRkZDNhMTgwZTQ4NWJkYTRiY2YzL3RhYmxlcmFuZ2U6NWUyMjE4NzVkODIxNGRkM2ExODBlNDg1YmRhNGJjZjNfMjEtMTUtMS0xLTczMjUz_d7af235b-cfd1-405e-8afe-526f41f6a11f">16,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">4</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_31"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AbbVie Inc. and Subsidiaries<br/>Condensed Consolidated Statements of Cash Flows (unaudited)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)&#160;(brackets&#160;denote&#160;cash&#160;outflows)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMy0xLTEtMS03MzI1Mw_80fac078-8b32-4c80-b927-2dc88edd69e2">4,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMy0zLTEtMS03MzI1Mw_d500c637-edf9-44ed-950c-68e7039183e0">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash from operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNS0xLTEtMS03MzI1Mw_24e88413-589b-4601-87b4-f383d75059bf">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNS0zLTEtMS03MzI1Mw_402ad0c7-3ab4-49c3-9a1e-42a4d9c21c06">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNi0xLTEtMS03MzI1Mw_b6f1d8a2-661b-49ce-9ca2-40c1658f2c75">1,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNi0zLTEtMS03MzI1Mw_2ae0780e-9ef5-4e68-b832-f4ab427bc96d">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNy0xLTEtMS03MzI1Mw_afe54c23-7efd-4a8a-ae0d-6941f1e8fed0">194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNy0zLTEtMS03MzI1Mw_f53d41e3-7463-4a58-95ad-07203cbdccc5">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfOC0xLTEtMS03MzI1Mw_2d5cf9e2-3f0f-42fa-a775-c11df713c463">748</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfOC0zLTEtMS03MzI1Mw_60c08583-37e0-4373-95be-5294b7400718">343</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfOS0xLTEtMS03MzI1Mw_c351812c-92d9-4643-9463-79416bd215e4">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfOS0zLTEtMS03MzI1Mw_eee48a5d-5d55-462e-a87c-436e7bb9d994">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D and milestones</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTAtMS0xLTEtNzMyNTM_5b5af473-f834-4897-9df3-4243c280a524">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTAtMy0xLTEtNzMyNTM_103b95d9-565a-4aa4-85ce-109ea9a96a99">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTQtMS0xLTEtNzMyNTM_f38ff337-003c-4ee4-a3e0-10b605a131b0">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTQtMy0xLTEtNzMyNTM_f83a0448-0a46-4991-8f25-8ccc17145c6b">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTYtMS0xLTEtNzMyNTM_beca9c04-a98b-461a-b2e4-a78761a13587">785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTYtMy0xLTEtNzMyNTM_0528fe90-cf4c-4a9d-8865-74aaec303d09">866</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTctMS0xLTEtNzMyNTM_c2f506d5-d282-473d-b6fe-fd4e00a76463">385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTctMy0xLTEtNzMyNTM_3fdcec7f-e492-4ae9-8ad7-585eff445445">187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTgtMS0xLTEtNzMyNTM_e00d50e6-cd69-4dbd-ad82-f3ea7101901c">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTgtMy0xLTEtNzMyNTM_f2903eae-8617-4a3e-8863-f79d2ee5ac9d">330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTktMS0xLTEtNzMyNTM_c8d318ca-6a71-4359-85ac-1da0811e1fee">258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMTktMy0xLTEtNzMyNTM_c28ed7cc-697d-450d-b997-a6fcd587d474">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax assets and liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjAtMS0xLTEtNzMyNTM_ed1ac336-279d-4f7d-8215-f465939cc486">438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjAtMy0xLTEtNzMyNTM_93690c4d-33d9-43f7-8b32-5a56aed5d3ff">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjEtMS0xLTEtNzMyNTM_c080bcc5-a3c7-4b09-ad50-96d15c4cf7ea">4,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjEtMy0xLTEtNzMyNTM_8e3fa2e8-f809-41a5-ac21-073b95f6b1c0">4,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjUtMS0xLTEtNzMyNTM_47c8edbb-989c-43aa-8243-12cc47110b50">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjUtMy0xLTEtNzMyNTM_87b82f96-3f08-4058-83a6-07cdffe36f8e">198</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjYtMS0xLTEtNzMyNTM_76da0d84-ce07-4933-90ab-36feec3b493b">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjYtMy0xLTEtNzMyNTM_f75c6bb1-4091-420b-a2c3-c4a2bd1b8191">188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjctMS0xLTEtNzMyNTM_39eff751-a0ab-45ee-a1f6-8dbf22910720">1,406</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjctMy0xLTEtNzMyNTM_df0f7ad2-7a21-4e5c-a0cb-36233c36684d">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjgtMS0xLTEtNzMyNTM_1d91aac2-1f44-4648-8a82-d23d28cfb3ce">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMjgtMy0xLTEtNzMyNTM_9cf3f9c9-1f5f-43f5-a035-ea10d814879c">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMzAtMS0xLTEtNzMyNTM_d7bdefaf-3413-4363-9357-b0956913b877">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMzAtMy0xLTEtNzMyNTM_6647c99c-aa07-4681-b47e-8a7a59d26c12">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMzEtMS0xLTEtNzMyNTM_e87c3884-7c44-437f-b474-0bc0528c238a">1,591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMzEtMy0xLTEtNzMyNTM_8a85eb77-b547-4add-b2e4-fba617944fef">342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMzctMS0xLTEtNzMyNTM_1668d5ac-759b-42cf-8d60-3630badbb4d1">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMzgtMS0xLTEtNzMyNTM_925d98f6-e312-42b2-b988-4bf7b6b3ca3f">4,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfMzgtMy0xLTEtNzMyNTM_fe6fef50-6172-452a-b0e6-f38129103e97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDAtMS0xLTEtNzMyNTM_c61925d8-4571-48bc-b518-cbd4952c3b53">2,526</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDAtMy0xLTEtNzMyNTM_18174dac-bd1c-4579-848f-63f5d711a0b3">2,322</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDEtMS0xLTEtNzMyNTM_8cdc5087-70d9-459d-b9b9-e84609070fbe">1,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDEtMy0xLTEtNzMyNTM_90c389bf-c744-47fb-b1db-4cda6953aca6">787</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDItMS0xLTEtNzMyNTM_721487df-8550-42d9-80c6-9dbebb835857">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDItMy0xLTEtNzMyNTM_89433244-e5dc-441e-830a-fb0fe92daba8">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDMtMS0xLTEtNzMyNTM_31fa4d18-090b-457f-b8c5-a6e8ee0e140d">246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDMtMy0xLTEtNzMyNTM_584c8981-5fd9-44f7-9789-9beeab833625">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDQtMS0xLTEtNzMyNTM_21725076-fb18-4bdb-a719-086edb5695bc">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDQtMy0xLTEtNzMyNTM_e96bd76f-24ba-4bea-9fef-42cb0452e9fe">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDUtMS0xLTEtNzMyNTM_a905dc6c-5f2c-426d-8a2f-fcb2e9f75eda">6,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDUtMy0xLTEtNzMyNTM_7aa33fb4-c3a8-4fd6-af39-13183ed1aea9">3,174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDYtMS0xLTEtNzMyNTM_96c7074f-1a3b-4977-bee1-51e3a67cae9b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDYtMy0xLTEtNzMyNTM_e8efbf01-768f-4bfe-95a8-6daa21523d46">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDctMS0xLTEtNzMyNTM_fba706d6-643c-45ca-ac30-2b9689cecb33">3,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDctMy0xLTEtNzMyNTM_c1c38629-d8e2-40b5-b292-fd25d037c7b5">1,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDgtMS0xLTEtNzMyNTM_123b7522-e492-4684-8b90-7cb48b9689bb">9,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6accb844205d4e909ea7d6f406d2b865_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNDgtMy0xLTEtNzMyNTM_fa43550a-572f-4d30-a73b-6e0786b16210">8,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and equivalents, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNTAtMS0xLTEtNzMyNTM_0099282e-98c8-4836-b09b-881db33ebff0">6,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf70c299b6747128fa4a148bd06c306_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zMS9mcmFnOjdlMjg4ZWViZTFkZDQ2YzFiNGRlMzg2YzRjZjhkZjRhL3RhYmxlOjI4NjUzZWQzN2RlZjQ1MzBiM2Y1Y2ZiNTc3NjExZmFmL3RhYmxlcmFuZ2U6Mjg2NTNlZDM3ZGVmNDUzMGIzZjVjZmI1Nzc2MTFmYWZfNTAtMy0xLTEtNzMyNTM_4a3d680a-ddd9-46fb-805e-5f623870d6b8">9,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">5</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_34"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AbbVie Inc. and Subsidiaries</span></div><div><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div><div id="ic89f06320f9c4f57b19c511822f36cac_37"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 1 <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zNy9mcmFnOmZkMGM5MjJiNGQ1ZTQ3ZGI4YTQ3ZmE5Mzg4MjUxMmMyL3RleHRyZWdpb246ZmQwYzkyMmI0ZDVlNDdkYjhhNDdmYTkzODgyNTEyYzJfMTg2Nw_8c079f7f-e042-4f01-9385-37c426f57d2e" continuedAt="i40942d3d59074b8ea55cf43884a2ff27" escape="true">Basis of Presentation </ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i40942d3d59074b8ea55cf43884a2ff27" continuedAt="ief6070f2aa2b427ba1975ae4ca7f0ad3">Basis of Historical Presentation </ix:continuation></span></div><ix:continuation id="ief6070f2aa2b427ba1975ae4ca7f0ad3" continuedAt="i1ee4eda7e4bb4836a8e521e10a92c8c1"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements of AbbVie Inc. (AbbVie or the company) have been prepared pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the company&#8217;s audited consolidated financial statements and notes included in the company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is management&#8217;s opinion that these financial statements include all normal and recurring adjustments necessary for a fair presentation of the company&#8217;s financial position and operating results. Net revenues and net earnings for any interim period are not necessarily indicative of future or annual results. </span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1ee4eda7e4bb4836a8e521e10a92c8c1">During the three months ended March 31, 2022, AbbVie revised its classification of development milestone expense associated with licensing and collaboration arrangements in the consolidated statement of earnings. Milestone payments incurred prior to regulatory approval, which were previously included in research and development expense, are now presented as acquired IPR&amp;D and milestones expense. The reclassification decreased research and development expense and increased acquired IPR&amp;D and milestones expense by $<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="abbv:ReclassificationOfDevelopmentMilestoneExpenseToIPRDAndMilestonesExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zNy9mcmFnOmZkMGM5MjJiNGQ1ZTQ3ZGI4YTQ3ZmE5Mzg4MjUxMmMyL3RleHRyZWdpb246ZmQwYzkyMmI0ZDVlNDdkYjhhNDdmYTkzODgyNTEyYzJfMzg0ODI5MDcwMzk4OA_42ce1def-6135-446b-8705-a77bfb198fcf"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="abbv:ReclassificationOfDevelopmentMilestoneExpenseFromResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY18zNy9mcmFnOmZkMGM5MjJiNGQ1ZTQ3ZGI4YTQ3ZmE5Mzg4MjUxMmMyL3RleHRyZWdpb246ZmQwYzkyMmI0ZDVlNDdkYjhhNDdmYTkzODgyNTEyYzJfMzg0ODI5MDcwMzk4OA_a6e7375b-84ed-4d73-acf8-ae02b5673c8a">115</ix:nonFraction></ix:nonFraction>&#160;million for the three months ended March 31, 2021. The company believes this presentation assists users of the financial statements to better understand the total upfront and subsequent development milestone payments incurred to acquire in-process research and development projects. Prior periods have been reclassified to conform to the current period presentation. The reclassification had no impact on total operating costs and expenses, operating earnings, net earnings, net earnings attributable to AbbVie, Inc., earnings per share, or total equity. Certain other reclassifications were made to conform the prior period interim condensed consolidated financial statements to the current period presentation.</ix:continuation> </span></div><div id="ic89f06320f9c4f57b19c511822f36cac_40"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 2 <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RleHRyZWdpb246ZDBjOWI0NjAxMDEwNDZkYmJjMWZmYWYwMTBiN2VhNjlfMTky_a67340a9-306f-420d-8872-a32c5ce6d0b1" continuedAt="if0297520cbe94a02b33ee9874e53beb6" escape="true">Supplemental Financial Information</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><ix:continuation id="if0297520cbe94a02b33ee9874e53beb6" continuedAt="i071758f3a20149d999c4a6c5406f7e5b"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RleHRyZWdpb246ZDBjOWI0NjAxMDEwNDZkYmJjMWZmYWYwMTBiN2VhNjlfMTgy_13328d94-63c9-40d2-be37-e768601adc56" escape="true"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjMwOGM5OGQ4Y2YzZDRkYjhiMTIzMDBlZmM0YTRlMjE3L3RhYmxlcmFuZ2U6MzA4Yzk4ZDhjZjNkNGRiOGIxMjMwMGVmYzRhNGUyMTdfMi02LTEtMS03MzI1Mw_6df3ebf5-89da-4017-b4eb-a66addaedb2e">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjMwOGM5OGQ4Y2YzZDRkYjhiMTIzMDBlZmM0YTRlMjE3L3RhYmxlcmFuZ2U6MzA4Yzk4ZDhjZjNkNGRiOGIxMjMwMGVmYzRhNGUyMTdfMi04LTEtMS03MzI1Mw_79a42790-1bb1-4799-8733-b62ca606e435">632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjMwOGM5OGQ4Y2YzZDRkYjhiMTIzMDBlZmM0YTRlMjE3L3RhYmxlcmFuZ2U6MzA4Yzk4ZDhjZjNkNGRiOGIxMjMwMGVmYzRhNGUyMTdfMy02LTEtMS03MzI1Mw_cf2b91cd-306f-4c29-876d-4cfbef4c9bdf">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjMwOGM5OGQ4Y2YzZDRkYjhiMTIzMDBlZmM0YTRlMjE3L3RhYmxlcmFuZ2U6MzA4Yzk4ZDhjZjNkNGRiOGIxMjMwMGVmYzRhNGUyMTdfMy04LTEtMS03MzI1Mw_571f535d-62d7-4cf2-8385-d56738479062">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjMwOGM5OGQ4Y2YzZDRkYjhiMTIzMDBlZmM0YTRlMjE3L3RhYmxlcmFuZ2U6MzA4Yzk4ZDhjZjNkNGRiOGIxMjMwMGVmYzRhNGUyMTdfNC02LTEtMS03MzI1Mw_effc7d6d-614c-4f21-9787-f80572a57ef9">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjMwOGM5OGQ4Y2YzZDRkYjhiMTIzMDBlZmM0YTRlMjE3L3RhYmxlcmFuZ2U6MzA4Yzk4ZDhjZjNkNGRiOGIxMjMwMGVmYzRhNGUyMTdfNC04LTEtMS03MzI1Mw_8d2f5397-ab23-4f75-9e01-f5bc4375ea71">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><ix:continuation id="i071758f3a20149d999c4a6c5406f7e5b"><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RleHRyZWdpb246ZDBjOWI0NjAxMDEwNDZkYmJjMWZmYWYwMTBiN2VhNjlfMTkw_9227b66f-6914-4b24-9e53-ee4be21a8e0e" escape="true"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, <br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjI4OTVlMmU3MmFiNTRkMGFiMmQxMDk3MDJiZTJjZjE1L3RhYmxlcmFuZ2U6Mjg5NWUyZTcyYWI1NGQwYWIyZDEwOTcwMmJlMmNmMTVfMS0xLTEtMS03MzI1Mw_e195b6b7-c71f-4dde-a55c-9ac423b9cc91">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjI4OTVlMmU3MmFiNTRkMGFiMmQxMDk3MDJiZTJjZjE1L3RhYmxlcmFuZ2U6Mjg5NWUyZTcyYWI1NGQwYWIyZDEwOTcwMmJlMmNmMTVfMS0zLTEtMS03MzI1Mw_5fd14cca-5970-4b67-80a4-471ce809ba27">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjI4OTVlMmU3MmFiNTRkMGFiMmQxMDk3MDJiZTJjZjE1L3RhYmxlcmFuZ2U6Mjg5NWUyZTcyYWI1NGQwYWIyZDEwOTcwMmJlMmNmMTVfMi0xLTEtMS03MzI1Mw_a6c80ffd-50a0-4c0c-98fa-1513502b1b87">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjI4OTVlMmU3MmFiNTRkMGFiMmQxMDk3MDJiZTJjZjE1L3RhYmxlcmFuZ2U6Mjg5NWUyZTcyYWI1NGQwYWIyZDEwOTcwMmJlMmNmMTVfMi0zLTEtMS03MzI1Mw_8f0e37bb-7935-4871-8c1e-604c4da04c73">1,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjI4OTVlMmU3MmFiNTRkMGFiMmQxMDk3MDJiZTJjZjE1L3RhYmxlcmFuZ2U6Mjg5NWUyZTcyYWI1NGQwYWIyZDEwOTcwMmJlMmNmMTVfMy0xLTEtMS03MzI1Mw_8cb23dbd-f42a-4285-9a7a-f4f04ba0ff67">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjI4OTVlMmU3MmFiNTRkMGFiMmQxMDk3MDJiZTJjZjE1L3RhYmxlcmFuZ2U6Mjg5NWUyZTcyYWI1NGQwYWIyZDEwOTcwMmJlMmNmMTVfMy0zLTEtMS03MzI1Mw_310c45c0-9a12-4227-9eb4-7d68654e6046">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjI4OTVlMmU3MmFiNTRkMGFiMmQxMDk3MDJiZTJjZjE1L3RhYmxlcmFuZ2U6Mjg5NWUyZTcyYWI1NGQwYWIyZDEwOTcwMmJlMmNmMTVfNC0xLTEtMS03MzI1Mw_b6572eee-fc88-4560-9ad0-ca06a06d11cd">3,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjI4OTVlMmU3MmFiNTRkMGFiMmQxMDk3MDJiZTJjZjE1L3RhYmxlcmFuZ2U6Mjg5NWUyZTcyYWI1NGQwYWIyZDEwOTcwMmJlMmNmMTVfNC0zLTEtMS03MzI1Mw_1e689099-8e75-4ca4-9396-4651ed5f743a">3,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RleHRyZWdpb246ZDBjOWI0NjAxMDEwNDZkYmJjMWZmYWYwMTBiN2VhNjlfMTc3_ff373261-3c67-4ae4-805b-73029f5230a7" escape="true"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, <br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjdhOTJiNzc5NjllYjQyZThhODg0YzQxYzBlYmIyMDQ0L3RhYmxlcmFuZ2U6N2E5MmI3Nzk2OWViNDJlOGE4ODRjNDFjMGViYjIwNDRfMS0xLTEtMS03MzI1Mw_e610d177-eaf8-4328-b627-318d49b6a4b0">10,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjdhOTJiNzc5NjllYjQyZThhODg0YzQxYzBlYmIyMDQ0L3RhYmxlcmFuZ2U6N2E5MmI3Nzk2OWViNDJlOGE4ODRjNDFjMGViYjIwNDRfMS0zLTEtMS03MzI1Mw_0dbeb4c5-82f7-498c-ad29-63c6e5742d48">10,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjdhOTJiNzc5NjllYjQyZThhODg0YzQxYzBlYmIyMDQ0L3RhYmxlcmFuZ2U6N2E5MmI3Nzk2OWViNDJlOGE4ODRjNDFjMGViYjIwNDRfMi0xLTEtMS03MzI1Mw_952b0f22-714e-4c37-813f-43eae26ebb6b">5,804</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjdhOTJiNzc5NjllYjQyZThhODg0YzQxYzBlYmIyMDQ0L3RhYmxlcmFuZ2U6N2E5MmI3Nzk2OWViNDJlOGE4ODRjNDFjMGViYjIwNDRfMi0zLTEtMS03MzI1Mw_31cc3151-50a4-4415-b539-6d0d43609708">5,617</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjdhOTJiNzc5NjllYjQyZThhODg0YzQxYzBlYmIyMDQ0L3RhYmxlcmFuZ2U6N2E5MmI3Nzk2OWViNDJlOGE4ODRjNDFjMGViYjIwNDRfMy0xLTEtMS03MzI1Mw_1c6f2ccd-f5e6-4c66-9047-67147aa3fa7c">5,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RhYmxlOjdhOTJiNzc5NjllYjQyZThhODg0YzQxYzBlYmIyMDQ0L3RhYmxlcmFuZ2U6N2E5MmI3Nzk2OWViNDJlOGE4ODRjNDFjMGViYjIwNDRfMy0zLTEtMS03MzI1Mw_297f9190-21dc-481c-8137-a788c5680950">5,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RleHRyZWdpb246ZDBjOWI0NjAxMDEwNDZkYmJjMWZmYWYwMTBiN2VhNjlfMTE5_24e88413-589b-4601-87b4-f383d75059bf">198</ix:nonFraction> million for the three months ended March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180MC9mcmFnOmQwYzliNDYwMTAxMDQ2ZGJiYzFmZmFmMDEwYjdlYTY5L3RleHRyZWdpb246ZDBjOWI0NjAxMDEwNDZkYmJjMWZmYWYwMTBiN2VhNjlfMTU1_402ad0c7-3ab4-49c3-9a1e-42a4d9c21c06">206</ix:nonFraction> million for the three months ended March 31, 2021.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">6</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_46"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 3 <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RleHRyZWdpb246NjI0MmViNjBmMmNhNGNhNzg5ZTBmYTQxZTgyODE1YTBfNjU2_8133a1ca-6d05-4acf-b8f3-0719081139bd" continuedAt="i4ea65841094a479b9e2fc1a9febdf937" escape="true">Earnings Per Share</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4ea65841094a479b9e2fc1a9febdf937" continuedAt="i3fb32f9bda40496faabd7f2d1aa65967">AbbVie grants certain restricted stock units (RSUs) that are considered to be participating securities. Due to the presence of participating securities, AbbVie calculates earnings per share (EPS) using the more dilutive of the treasury stock or the two-class method. For all periods presented, the two-class method was more dilutive.</ix:continuation></span></div><ix:continuation id="i3fb32f9bda40496faabd7f2d1aa65967"><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RleHRyZWdpb246NjI0MmViNjBmMmNhNGNhNzg5ZTBmYTQxZTgyODE1YTBfNjUw_00676859-7d33-48e4-859c-3b7e22d8e5bf" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the impact of the two-class method:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to AbbVie Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMy02LTEtMS03MzI1Mw_5ea84cb7-f8c1-4126-ab24-065cc25b643f">4,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMy04LTEtMS03MzI1Mw_ffc286d1-92ac-40f0-af96-16d774e7e676">3,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfNC02LTEtMS03MzI1Mw_fd28722b-bb5e-4352-8a69-9f85c18debbb">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfNC04LTEtMS03MzI1Mw_572631b0-1926-4446-986d-d849a116fb50">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfNS02LTEtMS03MzI1Mw_2d2642d3-cc12-4776-a18e-e6758746805e">4,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfNS04LTEtMS03MzI1Mw_b1ebddf7-1878-4df9-be8a-3980c22fc689">3,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average basic shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfNi02LTEtMS03MzI1Mw_63c1e6da-d80d-4cac-b7f7-eb485dd6172f">1,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfNi04LTEtMS03MzI1Mw_f45594dc-f550-4949-874e-ca9c8f3eea7f">1,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share attributable to AbbVie Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfNy02LTEtMS03MzI1Mw_dc2efae9-c01c-4cd9-9656-ebb26b3abf52">2.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfNy04LTEtMS03MzI1Mw_63ef66bc-5996-4973-9515-fc4333f588e7">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to AbbVie Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTAtNi0xLTEtNzMyNTM_fe3da331-9e20-46f8-aa4a-684324a4f81d">4,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTAtOC0xLTEtNzMyNTM_516a8f9e-bf09-4132-ba1f-a5feaf3fe758">3,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings allocated to participating securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTEtNi0xLTEtNzMyNTM_e2effa79-c3ae-4b3a-813b-2907762fc35b">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTEtOC0xLTEtNzMyNTM_44862c53-8d5d-42f3-b8e4-64d83c555722">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to common shareholders</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTItNi0xLTEtNzMyNTM_98c973ea-4e40-42f6-baae-639a2113e1fd">4,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTItOC0xLTEtNzMyNTM_7a9ceed3-fdae-40ba-af84-147b9420ead2">3,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTMtNi0xLTEtNzMyNTM_a9348e89-b9ff-4164-8118-ef1040cfc34c">1,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTMtOC0xLTEtNzMyNTM_b12e6d43-fb1b-40ac-9baf-3e54dd83e33c">1,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTQtNi0xLTEtNzMyNTM_14a75b83-f26c-4fbc-84dc-d6eb976200fb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTQtOC0xLTEtNzMyNTM_1946006e-7c5a-4e19-a293-97a8b2494252">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTUtNi0xLTEtNzMyNTM_39e72f7d-a217-4038-846a-4745696bc91a">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTUtOC0xLTEtNzMyNTM_9297f0cc-580c-4499-9d84-b338b7df9edc">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share attributable to AbbVie Inc.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTYtNi0xLTEtNzMyNTM_ff6ae615-0168-4a48-acfc-eae44cb224c9">2.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180Ni9mcmFnOjYyNDJlYjYwZjJjYTRjYTc4OWUwZmE0MWU4MjgxNWEwL3RhYmxlOmQ3YTBjZTY1MTViOTQyZmI5ZDg5MWRjZjg1MDMwNGUwL3RhYmxlcmFuZ2U6ZDdhMGNlNjUxNWI5NDJmYjlkODkxZGNmODUwMzA0ZTBfMTYtOC0xLTEtNzMyNTM_17337729-112a-43c0-bda8-fd904ba80298">1.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain shares issuable under stock-based compensation plans were excluded from the computation of EPS because the effect would have been antidilutive. The number of common shares excluded was insignificant for all periods presented.</span></div></ix:continuation><div id="ic89f06320f9c4f57b19c511822f36cac_49"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="abbv:AcquisitionsCollaborationsAndOtherArrangementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180OS9mcmFnOjRkZGVhYjRiNmM4YjQ4M2RhM2E4YTFmOTQ3ZjdmOGU1L3RleHRyZWdpb246NGRkZWFiNGI2YzhiNDgzZGEzYThhMWY5NDdmN2Y4ZTVfNzMwMg_f66ecb2b-441f-4981-b005-642435d85f25" continuedAt="i86a375476d5b4bf3be7fbd4db900c7bc" escape="true"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensing, Acquisitions and Other Arrangements</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i86a375476d5b4bf3be7fbd4db900c7bc"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash outflows related to acquisitions and investments totaled $<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180OS9mcmFnOjRkZGVhYjRiNmM4YjQ4M2RhM2E4YTFmOTQ3ZjdmOGU1L3RleHRyZWdpb246NGRkZWFiNGI2YzhiNDgzZGEzYThhMWY5NDdmN2Y4ZTVfMTg4OQ_b2431296-901c-4f58-9d51-6419e164a0fa">185</ix:nonFraction> million for the three months ended March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180OS9mcmFnOjRkZGVhYjRiNmM4YjQ4M2RhM2E4YTFmOTQ3ZjdmOGU1L3RleHRyZWdpb246NGRkZWFiNGI2YzhiNDgzZGEzYThhMWY5NDdmN2Y4ZTVfMTkwNw_34f13724-8ec5-4326-8d15-01caf31738fa">198</ix:nonFraction> million for the three months ended March 31, 2021. AbbVie recorded acquired IPR&amp;D and milestones charges of $<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180OS9mcmFnOjRkZGVhYjRiNmM4YjQ4M2RhM2E4YTFmOTQ3ZjdmOGU1L3RleHRyZWdpb246NGRkZWFiNGI2YzhiNDgzZGEzYThhMWY5NDdmN2Y4ZTVfMjAyMA_d3a0d7fb-9152-4301-8443-63aaed03d1ad">145</ix:nonFraction> million for the three months ended March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180OS9mcmFnOjRkZGVhYjRiNmM4YjQ4M2RhM2E4YTFmOTQ3ZjdmOGU1L3RleHRyZWdpb246NGRkZWFiNGI2YzhiNDgzZGEzYThhMWY5NDdmN2Y4ZTVfMjA5MQ_7e528561-c68f-4dbe-901a-09717b6f8c00">185</ix:nonFraction>&#160;million for the three months ended March 31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Syndesi Therapeutics SA</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, AbbVie acquired Syndesi Therapeutics SA and its portfolio of novel modulators of the synaptic vesicle protein 2A (SV2A), including its lead molecule SDI-118 and accounted for the transaction as an asset acquisition. SDI-118 is a small molecule currently in Phase 1b studies, which is being evaluated to target nerve terminals to enhance synaptic efficiency. Under the terms of the agreement, AbbVie made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i72db22a233c742cb9fdaf4ec7205f2f1_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180OS9mcmFnOjRkZGVhYjRiNmM4YjQ4M2RhM2E4YTFmOTQ3ZjdmOGU1L3RleHRyZWdpb246NGRkZWFiNGI2YzhiNDgzZGEzYThhMWY5NDdmN2Y4ZTVfMTA5OTUxMTY0OTU3NA_e6bed5d3-6d28-48fd-857e-0d0b90f2b770">130</ix:nonFraction> million which was recorded to acquired IPR&amp;D and milestones expense in the condensed consolidated statement of earnings in the first quarter of 2022. The agreement also includes additional future payments of up to $<ix:nonFraction unitRef="usd" contextRef="ieb3553129a064588b861cbad2e2e642e_I20220228" decimals="-6" name="abbv:PotentialPaymentsUnderAgreementCertainMilestones" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY180OS9mcmFnOjRkZGVhYjRiNmM4YjQ4M2RhM2E4YTFmOTQ3ZjdmOGU1L3RleHRyZWdpb246NGRkZWFiNGI2YzhiNDgzZGEzYThhMWY5NDdmN2Y4ZTVfMTA5OTUxMTY0OTYxNA_7fcf68ba-d520-42b3-8c2a-535631ddaaf6">870</ix:nonFraction> million upon the achievement of certain development, regulatory and commercial milestones.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">7</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_55"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 5</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RleHRyZWdpb246NTE3NTIyNTIyYTJkNDlkMWI2ZTMyNDU0MDBiZDRiZjRfNDIzNg_9ba26504-47c8-4831-99f2-9ce352b247d6" continuedAt="i1511636aa74744ae96c5e02d71534ecd" escape="true"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Collaborations</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has ongoing transactions with other entities through collaboration agreements. The following represent the significant collaboration agreements impacting the periods ended March 31, 2022 and 2021.</span></ix:nonNumeric></div><ix:continuation id="i1511636aa74744ae96c5e02d71534ecd" continuedAt="icd2bf390264c43d2900c71c41a0ccf91"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration with Janssen Biotech, Inc.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December&#160;2011, Pharmacyclics, a wholly-owned subsidiary of AbbVie, entered into a worldwide collaboration and license agreement with Janssen Biotech,&#160;Inc. and its affiliates (Janssen), one of the Janssen Pharmaceutical companies of Johnson&#160;&amp; Johnson, for the joint development and commercialization of Imbruvica, a novel, orally active, selective covalent inhibitor of Bruton&#8217;s tyrosine kinase and certain compounds structurally related to Imbruvica, for oncology and other indications, excluding all immune and inflammatory mediated diseases or conditions and all psychiatric or psychological diseases or conditions, in the United States and outside the United States.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collaboration provides Janssen with an exclusive license to commercialize Imbruvica outside of the United States and co-exclusively with AbbVie in the United States. Both parties are responsible for the development, manufacturing and marketing of any products generated as a result of the collaboration. The collaboration has no set duration or specific expiration date and provides for potential future development, regulatory and approval milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="i20abf2418b52449bbcdcb69db0df0b34_I20220331" decimals="-6" name="abbv:CollaborativeArrangementMilestoneMethodPaymentsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RleHRyZWdpb246NTE3NTIyNTIyYTJkNDlkMWI2ZTMyNDU0MDBiZDRiZjRfMTM5OQ_a56564d9-8362-48ab-96c1-35fff7159ec3">200</ix:nonFraction> million to AbbVie. The collaboration also includes a cost sharing arrangement for associated collaboration activities. Except in certain cases, Janssen is responsible for approximately <ix:nonFraction unitRef="number" contextRef="i1e7da2bc9100421a9871b5285fd9fa10_D20220101-20220331" decimals="2" name="abbv:CollaborativeArrangementsPercentageOfShareOfDevelopmentCostsResponsibleByThirdParty" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RleHRyZWdpb246NTE3NTIyNTIyYTJkNDlkMWI2ZTMyNDU0MDBiZDRiZjRfMTU3OQ_35405f7a-6b32-4bb2-a58c-4ed19b3101ca">60</ix:nonFraction>% of collaboration development costs and AbbVie is responsible for the remaining <ix:nonFraction unitRef="number" contextRef="i1e7da2bc9100421a9871b5285fd9fa10_D20220101-20220331" decimals="2" name="abbv:CollaborativeArrangementsPercentageOfShareOfDevelopmentCosts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RleHRyZWdpb246NTE3NTIyNTIyYTJkNDlkMWI2ZTMyNDU0MDBiZDRiZjRfMTY2MQ_75a5f607-5640-4c4f-9b1a-970139eab124">40</ix:nonFraction>% of collaboration development costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, both parties have co-exclusive rights to commercialize the products; however, AbbVie is the principal in the end-customer product sales. AbbVie and Janssen share pre-tax profits and losses equally from the commercialization of products. Sales of Imbruvica are included in AbbVie's net revenues. Janssen's share of profits is included in AbbVie's cost of products sold. Other costs incurred under the collaboration are reported in their respective expense line items, net of Janssen's share.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States, Janssen is responsible for and has exclusive rights to commercialize Imbruvica. AbbVie and Janssen share pre-tax profits and losses equally from the commercialization of products. AbbVie's share of profits is included in AbbVie's net revenues. Other costs incurred under the collaboration are reported in their respective expense line items, net of Janssen's share.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="i9fe4ce1afbad40ee8b142ccdca3cbdf7_D20220101-20220331" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RleHRyZWdpb246NTE3NTIyNTIyYTJkNDlkMWI2ZTMyNDU0MDBiZDRiZjRfNDI0MA_6733a072-32a9-4c46-bfa1-d8e5f9b40dfc" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the profit and cost sharing relationship between Janssen and AbbVie:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States - Janssen's share of profits (included in cost of products sold)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757157a6b1f24339a6987f24f728b796_D20220101-20220331" decimals="-6" name="abbv:CostofGoodsAndServicesSoldFromCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOjRjODRmMjI1MWU4YzQ3OTU4MTEwNDIyYzA1MzYwNjA0L3RhYmxlcmFuZ2U6NGM4NGYyMjUxZThjNDc5NTgxMTA0MjJjMDUzNjA2MDRfMi02LTEtMS03MzI1Mw_58b93f1f-0956-4720-a0e7-cdb12978e2e0">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c90b03e0a9d4b959d426288837a1ac9_D20210101-20210331" decimals="-6" name="abbv:CostofGoodsAndServicesSoldFromCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOjRjODRmMjI1MWU4YzQ3OTU4MTEwNDIyYzA1MzYwNjA0L3RhYmxlcmFuZ2U6NGM4NGYyMjUxZThjNDc5NTgxMTA0MjJjMDUzNjA2MDRfMi04LTEtMS03MzI1Mw_40d1e102-553a-4e2c-857b-ee2a2368bcfb">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International - AbbVie's share of profits (included in net revenues)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f9f25b9cf5e4ee0bbe7e382b04feba9_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOjRjODRmMjI1MWU4YzQ3OTU4MTEwNDIyYzA1MzYwNjA0L3RhYmxlcmFuZ2U6NGM4NGYyMjUxZThjNDc5NTgxMTA0MjJjMDUzNjA2MDRfMy02LTEtMS03MzI1Mw_77523dcb-1dca-4a8b-814f-67c11c5f13b7">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1248f479629473abbdb6ed040285ccc_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOjRjODRmMjI1MWU4YzQ3OTU4MTEwNDIyYzA1MzYwNjA0L3RhYmxlcmFuZ2U6NGM4NGYyMjUxZThjNDc5NTgxMTA0MjJjMDUzNjA2MDRfMy04LTEtMS03MzI1Mw_c0404797-473a-4638-9b3c-3f50af1aaca5">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global - AbbVie's share of other costs (included in respective line items)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e7da2bc9100421a9871b5285fd9fa10_D20220101-20220331" decimals="-6" name="abbv:OtherExpensesFromCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOjRjODRmMjI1MWU4YzQ3OTU4MTEwNDIyYzA1MzYwNjA0L3RhYmxlcmFuZ2U6NGM4NGYyMjUxZThjNDc5NTgxMTA0MjJjMDUzNjA2MDRfNC02LTEtMS03MzI1Mw_5b9896c2-d069-4211-a7ae-1a4cb3be9dd5">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7189bfa6119440549f13eb789b20c623_D20210101-20210331" decimals="-6" name="abbv:OtherExpensesFromCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOjRjODRmMjI1MWU4YzQ3OTU4MTEwNDIyYzA1MzYwNjA0L3RhYmxlcmFuZ2U6NGM4NGYyMjUxZThjNDc5NTgxMTA0MjJjMDUzNjA2MDRfNC04LTEtMS03MzI1Mw_7b628509-f3af-4aa7-8a86-31259dadb6b6">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie&#8217;s receivable from Janssen, included in accounts receivable, net, was $<ix:nonFraction unitRef="usd" contextRef="i20abf2418b52449bbcdcb69db0df0b34_I20220331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RleHRyZWdpb246NTE3NTIyNTIyYTJkNDlkMWI2ZTMyNDU0MDBiZDRiZjRfMjczOQ_997fb397-5c79-47b0-bce7-7801020ee04b">336</ix:nonFraction> million at March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i503b434bb2cd4949ab32e3eea0c0a13b_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RleHRyZWdpb246NTE3NTIyNTIyYTJkNDlkMWI2ZTMyNDU0MDBiZDRiZjRfMjc1Mg_f5a7ed10-7ba1-446a-8a1a-b67b0d594e63">294</ix:nonFraction> million at December 31, 2021. AbbVie&#8217;s payable to Janssen, included in accounts payable and accrued liabilities, was $<ix:nonFraction unitRef="usd" contextRef="i20abf2418b52449bbcdcb69db0df0b34_I20220331" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RleHRyZWdpb246NTE3NTIyNTIyYTJkNDlkMWI2ZTMyNDU0MDBiZDRiZjRfMjg0OQ_62c234a4-10da-4a9b-95c1-c19ad83124a4">401</ix:nonFraction> million at March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i503b434bb2cd4949ab32e3eea0c0a13b_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RleHRyZWdpb246NTE3NTIyNTIyYTJkNDlkMWI2ZTMyNDU0MDBiZDRiZjRfMjg2Mg_9c36f40b-3bd0-4cca-9f33-e51234524f40">509</ix:nonFraction> million at December 31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration with Genentech, Inc.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie and Genentech, Inc. (Genentech), a member of the Roche Group, are parties to a collaboration and license agreement executed in 2007 to jointly research, develop and commercialize human therapeutic products containing BCL-2 inhibitors and certain other compound inhibitors which includes Venclexta, a BCL-2 inhibitor used to treat certain hematological malignancies. AbbVie shares equally with Genentech all pre-tax profits and losses from the development and commercialization of Venclexta in the United States. AbbVie pays royalties on Venclexta net revenues outside the United States. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie manufactures and distributes Venclexta globally and is the principal in the end-customer product sales. Sales of Venclexta are included in AbbVie&#8217;s net revenues. Genentech&#8217;s share of United States profits is included in AbbVie&#8217;s cost of products sold. AbbVie records sales and marketing costs associated with the United States collaboration as part of selling, general and administrative (SG&amp;A) expenses and global development costs as part of research and development (R&amp;D) expenses, net of Genentech&#8217;s share. Royalties paid for Venclexta revenues outside the United States are also included in AbbVie&#8217;s cost of products sold.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">8</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:continuation id="icd2bf390264c43d2900c71c41a0ccf91"><ix:nonNumeric contextRef="i7e417e1f49424cb4b129ec6ce7c723da_D20220101-20220331" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RleHRyZWdpb246NTE3NTIyNTIyYTJkNDlkMWI2ZTMyNDU0MDBiZDRiZjRfNDIzOA_8a3ef206-6824-47f7-b50f-3e799c9219f3" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the profit and cost sharing relationship between Genentech and AbbVie:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genentech's share of profits, including royalties (included in cost of products sold)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70fdebf15534416b657e3efc08cb7de_D20220101-20220331" decimals="-6" name="abbv:CostofGoodsAndServicesSoldFromCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOmNkNTNlOTU4Yzc5MjRiNmFiZTg3MzczYmRiZWRhMWU3L3RhYmxlcmFuZ2U6Y2Q1M2U5NThjNzkyNGI2YWJlODczNzNiZGJlZGExZTdfMi02LTEtMS03MzI1Mw_57083e0f-4ae5-4484-85b2-2d1daeaf9290">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b131031330347efae33d3283c798c08_D20210101-20210331" decimals="-6" name="abbv:CostofGoodsAndServicesSoldFromCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOmNkNTNlOTU4Yzc5MjRiNmFiZTg3MzczYmRiZWRhMWU3L3RhYmxlcmFuZ2U6Y2Q1M2U5NThjNzkyNGI2YWJlODczNzNiZGJlZGExZTdfMi04LTEtMS03MzI1Mw_f2133e4f-ea47-4f21-adfd-53c86d998485">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AbbVie's share of sales and marketing costs from U.S. collaboration (included in SG&amp;A)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia91bb22b751b4f769a3ed871c1a8e163_D20220101-20220331" decimals="-6" name="abbv:SellingGeneralAndAdministrativeExpenseFromCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOmNkNTNlOTU4Yzc5MjRiNmFiZTg3MzczYmRiZWRhMWU3L3RhYmxlcmFuZ2U6Y2Q1M2U5NThjNzkyNGI2YWJlODczNzNiZGJlZGExZTdfMy02LTEtMS03MzI1Mw_f3d66a49-4ef0-45c7-85b3-8bc1a231050c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6409d59d48544dd3b57e4e907e0daf25_D20210101-20210331" decimals="-6" name="abbv:SellingGeneralAndAdministrativeExpenseFromCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOmNkNTNlOTU4Yzc5MjRiNmFiZTg3MzczYmRiZWRhMWU3L3RhYmxlcmFuZ2U6Y2Q1M2U5NThjNzkyNGI2YWJlODczNzNiZGJlZGExZTdfMy04LTEtMS03MzI1Mw_e76f6f95-8b62-4c86-a975-7b54c00c2ce9">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AbbVie's share of development costs (included in R&amp;D)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70fdebf15534416b657e3efc08cb7de_D20220101-20220331" decimals="-6" name="abbv:ResearchAndDevelopmentExpenseFromCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOmNkNTNlOTU4Yzc5MjRiNmFiZTg3MzczYmRiZWRhMWU3L3RhYmxlcmFuZ2U6Y2Q1M2U5NThjNzkyNGI2YWJlODczNzNiZGJlZGExZTdfNC02LTEtMS03MzI1Mw_4b6a3fc0-2843-4e85-8590-6652f68f26d6">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b131031330347efae33d3283c798c08_D20210101-20210331" decimals="-6" name="abbv:ResearchAndDevelopmentExpenseFromCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181NS9mcmFnOjUxNzUyMjUyMmEyZDQ5ZDFiNmUzMjQ1NDAwYmQ0YmY0L3RhYmxlOmNkNTNlOTU4Yzc5MjRiNmFiZTg3MzczYmRiZWRhMWU3L3RhYmxlcmFuZ2U6Y2Q1M2U5NThjNzkyNGI2YWJlODczNzNiZGJlZGExZTdfNC04LTEtMS03MzI1Mw_2860bb34-1669-4399-86df-b629e5bc0350">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="ic89f06320f9c4f57b19c511822f36cac_58"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 6 <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RleHRyZWdpb246ZDU3MjAxODg3ZWE2NDAwZDhkMDA1YmYxZGRmN2JlZTZfMTIxMw_1bbc4a0f-0118-4290-95ba-1e32b7e75ae8" continuedAt="i0a2d18b46f52425aa68f9ee340226a60" escape="true">Goodwill and Intangible Assets</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i0a2d18b46f52425aa68f9ee340226a60" continuedAt="i85d7e10681914c78b2ad8980462a2b47">Goodwill</ix:continuation></span></div><ix:continuation id="i85d7e10681914c78b2ad8980462a2b47"><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RleHRyZWdpb246ZDU3MjAxODg3ZWE2NDAwZDhkMDA1YmYxZGRmN2JlZTZfMTIwMg_8af45836-2049-4f39-855d-005cf1e6eecf" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjZhMjhmMTEwNmFjMzQyZTNiMjE4ZDFjZDRkOWE5MDFkL3RhYmxlcmFuZ2U6NmEyOGYxMTA2YWMzNDJlM2IyMThkMWNkNGQ5YTkwMWRfMS0xLTEtMS03MzI1Mw_c76b4fe7-6a87-437e-b6bd-e821c498b492">32,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjZhMjhmMTEwNmFjMzQyZTNiMjE4ZDFjZDRkOWE5MDFkL3RhYmxlcmFuZ2U6NmEyOGYxMTA2YWMzNDJlM2IyMThkMWNkNGQ5YTkwMWRfNC0xLTEtMS03MzI1Mw_08467d8a-d66e-4e4d-8668-065794835b89">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjZhMjhmMTEwNmFjMzQyZTNiMjE4ZDFjZDRkOWE5MDFkL3RhYmxlcmFuZ2U6NmEyOGYxMTA2YWMzNDJlM2IyMThkMWNkNGQ5YTkwMWRfNS0xLTEtMS03MzI1Mw_7dd24f25-f89e-4913-aa2c-ee06fcafa4f3">32,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company performs its annual goodwill impairment assessment in the third quarter, or earlier if impairment indicators exist. As of March 31, 2022, there were <ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="INF" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RleHRyZWdpb246ZDU3MjAxODg3ZWE2NDAwZDhkMDA1YmYxZGRmN2JlZTZfMzMy_042753cf-6a11-4355-9825-9266f2f112f6">no</ix:nonFraction> accumulated goodwill impairment losses.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div style="margin-top:8pt"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RleHRyZWdpb246ZDU3MjAxODg3ZWE2NDAwZDhkMDA1YmYxZGRmN2JlZTZfMTIxMg_4c6f5c5e-1a98-4d43-9646-1e1d96b9b6c5" escape="true"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RleHRyZWdpb246ZDU3MjAxODg3ZWE2NDAwZDhkMDA1YmYxZGRmN2JlZTZfMTIyOQ_d9a84588-4a59-4a4b-8ce6-b5ae2b368ab7" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes intangible assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.046%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>carrying <br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net <br/>carrying <br/>amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>carrying <br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net <br/>carrying <br/>amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed product rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d0443c07a5417ca515d44ddc962b47_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfMy0xLTEtMS03MzI1Mw_739e5d82-421a-48ea-a93e-1b7aa567c656">88,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d0443c07a5417ca515d44ddc962b47_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfMy0zLTEtMS03MzI1Mw_6b27bd28-9930-4664-a146-19480f83ed4f">20,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d0443c07a5417ca515d44ddc962b47_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfMy01LTEtMS03MzI1Mw_0d0f02b6-a6c3-4343-b8a5-130d29d7133c">68,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4ad2d90a3249b7ab95933f6531b3bf_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfMy03LTEtMS03MzI1Mw_adb954e7-e01d-4e81-9173-c83c6bb6eda7">88,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d4ad2d90a3249b7ab95933f6531b3bf_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfMy05LTEtMS03MzI1Mw_c40a4540-70c7-4b2c-9bd4-bd4541a7b658">18,463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4ad2d90a3249b7ab95933f6531b3bf_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfMy0xMS0xLTEtNzMyNTM_aa37f470-40cf-4823-aaae-bc6dd3f74cc7">70,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d7032a627d4586b0df7536454a2953_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNC0xLTEtMS03MzI1Mw_3070ad73-e52d-4ed6-a946-62bb29f77c42">8,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85d7032a627d4586b0df7536454a2953_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNC0zLTEtMS03MzI1Mw_4313cddf-4284-4a09-a034-307f3ed69577">3,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d7032a627d4586b0df7536454a2953_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNC01LTEtMS03MzI1Mw_b1b5453e-3a7c-4a9b-a6fc-a88eb00bfb6d">4,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6abf8b13366e446b8e4d345e553af9c0_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNC03LTEtMS03MzI1Mw_1470c6e9-4e5d-4e37-9f98-7df2ed9bbbf1">8,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6abf8b13366e446b8e4d345e553af9c0_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNC05LTEtMS03MzI1Mw_15245439-750b-447b-b75e-8beb8e5b4a93">3,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6abf8b13366e446b8e4d345e553af9c0_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNC0xMS0xLTEtNzMyNTM_80af6bb4-0d53-4ac6-9bcf-6c810a45195d">4,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total definite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNS0xLTEtMS03MzI1Mw_07d302e4-cf01-4d3f-8bfc-54dad3f66514">97,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNS0zLTEtMS03MzI1Mw_430cd687-4277-4973-bdd4-5fab25d62855">23,988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNS01LTEtMS03MzI1Mw_32183789-ccf8-4390-a81c-a15e92299fd2">73,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNS03LTEtMS03MzI1Mw_b525b944-d971-4c7f-a46d-28e2703dfeeb">97,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNS05LTEtMS03MzI1Mw_44984e27-d9a5-4143-a7a0-c2478d5e0a34">22,151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNS0xMS0xLTEtNzMyNTM_6cd29f98-8939-476e-9a18-64d149ebadb7">75,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNi0xLTEtMS03MzI1Mw_cff4191d-b3ef-40ce-9a40-2d773fd723c0">670</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNi01LTEtMS03MzI1Mw_b5c96bfb-348c-411e-9331-7de6f3913cc6">670</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNi03LTEtMS03MzI1Mw_bc8ab582-6b9c-4c68-a21d-dd1ee55f8ea2">670</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNi0xMS0xLTEtNzMyNTM_7d016bfb-99d1-4ff4-8ce6-57c5537bccd9">670</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNy0xLTEtMS03MzI1Mw_e6afaeb4-bd82-482b-b779-f16a88b62722">97,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNy0zLTEtMS03MzI1Mw_b749fed3-b1b5-4675-a2db-eb0fc970e709">23,988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNy01LTEtMS03MzI1Mw_98e19dc6-185b-4d7b-9f72-0e532b684af7">73,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNy03LTEtMS03MzI1Mw_e5dbe46c-049a-47b3-8cb7-d7eccdb101c5">98,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNy05LTEtMS03MzI1Mw_d78f2269-523e-4b35-9bd7-65c58195c606">22,151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RhYmxlOjA1MmNkZjQwMDE1NDQzZGY5MDg5ZjQ2MzYyMmE2ZTEzL3RhYmxlcmFuZ2U6MDUyY2RmNDAwMTU0NDNkZjkwODlmNDYzNjIyYTZlMTNfNy0xMS0xLTEtNzMyNTM_547e5f9b-fec2-45b6-8572-1935bd956d21">75,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Definite-Lived Intangible Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RleHRyZWdpb246ZDU3MjAxODg3ZWE2NDAwZDhkMDA1YmYxZGRmN2JlZTZfNzgz_3cb31f76-e339-4554-9ea2-56f25b658ff5">1.9</ix:nonFraction> billion for the three months ended March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY181OC9mcmFnOmQ1NzIwMTg4N2VhNjQwMGQ4ZDAwNWJmMWRkZjdiZWU2L3RleHRyZWdpb246ZDU3MjAxODg3ZWE2NDAwZDhkMDA1YmYxZGRmN2JlZTZfODE5_b67eebf2-570d-45ae-9ed6-1dceae33a029">2.0</ix:nonFraction> billion for the three months ended March 31, 2021. Amortization expense was included in cost of products sold in the condensed consolidated statements of earnings.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indefinite-Lived Intangible Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets represent in-process research and development associated with products that have not yet received regulatory approval. The company performs its annual impairment assessment of indefinite-lived intangible assets in the third quarter, or earlier if impairment indicators exist.</span></div></ix:continuation><div id="ic89f06320f9c4f57b19c511822f36cac_64"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 7 <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RleHRyZWdpb246ODQwNzQ2MGM4MzRjNGU0ZWE0MTBjMDI5NWViN2FlODJfMTAwOQ_8a8fd8c7-fe86-44ca-a9b3-03738467f08d" continuedAt="i734389659f49461f9802524e7e0ef962" escape="true">Integration and Restructuring Plans</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i734389659f49461f9802524e7e0ef962" continuedAt="iaf16704e581b44119f9a68f9c386c880">Allergan Integration Plan </ix:continuation></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaf16704e581b44119f9a68f9c386c880" continuedAt="ic5b49503f83443ea9ddc04ba843afaf6">Following the closing of the Allergan acquisition, AbbVie implemented an integration plan designed to reduce costs, integrate and optimize the combined organization. To achieve these integration objectives, AbbVie expects to incur total cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="id13caefd7d5a471aa354ceb296f2d670_I20220331" decimals="-9" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RleHRyZWdpb246ODQwNzQ2MGM4MzRjNGU0ZWE0MTBjMDI5NWViN2FlODJfMzEx_bbea9fbb-6a93-4faa-8453-923500b312e4">2</ix:nonFraction> billion through 2022. These costs consist of severance and employee benefit costs (cash severance, non-cash severance including accelerated equity award compensation expense, retention and other termination benefits) and other integration expenses.</ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">9</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ic5b49503f83443ea9ddc04ba843afaf6"><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="ib2fa833e1b5a4350b5373871f1e0b8db_D20220101-20220331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RleHRyZWdpb246ODQwNzQ2MGM4MzRjNGU0ZWE0MTBjMDI5NWViN2FlODJfMTAyNQ_e09fa609-5bf9-489b-b7b7-deef56b2636c" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the charges associated with the Allergan acquisition integration plan:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.066%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Severance and employee benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other integration</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dbf40f3d8814b2cb5a231dbbd3418e6_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfMy05LTEtMS03MzI1Mw_7bf43eb0-b1b2-4399-82e3-5da6189898f6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc654c5b431f4e2c81e6d3dc971bbfce_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfMy0xMS0xLTEtNzMyNTM_011c9bb1-390a-469e-833e-0c20ca3264aa">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0e02057646439c9b219a540ab6bba4_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfMy0yMC0xLTEtNzMyNTM_e31712b2-3d62-4198-9d4b-e26d67df5d02">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d31e315887b49cf9383108785d5b7a2_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfMy0yMi0xLTEtNzMyNTM_16629045-e546-48f5-8e2d-9b9a9bce8d1c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b0ea0dc41fe4934b7afc79df8635743_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNC05LTEtMS03MzI1Mw_17fafda7-8e08-4800-8519-94a5854da0df">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28ae11319ad4812a556b3a24a0d7eb8_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNC0xMS0xLTEtNzMyNTM_d3b46a36-c6f2-4b62-bd25-bf5c202c6c60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b089c0fc324d5b82b75e000f5fe9cd_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNC0yMC0xLTEtNzMyNTM_a350ce18-4e0e-4120-9288-4be5e511c716">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6435c30e6b40489560149b0efd5c0b_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNC0yMi0xLTEtNzMyNTM_34e3ad9e-bb06-4287-9949-4e79e2b0bf8f">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2be7d9eaa6f4f369f0de369cbb043f8_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNS05LTEtMS03MzI1Mw_b1fa0b8b-f423-4c43-9d42-21b1af0daf05">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7f0edb319054698965e395df2f44e5f_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNS0xMS0xLTEtNzMyNTM_89f2afa9-f69f-4176-bb67-d1fcfc8e8093">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b13ed86da2945de8f2c44a2373537a6_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNS0yMC0xLTEtNzMyNTM_cdc96601-74f8-485c-95b4-0dc54f1d907b">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e369611bfc4546bf3c8e89fd8a3f48_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNS0yMi0xLTEtNzMyNTM_2547a9af-442f-48d1-85c8-e27559a97cd4">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b7593516564b7588f173a9d381ac8a_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNi05LTEtMS03MzI1Mw_e7b51868-fd5d-431c-9fd5-304ff43d96ec">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77324bf397cc41f7a15e4eef24ecff2d_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNi0xMS0xLTEtNzMyNTM_a5e29a83-b30f-47b2-a860-8b6626652bd6">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e0d98c3744bdb9096abdccc0ad91a_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNi0yMC0xLTEtNzMyNTM_4e793946-b2aa-4367-83cc-794053862c48">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f1ab36dc934e39ae4bfefcbe05705e_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmM0NzUyNmFhYjc3ODRiZjg4ZjdmZDUwNzlkN2Q4NTMwL3RhYmxlcmFuZ2U6YzQ3NTI2YWFiNzc4NGJmODhmN2ZkNTA3OWQ3ZDg1MzBfNi0yMi0xLTEtNzMyNTM_c5e3e930-a200-43b2-b58e-0485d79d1126">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="ib2fa833e1b5a4350b5373871f1e0b8db_D20220101-20220331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RleHRyZWdpb246ODQwNzQ2MGM4MzRjNGU0ZWE0MTBjMDI5NWViN2FlODJfMTAxMg_4a3dac44-80ee-4379-9910-874626f28122" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the cash activity in the recorded liability associated with the integration plan for the three months ended March 31, 2022: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Severance and employee benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other integration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714dfb429c6f451eb83c696c0379c6ab_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmY3YzZlMWUxYzEyNjQxYzc5ODRhMzVkYzhiZTg0YzEwL3RhYmxlcmFuZ2U6ZjdjNmUxZTFjMTI2NDFjNzk4NGEzNWRjOGJlODRjMTBfMS0xLTEtMS03MzI1Mw_f4056cc2-ff45-460d-8df2-578435740392">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5007646043540a1b0e932caf506c8b2_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmY3YzZlMWUxYzEyNjQxYzc5ODRhMzVkYzhiZTg0YzEwL3RhYmxlcmFuZ2U6ZjdjNmUxZTFjMTI2NDFjNzk4NGEzNWRjOGJlODRjMTBfMS0zLTEtMS03MzI1Mw_8adae501-dbf6-45c0-94f8-73ebbf1fb1f5">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b7593516564b7588f173a9d381ac8a_D20220101-20220331" decimals="-6" name="abbv:RestructuringReserveCashSettledRestructuringGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmY3YzZlMWUxYzEyNjQxYzc5ODRhMzVkYzhiZTg0YzEwL3RhYmxlcmFuZ2U6ZjdjNmUxZTFjMTI2NDFjNzk4NGEzNWRjOGJlODRjMTBfMi0xLTEtMS03MzI1Mw_41317c09-c765-475f-b497-27bb52e01f6d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5e0d98c3744bdb9096abdccc0ad91a_D20220101-20220331" decimals="-6" name="abbv:RestructuringReserveCashSettledRestructuringGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmY3YzZlMWUxYzEyNjQxYzc5ODRhMzVkYzhiZTg0YzEwL3RhYmxlcmFuZ2U6ZjdjNmUxZTFjMTI2NDFjNzk4NGEzNWRjOGJlODRjMTBfMi0zLTEtMS03MzI1Mw_e1dda12e-53f1-4298-9404-3e68fe298d47">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20b7593516564b7588f173a9d381ac8a_D20220101-20220331" decimals="-6" name="abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmY3YzZlMWUxYzEyNjQxYzc5ODRhMzVkYzhiZTg0YzEwL3RhYmxlcmFuZ2U6ZjdjNmUxZTFjMTI2NDFjNzk4NGEzNWRjOGJlODRjMTBfNS0xLTEtMS03MzI1Mw_a2cc1610-6eda-40bb-8f28-80758ca7ccd3">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5e0d98c3744bdb9096abdccc0ad91a_D20220101-20220331" decimals="-6" name="abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmY3YzZlMWUxYzEyNjQxYzc5ODRhMzVkYzhiZTg0YzEwL3RhYmxlcmFuZ2U6ZjdjNmUxZTFjMTI2NDFjNzk4NGEzNWRjOGJlODRjMTBfNS0zLTEtMS03MzI1Mw_6eafc033-57d8-4340-9fa8-ee1b40fd0735">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae8327b6e3b446c39bc4154fdcab2095_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmY3YzZlMWUxYzEyNjQxYzc5ODRhMzVkYzhiZTg0YzEwL3RhYmxlcmFuZ2U6ZjdjNmUxZTFjMTI2NDFjNzk4NGEzNWRjOGJlODRjMTBfNi0xLTEtMS03MzI1Mw_7deed78d-1cd0-4ed3-97dd-ec009bf23675">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id430b90a4b4b4e00accb2dafe2190824_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmY3YzZlMWUxYzEyNjQxYzc5ODRhMzVkYzhiZTg0YzEwL3RhYmxlcmFuZ2U6ZjdjNmUxZTFjMTI2NDFjNzk4NGEzNWRjOGJlODRjMTBfNi0zLTEtMS03MzI1Mw_f274fcfe-95ba-4b1e-b215-71b2790e9dbb">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Restructuring</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie recorded restructuring charges of $<ix:nonFraction unitRef="usd" contextRef="i35524fcc0d8743e3af6573cf03287f13_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RleHRyZWdpb246ODQwNzQ2MGM4MzRjNGU0ZWE0MTBjMDI5NWViN2FlODJfODUw_7ce8e00f-d9ca-49b0-9bbd-b4b209870933">57</ix:nonFraction> million for the three months ended March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i7f4c4b3745f349e198629a93da34561b_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RleHRyZWdpb246ODQwNzQ2MGM4MzRjNGU0ZWE0MTBjMDI5NWViN2FlODJfOTA0_b05bc93e-bcb8-4fa0-bee3-e62751d0614c">38</ix:nonFraction> million for the three months ended March 31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="i35524fcc0d8743e3af6573cf03287f13_D20220101-20220331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RleHRyZWdpb246ODQwNzQ2MGM4MzRjNGU0ZWE0MTBjMDI5NWViN2FlODJfMTAyNA_3724d122-3c48-4de5-b1c8-1f9579bde51a" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the cash activity in the restructuring reserve for the three months ended March 31, 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e8c16288ca4a859ec70b21f89ef7a7_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmRkZGU5ZjJmY2JhNzRhODRiOWI5ZGMwNzI1MzQzOGRiL3RhYmxlcmFuZ2U6ZGRkZTlmMmZjYmE3NGE4NGI5YjlkYzA3MjUzNDM4ZGJfMS0xLTEtMS03MzI1Mw_1fcc67f2-9c49-4957-b123-c4d67eec92d4">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35524fcc0d8743e3af6573cf03287f13_D20220101-20220331" decimals="-6" name="abbv:RestructuringReserveCashSettledRestructuringGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmRkZGU5ZjJmY2JhNzRhODRiOWI5ZGMwNzI1MzQzOGRiL3RhYmxlcmFuZ2U6ZGRkZTlmMmZjYmE3NGE4NGI5YjlkYzA3MjUzNDM4ZGJfMi0xLTEtMS03MzI1Mw_53e72d9f-1304-4df0-a253-c935bfed62b5">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35524fcc0d8743e3af6573cf03287f13_D20220101-20220331" decimals="-6" name="abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmRkZGU5ZjJmY2JhNzRhODRiOWI5ZGMwNzI1MzQzOGRiL3RhYmxlcmFuZ2U6ZGRkZTlmMmZjYmE3NGE4NGI5YjlkYzA3MjUzNDM4ZGJfMy0xLTEtMS03MzI1Mw_c421229a-510c-4593-9080-23a0c0eadc44">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a368d5034e44f028f602236d3ab8057_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY182NC9mcmFnOjg0MDc0NjBjODM0YzRlNGVhNDEwYzAyOTVlYjdhZTgyL3RhYmxlOmRkZGU5ZjJmY2JhNzRhODRiOWI5ZGMwNzI1MzQzOGRiL3RhYmxlcmFuZ2U6ZGRkZTlmMmZjYmE3NGE4NGI5YjlkYzA3MjUzNDM4ZGJfNC0xLTEtMS03MzI1Mw_190f62e2-83c1-402a-accd-a83bfdc2d808">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-bottom:8pt"><span><br/></span></div><div id="ic89f06320f9c4f57b19c511822f36cac_70"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 8 <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTA5OTUxMTY1NTY5OQ_f5b84c9c-1771-46a0-b9c6-81a00e13e3f4" continuedAt="id16b3357b3c9444382c070c9a1d54b9c" escape="true">Financial Instruments and Fair Value Measures</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="id16b3357b3c9444382c070c9a1d54b9c" continuedAt="i8bdbd381e9d84f64ad7af3858f51dcb1">Risk Management Policy</ix:continuation></span></div><ix:continuation id="i8bdbd381e9d84f64ad7af3858f51dcb1" continuedAt="idd6d13563f3c4318845cbf0fb480f4ac"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 to the company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021 for a summary of AbbVie&#8217;s risk management policy and use of derivative instruments.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various AbbVie foreign subsidiaries enter into foreign currency forward exchange contracts to manage exposures to changes in foreign exchange rates for anticipated intercompany transactions denominated in a currency other than the functional currency of the local entity. These contracts, with notional amounts totaling $<ix:nonFraction unitRef="usd" contextRef="i2d0578582acc4184bae1fe1a5d03842e_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNTM4_7e984bc2-0032-46f2-9ddc-c43ad4af5144">904</ix:nonFraction> million at March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i64d7cd1d96fd463d81f7b441a15f7907_I20211231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjE5OTAyMzI3NTk4OA_0bfb1145-2dac-420c-8c45-46dac441b71e">1.1</ix:nonFraction> billion at December 31, 2021, are designated as cash flow hedges and are recorded at fair value. The durations of these forward exchange contracts were generally less than <ix:nonNumeric contextRef="i85e773fb160f4868b7b34f01835f244e_D20220101-20220331" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNjk3_ccb006f8-97c8-40b1-aa1d-00cc539c1f5c">18</ix:nonNumeric> months. Accumulated gains and losses as of March 31, 2022 are reclassified from accumulated other comprehensive income (loss) (AOCI) and included in cost of products sold at the time the products are sold, generally not exceeding <ix:nonNumeric contextRef="i85e773fb160f4868b7b34f01835f244e_D20220101-20220331" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfODky_9b90ee31-5ade-4391-beb4-3d70c0cd3fed">six months</ix:nonNumeric> from the date of settlement.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2019, the company entered into treasury rate lock agreements with notional amounts totaling $<ix:nonFraction unitRef="usd" contextRef="id4dcf7772a434cca8535434fc724868d_I20190930" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTA0MA_333ec003-b595-40e5-bbce-29e4f22313ec">10.0</ix:nonFraction> billion to hedge exposure to variability in future cash flows resulting from changes in interest rates related to the issuance of long-term debt in connection with the acquisition of Allergan. The treasury rate lock agreements were designated as cash flow hedges and recorded at fair value. The agreements were net settled upon issuance of the senior notes in November 2019 and the resulting net gain was recognized in other comprehensive loss. This gain is reclassified to interest expense, net over the term of the related debt. </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">10</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="idd6d13563f3c4318845cbf0fb480f4ac" continuedAt="i37c6dfcc19ba48d6a45edb0496263c25"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company is a party to interest rate swap contracts designated as cash flow hedges with notional amounts totaling $<ix:nonFraction unitRef="usd" contextRef="id7c27a6d499a4374bb62731e6ee3c5ad_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTY0MQ_b2426b17-156b-4468-bfc5-2c172d2c1229"><ix:nonFraction unitRef="usd" contextRef="i1ea6c9f4ab71401f8e112e105b0a87ea_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTY0MQ_d748b9f3-f550-4a66-9964-b92f43cab6e3">750</ix:nonFraction></ix:nonFraction> million at March 31, 2022 and December 31, 2021. The effect of the hedge contracts is to change a floating-rate interest obligation to a fixed rate for that portion of the floating-rate debt. Realized and unrealized gains or losses are included in AOCI and are reclassified to interest expense, net over the lives of the floating-rate debt.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company also enters into foreign currency forward exchange contracts to manage its exposure to foreign currency denominated trade payables and receivables and intercompany loans. These contracts are not designated as hedges and are recorded at fair value. Resulting gains or losses are reflected in net foreign exchange gain or loss in the condensed consolidated statements of earnings and are generally offset by losses or gains on the foreign currency exposure being managed. These contracts had notional amounts totaling $<ix:nonFraction unitRef="usd" contextRef="i14c87abe9559493098137ef93eb16897_I20220331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjQyMg_b9ede7a2-fb87-416e-b3b6-f0b0f052ec84">7.0</ix:nonFraction> billion at March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i56fd5370a66349abb5a708fcca3df153_I20211231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjQzNQ_e01f78ae-f624-47d5-8815-107b9a9edd29">8.2</ix:nonFraction> billion at December 31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company also uses foreign currency forward exchange contracts or foreign currency denominated debt to hedge its net investments in certain foreign subsidiaries and affiliates. The company had foreign currency forward exchange contracts designated as net investment hedges with notional amounts totaling &#8364;<ix:nonFraction unitRef="eur" contextRef="i8e5c418235f74f58be5d142972173da3_I20211231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjcxNg_2d490390-e3a3-4757-b063-5a46f43f0fdc"><ix:nonFraction unitRef="eur" contextRef="i1440f6810115464aaba75d7ad2e205fa_I20220331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjcxNg_f6ea4fa2-547b-4389-b71b-29a557ce1739">4.3</ix:nonFraction></ix:nonFraction>&#160;billion at March 31, 2022 and December 31, 2021. The company also had an aggregate principal amount of senior Euro notes designated as net investment hedges of &#8364;<ix:nonFraction unitRef="eur" contextRef="i5e04d5b1b77e42338343cb7a394365ac_I20220331" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjg1MA_04fce40f-facb-4782-914b-fb507f1487a3"><ix:nonFraction unitRef="eur" contextRef="ida1c9540265a40ae89ed8e5bac26055b_I20211231" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjg1MA_eaa64f96-a3ab-4b87-8245-0612241ca890">5.9</ix:nonFraction></ix:nonFraction> billion at March 31, 2022 and December 31, 2021. The company uses the spot method of assessing hedge effectiveness for derivative instruments designated as net investment hedges. Realized and unrealized gains and losses from these hedges are included in AOCI and the initial fair value of hedge components excluded from the assessment of effectiveness is recognized in interest expense, net over the life of the hedging instrument.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company is a party to interest rate swap contracts designated as fair value hedges with notional amounts totaling $<ix:nonFraction unitRef="usd" contextRef="i0695b54b4eee4244ad7f53879aaf2b88_I20220331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMzM1Mw_25ca30eb-8ac9-4a1e-bfbd-059e11e83f36"><ix:nonFraction unitRef="usd" contextRef="i3023f47a89be437a8979714fa7aeb5ea_I20211231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMzM1Mw_6fec68bb-b9f4-4828-830f-f9227f10a9e9">4.5</ix:nonFraction></ix:nonFraction> billion at March 31, 2022 and December 31, 2021. The effect of the hedge contracts is to change a fixed-rate interest obligation to a floating rate for that portion of the debt. AbbVie records the contracts at fair value and adjusts the carrying amount of the fixed-rate debt by an offsetting amount.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="INF" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMzYyNQ_1bf50e2c-8a3f-4259-a68c-d2537d7710d0"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="INF" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMzYyNQ_4c6a8844-3155-49a5-b49d-2a89afc8f0b3"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="INF" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMzYyNQ_a6f6229d-d536-4eae-8e5c-b80e00813b3f"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="INF" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMzYyNQ_c09d4521-09ef-4f4b-8f08-d912c07d4c2e">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> amounts are excluded from the assessment of effectiveness for cash flow hedges or fair value hedges.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMTU_53f9dc5b-fc2a-4088-ae94-e2f7a47dd673" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amounts and location of AbbVie&#8217;s derivative instruments on the condensed consolidated balance sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value &#8211; <br/>Derivatives in asset position</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value &#8211;<br/>Derivatives&#160;in&#160;liability&#160;position</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;sheet&#160;caption</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;sheet&#160;caption</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae50d2fb61c84091860a38b122dcec5e_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMy0yLTEtMS03MzI1Mw_05bd43f8-490e-4cba-8c56-d8f81c3903aa">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3896b7812d9c4f458a6ee1c222fdc5d4_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMy0zLTEtMS03MzI1Mw_6eac45d5-1237-425e-bf92-b1d028f958d6">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf844e180d3a469caf77cbfd640ee06a_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMy02LTEtMS03MzI1Mw_3c6d2c4d-215b-4764-b705-62095d9e0745">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i278c392732fe405ca9790ebca84a2b5a_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMy03LTEtMS03MzI1Mw_2add260a-a4ab-4cb3-9485-4543083f0780">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Designated as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2759b8249f9b4c0abfb4b6e0d5d1f19a_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNS0yLTEtMS03MzI1Mw_bb62e646-bb56-4758-800d-50526cb54648">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ebd92b09814dbd9c34016fbe056f80_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNS0zLTEtMS03MzI1Mw_721d6644-d13d-4f6f-b2ed-81f5242df375">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37efff4161cb4c0493595e73c1b6c251_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNS02LTEtMS03MzI1Mw_a46a5b79-2872-43ac-8d56-f20fa8bb99b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42302eafa7c143eea1f93c5698a3de9f_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNS03LTEtMS03MzI1Mw_8e0f1d61-5a25-4422-bb73-3590338f624d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Designated as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a96d28015b45949c078f6766332529_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNi0yLTEtMS04MDI5Ng_087a6b9c-51e8-45ef-a26d-3fbb70d5db53">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8fe28e93231442a879e677d581e007a_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNi0zLTEtMS03ODM1MQ_a294f124-4f95-483a-b4a0-66144ce5bc96">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21f5ff90441c477985db4a043e94ba99_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNi02LTEtMS04MDMxMg_49fffed9-f982-4aae-8843-6724860f568b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081e9eccbec84d14b3e5e990418ead24_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNi03LTEtMS04MDMxNQ_5514a864-7e6a-4346-8c3d-63887fafe689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2762b41ed6f34461bfde8f1333fdf996_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNi0yLTEtMS03MzI1Mw_6bc669d7-e7a4-43c8-9a0d-9424d4676f7b">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6c7748fb844f8387515876c985d86a_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNi0zLTEtMS03MzI1Mw_cc6b3700-c2eb-4835-b1aa-1da6a7d3e917">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i435b30592ac747d989c50678808fe1d0_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNi02LTEtMS03MzI1Mw_91337926-8ce6-4061-929b-ec746a33ad49">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e7a78e77c640c0978087e1e5aa5365_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfNi03LTEtMS03MzI1Mw_f264b3da-4d41-4a31-b44d-4091bb0d23f5">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Designated as cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic20d6c5cd9154d11b748fba274562228_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfOC0yLTEtMS03MzI1Mw_ee9d473c-0b6c-4c59-8a50-dca2426feea5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec68c25a887f49d4b34b8179ed6dda01_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfOC0zLTEtMS03MzI1Mw_4e2d79a2-b744-45a4-8a27-2add5c169b70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24765f81c1fb4287a6f15e1f08b37561_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfOC02LTEtMS03MzI1Mw_4d45a2d6-28ef-48a1-a1c5-593e3bd1414c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84610d1bd2b740fb98e00437e286d300_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfOC03LTEtMS03MzI1Mw_ab48ac2b-a0b9-48dc-92dc-56f386f434fc">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Designated as fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099396de57cc428db3ba3fa6496e9806_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMTEtMi0xLTEtNzMyNTM_59f38e48-27bd-404c-8870-2cfe955d7317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bb723c8d7d94576a2e267ad0bde0d6a_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMTEtMy0xLTEtNzMyNTM_eaa3336a-0a29-4bf2-a151-f98867a53e90">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84f403b6217414e9c4727bdaddefefa_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMTEtNi0xLTEtNzMyNTM_dcad8185-f3bb-40fd-b768-080583835cf4">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i993003f0c8794563b176024ce0433091_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMTEtNy0xLTEtNzMyNTM_053c44c7-1742-42c1-9aa4-790f96f2baae">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMTItMi0xLTEtNzMyNTM_0c8e3edc-5b93-4d09-8d92-fa4d0a8b0fa2">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMTItMy0xLTEtNzMyNTM_a1e9a9d4-ac6d-499c-a11d-724c9f8a219d">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMTItNi0xLTEtNzMyNTM_79427a3d-f707-4690-bfc8-1caac4d8d74b">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmFlOTczNDI2NTUyOTRmYTU4N2VjNGE3OGVlZjExN2FlL3RhYmxlcmFuZ2U6YWU5NzM0MjY1NTI5NGZhNTg3ZWM0YTc4ZWVmMTE3YWVfMTItNy0xLTEtNzMyNTM_ec03982e-0e72-471b-b234-34d96a927c93">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While certain derivatives are subject to netting arrangements with the company&#8217;s counterparties, the company does not offset derivative assets and liabilities within the condensed consolidated balance sheets.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">11</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i37c6dfcc19ba48d6a45edb0496263c25" continuedAt="ic3a8d7b334ad417381e4c2aaa00d47cc"><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMDE_09cdfda0-e5a7-4b25-aab7-d360e30ea89f" escape="true"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMzA_ec0bb620-ef75-4536-941b-ecc45f8e3043" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the pre-tax amounts of gains (losses) from derivative instruments recognized in other comprehensive loss:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf6856ef91ba4d929d656629013d3068_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjM1ZTQ5NjA0N2UwYzQzMTFiNGQ0MmY3NmY1Zjc1Y2FiL3RhYmxlcmFuZ2U6MzVlNDk2MDQ3ZTBjNDMxMWI0ZDQyZjc2ZjVmNzVjYWJfMy02LTEtMS03MzI1Mw_385ec5c6-8df6-40db-a3ca-8e5c6475fb74">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie282fe45ad5d4fabb47f2e2e934d4440_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjM1ZTQ5NjA0N2UwYzQzMTFiNGQ0MmY3NmY1Zjc1Y2FiL3RhYmxlcmFuZ2U6MzVlNDk2MDQ3ZTBjNDMxMWI0ZDQyZjc2ZjVmNzVjYWJfMy04LTEtMS03MzI1Mw_9de6fab8-129e-4e53-b7aa-392f21edc1c5">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6856ef91ba4d929d656629013d3068_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjM1ZTQ5NjA0N2UwYzQzMTFiNGQ0MmY3NmY1Zjc1Y2FiL3RhYmxlcmFuZ2U6MzVlNDk2MDQ3ZTBjNDMxMWI0ZDQyZjc2ZjVmNzVjYWJfNC02LTEtMS03MzI1Mw_12060727-9927-483b-8456-5e9ab0deed03">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie282fe45ad5d4fabb47f2e2e934d4440_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjM1ZTQ5NjA0N2UwYzQzMTFiNGQ0MmY3NmY1Zjc1Y2FiL3RhYmxlcmFuZ2U6MzVlNDk2MDQ3ZTBjNDMxMWI0ZDQyZjc2ZjVmNzVjYWJfNC04LTEtMS03MzI1Mw_41dfc4e0-f499-42f0-afa7-d9915f95df04">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i621e08f15f004824aefad73ab5851795_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjM1ZTQ5NjA0N2UwYzQzMTFiNGQ0MmY3NmY1Zjc1Y2FiL3RhYmxlcmFuZ2U6MzVlNDk2MDQ3ZTBjNDMxMWI0ZDQyZjc2ZjVmNzVjYWJfNS02LTEtMS03MzI1Mw_b44fe433-bb6a-4e44-8e35-0c7cae8096f2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i179bb4a086e74b04bc986f5bbbb847c6_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjM1ZTQ5NjA0N2UwYzQzMTFiNGQ0MmY3NmY1Zjc1Y2FiL3RhYmxlcmFuZ2U6MzVlNDk2MDQ3ZTBjNDMxMWI0ZDQyZjc2ZjVmNzVjYWJfNS04LTEtMS03MzI1Mw_3c25781a-dfdc-4a06-9c77-0aafeb684adc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming market rates remain constant through contract maturities, the company expects to reclassify pre-tax gains of $<ix:nonFraction unitRef="usd" contextRef="i0ed7b475bcdf40e59be351b723196753_I20220331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNDIzNQ_49777b53-4953-4b1f-820b-3ee530df7804">52</ix:nonFraction>&#160;million into cost of products sold for foreign currency cash flow hedges, pre-tax losses of $<ix:nonFraction unitRef="usd" contextRef="if0ba58f0b4804781a450e1eafe670429_I20220331" decimals="-6" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNDI5OQ_59517e26-6648-47b8-a5d5-66cc61d9e096">1</ix:nonFraction> million into interest expense, net for interest rate swap cash flow hedges and pre-tax gains of $<ix:nonFraction unitRef="usd" contextRef="if0ba58f0b4804781a450e1eafe670429_I20220331" decimals="-6" name="abbv:TreasuryLockCashFlowHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNDM2OA_5bf27f04-52e7-45b2-bc56-7378bbae3bc5">24</ix:nonFraction> million into interest expense, net for treasury rate lock agreement cash flow hedges during the next 12 months.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related to AbbVie&#8217;s non-derivative, foreign currency denominated debt designated as net investment hedges, the company recognized in other comprehensive loss pre-tax gains of $<ix:nonFraction unitRef="usd" contextRef="i73a0138eece144c7b6d7536ce561b961_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNDYzOA_adce4b49-a22e-40ee-b39b-b1b1c56d0e9f">99</ix:nonFraction>&#160;million for the three months ended March 31, 2022 and pre-tax gains of $<ix:nonFraction unitRef="usd" contextRef="ia6e338b61d1141f5b8c13e661709f6b5_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNDY3MA_8a56b895-8328-4a49-96ef-91c9654e7a4a">382</ix:nonFraction> million for the three months ended March 31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMDQ_b95539fd-da20-4667-aa8d-b2652a132805" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax amounts and location of derivative instrument net gains (losses) recognized in the condensed consolidated statements of earnings, including the net gains (losses) reclassified out of AOCI into net earnings. See Note 10 for the amount of net gains (losses) reclassified out of AOCI.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Statement&#160;of earnings caption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7bd97603484ae1802843d027d4882c_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfMy03LTEtMS03MzI1Mw_0cb0bea1-24e5-40e3-8bfd-8d2458e45033">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1681dbbb7fe645d6853c751bdc56bbad_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfMy05LTEtMS03MzI1Mw_d8917499-82e5-4397-8dfc-20cc3f72e97f">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed8d036846c41e7ae1fd8954a4b4f77_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfNC03LTEtMS03MzI1Mw_8c468b34-767b-4438-804a-9118565a0750">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f7ce3635354a61a150bfdfc38169f5_D20210101-20210331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfNC05LTEtMS03MzI1Mw_0c4d7810-2dcb-40a7-8ac4-98fd4d7cfd23">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id741975d93ce432ca3360bc759262c9c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfNS03LTEtMS03MzI1Mw_3d5c0c73-31e3-4307-aa58-33ca4e4cdf43">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib000460db5074562808f7f1eb5c6419e_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfNS05LTEtMS03MzI1Mw_0e0f472a-82bf-4f34-ab04-f8e868d48846">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury rate lock agreements designated as cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f6fa4fbbe04394a9fe1a7d581eaec0_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfNi03LTEtMS03MzI1Mw_013212d1-04ae-40dc-8009-2e2f0db68953">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib64b83983f224c629b47278996994efe_D20210101-20210331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfNi05LTEtMS03MzI1Mw_02602c5d-26a2-4d1f-96c1-5b37926c4693">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated as cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47ba7efcd0f44228bd851a9cfd907eca_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfOC03LTEtMS03MzI1Mw_e5121cac-f89a-4001-af69-ddcb87c5eeb0">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if79203b4f0e042919ad95c75b6c9ed1d_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfOC05LTEtMS03MzI1Mw_9fccdeea-6701-4e41-8fa8-61aaaca2748f">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated as fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3338f9b94ba644cdb8a5bfb1a5c29358_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfOS03LTEtMS03MzI1Mw_a02dce1c-74c9-4023-a5c2-997ce86f63eb">184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib576612385b34159a385efbbb44ac312_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfOS05LTEtMS03MzI1Mw_f3c726d5-7bec-45f3-bbdb-687d1ec7493b">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt designated as hedged item in fair value hedges</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2ab8d0faba462a8cdae1d115c9ac72_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfMTAtNy0xLTEtNzMyNTM_783d6ef0-3f94-4448-b483-86b61e631983">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859211caa6b54eaa83b28f597db71274_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjUwYTk1NmRjZGQyNTQ4YjBiNGE5ZDRjNjc1OTE2MDMxL3RhYmxlcmFuZ2U6NTBhOTU2ZGNkZDI1NDhiMGI0YTlkNGM2NzU5MTYwMzFfMTAtOS0xLTEtNzMyNTM_6863731a-7c13-4d95-9362-b645f2ce21c3">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy consists of the following three levels:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:27pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.27pt">Level 1 &#8211; Valuations based on unadjusted quoted prices in active markets for identical assets that the company has the ability to access;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:27pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.27pt">Level 2 &#8211; Valuations based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations in which all significant inputs are observable in the market; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:27pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.27pt">Level 3 &#8211; Valuations using significant inputs that are unobservable in the market and include the use of judgment by the company&#8217;s management about the assumptions market participants would use in pricing the asset or liability.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">12</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ic3a8d7b334ad417381e4c2aaa00d47cc" continuedAt="i3ced7f853c1c4ae1a585dd65d5426a15"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIwOTM_e53bdd43-136c-42df-b926-56fab805c90c" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the bases used to measure certain assets and liabilities carried at fair value on a recurring basis on the condensed consolidated balance sheet as of March 31, 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis&#160;of&#160;fair&#160;value&#160;measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;prices&#160;in active markets&#160;for identical assets <br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant other observable <br/>inputs <br/>(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant unobservable inputs <br/>(Level&#160;3)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38e263f9b26407aad657967962464cc_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMy0xLTEtMS03MzI1Mw_7b1af346-6b60-4afe-ad70-649e4551882d">6,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab718c63b5884ec79c89e37caa022504_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMy0zLTEtMS03MzI1Mw_3db9dd1b-1da1-41b0-8918-e8afdb852e58">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d51b5f39b30417591b468b9cc37d240_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMy01LTEtMS03MzI1Mw_397f23db-81d3-4c43-ae61-ba928277ebcb">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdce0bbf0ade46c2bcb9b28658b93b26_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMy03LTEtMS03MzI1Mw_6577533d-eae6-4531-afc3-5de6c4901dd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a1275578fd4eab9c1a98a3a69b8994_I20220331" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNC0xLTEtMS03MzI1Mw_3b45f71f-9932-42a7-bb50-3ef82bfa9984">1,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547378d779a94424afb2f81c95c765e8_I20220331" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNC0zLTEtMS03MzI1Mw_01ffaaeb-6f4e-4421-9c54-f7518f626e8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifced2c43ef9a4921b504c12eeb7b2ef1_I20220331" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNC01LTEtMS03MzI1Mw_49a5a642-84c0-437a-9921-4ed756e32357">1,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0d7604169c4be790295c65966d9417_I20220331" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNC03LTEtMS03MzI1Mw_fff10398-75b6-463e-9f76-f8dedad6af83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38e263f9b26407aad657967962464cc_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNS0xLTEtMS03MzI1Mw_b850f83a-36a5-4b80-9123-92c1215589c3">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab718c63b5884ec79c89e37caa022504_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNS0zLTEtMS03MzI1Mw_874ac87f-3468-4d66-af4a-fb6ce5adb02d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d51b5f39b30417591b468b9cc37d240_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNS01LTEtMS03MzI1Mw_0483490f-fa53-41cb-847f-7836fc72109d">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdce0bbf0ade46c2bcb9b28658b93b26_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNS03LTEtMS03MzI1Mw_26045942-d79b-4551-adf7-5f7da76b3a5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38e263f9b26407aad657967962464cc_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNi0xLTEtMS03MzI1Mw_5d383c0b-701c-4ae8-9cf8-8a34697d8fd4">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab718c63b5884ec79c89e37caa022504_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNi0zLTEtMS03MzI1Mw_49db4075-9ef8-4cb3-8d68-d4864688f042">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d51b5f39b30417591b468b9cc37d240_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNi01LTEtMS03MzI1Mw_8e778f80-a6b9-472d-afd3-23e2ae26deeb">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdce0bbf0ade46c2bcb9b28658b93b26_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfNi03LTEtMS03MzI1Mw_e8282ac4-cc16-4594-83f9-e108938eed27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ad1758bd2446cea957f2ad4754f617_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfOC0xLTEtMS03MzI1Mw_88004ab2-39f5-467b-aa38-7aea65a00b21">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e694d0a849640f2baad8365a826d153_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfOC0zLTEtMS03MzI1Mw_84f56ad2-b2f0-45d1-b9d5-996f14ff6244">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfa6a41f682746a8ace32ddbe43016b7_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfOC01LTEtMS03MzI1Mw_9c48b418-3f14-4a0a-a9cb-f2c5ee3026cd">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af1965f163b48ea903e4c8e2f20baed_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfOC03LTEtMS03MzI1Mw_3dcc88ac-c343-4c53-943b-b4b193b6244c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38e263f9b26407aad657967962464cc_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTAtMS0xLTEtNzMyNTM_55954aab-ae51-4410-98b5-6b6292640ee4">7,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab718c63b5884ec79c89e37caa022504_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTAtMy0xLTEtNzMyNTM_0759bc3e-5a02-4b62-a3ee-c4105230f97a">3,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d51b5f39b30417591b468b9cc37d240_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTAtNS0xLTEtNzMyNTM_bbba2543-0a54-4e22-ac11-ccbe5b21ca64">4,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdce0bbf0ade46c2bcb9b28658b93b26_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTAtNy0xLTEtNzMyNTM_a40b3004-17e4-4118-a975-2231f1eeae21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38e263f9b26407aad657967962464cc_I20220331" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTItMS0xLTEtNzMyNTM_ec198ca6-e7ca-4ca8-83f4-d54d2aea7962">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab718c63b5884ec79c89e37caa022504_I20220331" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTItMy0xLTEtNzMyNTM_67fb8181-7d7d-4743-a227-c5855c5324f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d51b5f39b30417591b468b9cc37d240_I20220331" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTItNS0xLTEtNzMyNTM_3ca3d180-ddf3-4aef-9108-0ea1aca467a3">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdce0bbf0ade46c2bcb9b28658b93b26_I20220331" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTItNy0xLTEtNzMyNTM_537bdbaa-7879-4120-9542-61c3b065122f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ad1758bd2446cea957f2ad4754f617_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTMtMS0xLTEtNzMyNTM_47872965-1ecd-4626-877e-b39e96fcb09a">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e694d0a849640f2baad8365a826d153_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTMtMy0xLTEtNzMyNTM_f3988187-cb99-4348-9a39-0923218b3f58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfa6a41f682746a8ace32ddbe43016b7_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTMtNS0xLTEtNzMyNTM_eb1fd52e-074e-4e11-bc7f-08db91db4f0d">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af1965f163b48ea903e4c8e2f20baed_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTMtNy0xLTEtNzMyNTM_1ec79ab3-6082-42d6-9d74-a05a3f92fae9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38e263f9b26407aad657967962464cc_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTUtMS0xLTEtNzMyNTM_8b9ef945-5ed1-492d-9629-461ea4b6aec3">13,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab718c63b5884ec79c89e37caa022504_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTUtMy0xLTEtNzMyNTM_fd291f51-14eb-491b-a375-a142de623dd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d51b5f39b30417591b468b9cc37d240_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTUtNS0xLTEtNzMyNTM_6c572255-7e81-4c5e-bc68-c27b48b71901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdce0bbf0ade46c2bcb9b28658b93b26_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTUtNy0xLTEtNzMyNTM_d638b04e-76e9-4a9b-ba30-688c529dfd4f">13,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38e263f9b26407aad657967962464cc_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTYtMS0xLTEtNzMyNTM_7f7c3b55-442a-48f5-b071-f03cc484fd8a">14,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab718c63b5884ec79c89e37caa022504_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTYtMy0xLTEtNzMyNTM_359a31a3-0140-4e41-ad59-136477d0badd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d51b5f39b30417591b468b9cc37d240_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTYtNS0xLTEtNzMyNTM_a8c03493-0152-44c6-bc77-6c3de1767703">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdce0bbf0ade46c2bcb9b28658b93b26_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjBjYjRjMDMwNzY4ODRhODM4ZmM1MzBmNDk0NWMyNmY1L3RhYmxlcmFuZ2U6MGNiNGMwMzA3Njg4NGE4MzhmYzUzMGY0OTQ1YzI2ZjVfMTYtNy0xLTEtNzMyNTM_2baf25d4-3c2f-4a71-97fd-dcb994f46b3b">13,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the bases used to measure certain assets and liabilities carried at fair value on a recurring basis on the condensed consolidated balance sheet as of December 31, 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis&#160;of&#160;fair&#160;value&#160;measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;prices&#160;in active markets&#160;for identical assets <br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant other observable<br/>inputs <br/>(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant unobservable inputs <br/>(Level&#160;3)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626df6b5d80b4e98b0edeaa02ad00831_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMy0xLTEtMS03MzI1Mw_a2f3450b-d97b-4c93-b280-f4539b8b6948">9,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if649f364c260430e996cc0e7faf77825_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMy0zLTEtMS03MzI1Mw_2b54e3ba-2294-4da1-b500-f777557162bb">4,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f48fccb6a964533ad0a2bc9fa1b69d4_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMy01LTEtMS03MzI1Mw_78a5fd77-c85c-4dd7-b0eb-355ae24a6ce6">5,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5d7c1351314f0aa35ce7a44c4a1460_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMy03LTEtMS03MzI1Mw_f72e3675-6df8-457f-82c8-58c702f6c47a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b425e8bb2fc4bf98f7703e322eb47ea_I20211231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNC0xLTEtMS03MzI1Mw_5e3f2279-d16c-419f-86cb-92bb1820b36e">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e2a58ae48e34c639ba8dc2259cc6bf8_I20211231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNC0zLTEtMS03MzI1Mw_10188c07-d41c-4860-a961-f960064fc53c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99530b1ca1f4637a531747b189b68e1_I20211231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNC01LTEtMS03MzI1Mw_3fa8bad5-a326-43ad-9532-72462249db78">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b92c917f6c46e8bec270fac1ab97be_I20211231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNC03LTEtMS03MzI1Mw_e09763d9-ccfe-41ec-9417-91c36f74d518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626df6b5d80b4e98b0edeaa02ad00831_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNS0xLTEtMS03MzI1Mw_2ef959ad-e53f-44ed-87ff-f399e3fc54ef">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if649f364c260430e996cc0e7faf77825_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNS0zLTEtMS03MzI1Mw_9482f454-42ee-4a6d-9ab6-ef8b5b494fc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f48fccb6a964533ad0a2bc9fa1b69d4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNS01LTEtMS03MzI1Mw_314bc895-2e97-48bb-b711-eebf835e44a8">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5d7c1351314f0aa35ce7a44c4a1460_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNS03LTEtMS03MzI1Mw_2c55d62b-bbdd-45b2-9e50-26902c14b7cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626df6b5d80b4e98b0edeaa02ad00831_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNi0xLTEtMS03MzI1Mw_e1a8d3de-3174-4ce2-913f-10f731262240">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if649f364c260430e996cc0e7faf77825_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNi0zLTEtMS03MzI1Mw_0015bc62-d9d9-45a3-9056-8725ee4fab66">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f48fccb6a964533ad0a2bc9fa1b69d4_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNi01LTEtMS03MzI1Mw_4af78264-b00b-4341-9f4a-aa6c802a2a27">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5d7c1351314f0aa35ce7a44c4a1460_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNi03LTEtMS03MzI1Mw_bcff001a-760b-477c-9570-8b3c30cafa77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626df6b5d80b4e98b0edeaa02ad00831_I20211231" decimals="-6" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNy0xLTEtMS03MzI1Mw_25607d2c-7295-4d86-8bf9-ffacef8bd111">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if649f364c260430e996cc0e7faf77825_I20211231" decimals="-6" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNy0zLTEtMS03MzI1Mw_9f3a0f60-f481-4edb-9d20-e3a44b2dcd71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f48fccb6a964533ad0a2bc9fa1b69d4_I20211231" decimals="-6" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNy01LTEtMS03MzI1Mw_d325db0e-252d-4adc-820b-abbf846c4d04">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5d7c1351314f0aa35ce7a44c4a1460_I20211231" decimals="-6" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfNy03LTEtMS03MzI1Mw_339ac371-0314-4401-be84-6db5e7c6d3a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87ad90d3c5e24243a4f6eb626050ecbe_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfOC0xLTEtMS03MzI1Mw_f38f3d0d-ec7f-46e7-9b25-62c5be07af4f">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1c1d4df013d43b6a59943a73db0d1fc_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfOC0zLTEtMS03MzI1Mw_34ac3567-513f-4ec0-a22d-0aeb5193947e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e05944c5ce844a18dea78c42fefb97f_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfOC01LTEtMS03MzI1Mw_da5eb27b-a0b4-40e9-b584-8b0f93fa5bda">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2306289346ba4f6eac115558f89ffb15_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfOC03LTEtMS03MzI1Mw_19739ae7-eed7-41ef-a382-2d3a2942e887">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626df6b5d80b4e98b0edeaa02ad00831_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTAtMS0xLTEtNzMyNTM_edcc36d0-19e1-43fa-b4a1-0463957e2213">10,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if649f364c260430e996cc0e7faf77825_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTAtMy0xLTEtNzMyNTM_da49f0f6-a342-4082-a1c9-bc6af140ca95">4,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f48fccb6a964533ad0a2bc9fa1b69d4_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTAtNS0xLTEtNzMyNTM_ee70abd1-c97f-4c9b-bea1-2ee4940783ea">5,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5d7c1351314f0aa35ce7a44c4a1460_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTAtNy0xLTEtNzMyNTM_84924d73-1989-42d5-960c-68cf624064b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626df6b5d80b4e98b0edeaa02ad00831_I20211231" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTItMS0xLTEtNzMyNTM_df7f0640-fa17-4513-9e7e-63f6c9c27efa">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if649f364c260430e996cc0e7faf77825_I20211231" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTItMy0xLTEtNzMyNTM_3fd91619-82cb-42aa-9115-9c628298e614">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f48fccb6a964533ad0a2bc9fa1b69d4_I20211231" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTItNS0xLTEtNzMyNTM_882e8e86-3fc9-4077-89c4-e0ec24b7e088">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5d7c1351314f0aa35ce7a44c4a1460_I20211231" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTItNy0xLTEtNzMyNTM_97198781-e44d-4c5a-a6d6-2bd6761340cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87ad90d3c5e24243a4f6eb626050ecbe_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTMtMS0xLTEtNzMyNTM_6f7daaeb-06d9-4d73-91a0-e968a57db3ed">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1c1d4df013d43b6a59943a73db0d1fc_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTMtMy0xLTEtNzMyNTM_20d770c6-8581-48d4-bc69-298c5da76620">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e05944c5ce844a18dea78c42fefb97f_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTMtNS0xLTEtNzMyNTM_4b33ccd3-3c74-4681-a12f-a7246aba7e6a">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2306289346ba4f6eac115558f89ffb15_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTMtNy0xLTEtNzMyNTM_02b7fc5b-e60a-48e3-8f79-414f08b51774">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626df6b5d80b4e98b0edeaa02ad00831_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTUtMS0xLTEtNzMyNTM_872f550f-ebe9-4aa1-b978-3cb8e86b3a53">14,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if649f364c260430e996cc0e7faf77825_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTUtMy0xLTEtNzMyNTM_64cd1b18-bbea-4ffc-93ed-0171c4866d60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f48fccb6a964533ad0a2bc9fa1b69d4_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTUtNS0xLTEtNzMyNTM_4f18e23d-542d-4dbd-aef2-dbc49719f1ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5d7c1351314f0aa35ce7a44c4a1460_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTUtNy0xLTEtNzMyNTM_c55aef7d-7b8c-4134-87e4-0b28c0a22ec3">14,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626df6b5d80b4e98b0edeaa02ad00831_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTYtMS0xLTEtNzMyNTM_b6c29017-c8fe-4bd1-9798-15145261e8b8">14,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if649f364c260430e996cc0e7faf77825_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTYtMy0xLTEtNzMyNTM_e57d396e-5112-4854-8ba6-14371266e3bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f48fccb6a964533ad0a2bc9fa1b69d4_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTYtNS0xLTEtNzMyNTM_4cbc0d2f-52b6-4585-978f-d2b3b0b98e37">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5d7c1351314f0aa35ce7a44c4a1460_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjA0NWE5ZmUyZWI0MjQzMThhMDM3YjAwYTk1NjhhYmFkL3RhYmxlcmFuZ2U6MDQ1YTlmZTJlYjQyNDMxOGEwMzdiMDBhOTU2OGFiYWRfMTYtNy0xLTEtNzMyNTM_bee800ca-cb65-41f3-a5db-a8481df13dc0">14,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds and time deposits are valued using relevant observable market inputs including quoted prices for similar assets and interest rate curves. Equity securities consist of investments for which the fair values were determined by using the published market price per unit multiplied by the number of units held, without consideration of transaction costs. The derivatives entered into by the company were valued using observable market inputs including published interest rate curves and both forward and spot prices for foreign currencies. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurements of the contingent consideration liabilities were determined based on significant unobservable inputs, including the discount rate, estimated probabilities and timing of achieving specified development, regulatory and commercial milestones and the estimated amount of future sales of the acquired products. The potential contingent consideration payments are estimated by applying a probability-weighted expected payment model for contingent milestone payments and a Monte Carlo simulation model for contingent royalty payments, which are then discounted to present value. Changes to the fair value of the contingent consideration liabilities can result from changes to one or a number of inputs, including discount rates, the probabilities of achieving the milestones, the time required to achieve the milestones and estimated future sales. Significant judgment is </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">13</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i3ced7f853c1c4ae1a585dd65d5426a15" continuedAt="i653d992abe1a41be812978532a3d9c4e"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employed in determining the appropriateness of certain of these inputs. Changes to the inputs described above could have a material impact on the company's financial position and results of operations in any given period. </span></div><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMDU_da4c56ee-ab84-436c-a951-b6b285156327" continuedAt="i59f9e4eefcf5436d81aa9f8e3489dad0" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the company's contingent consideration liabilities was calculated using the following significant unobservable inputs:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if76fd003b44e4e00b01dd0219527e8f6_I20220331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0xLTEtMS04MTA3OC90ZXh0cmVnaW9uOjJlOTI4ZjljOWU4NTRlNWZiMTYwNGY3ODQ4YWRlMTNmXzE2NDkyNjc0NDE2ODQ_d0e959fe-d860-4795-9cc3-b8545de9d413">0.9</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i3316afc52f864995939b74f4200c4d5d_I20220331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0xLTEtMS04MTA3OC90ZXh0cmVnaW9uOjJlOTI4ZjljOWU4NTRlNWZiMTYwNGY3ODQ4YWRlMTNmXzE2NDkyNjc0NDE2OTI_9c21d1ed-e8c7-4e75-a080-5a00391862a4">3.6</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie41be7ae9a7746e29ab56e1c3957336c_I20220331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0yLTEtMS04MTA4MC90ZXh0cmVnaW9uOmI2ODBhMDkwNGJjZTQ2ZmViMjljYmVjY2Y1NGIzYzMyXzI3NDg3NzkwNjk0NTA_cef10409-9e56-4640-b348-5c474e51230b">3.0</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibaaf5c1772824540821269f5a7d5d060_I20211231" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMS0xLTEtMS03MzI1My90ZXh0cmVnaW9uOjRhOWUwNTg1ZjEzODQ1Y2E4NzAzMzliOTdkNzlhOGMzXzI3NDg3NzkwNjk0NTM_65a9005a-a7d0-4fee-b00e-9235bc5a3160">0.2</ix:nonFraction>%- <ix:nonFraction unitRef="number" contextRef="i2e6a0250795b4caeb9007fccb2fb25e6_I20211231" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMS0xLTEtMS03MzI1My90ZXh0cmVnaW9uOjRhOWUwNTg1ZjEzODQ1Y2E4NzAzMzliOTdkNzlhOGMzXzI3NDg3NzkwNjk0NTY_a93bfc2a-eb8e-4cdd-b65f-f9573a7ae001">2.6</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7064869e3d004e11826a6f8e545956e8_I20211231" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMS0yLTEtMS03MzI1My90ZXh0cmVnaW9uOjgzM2JmZTkxZDBkZDQyMWE5NDI5NmQxMjEyNGE3M2MzXzI3NDg3NzkwNjk0NDQ_274ad924-0f34-4f79-977f-36dc21f67545">1.7</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment for unachieved milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib0e23bbc802e473d941d50ddec1eac96_I20220331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNC0xLTEtMS04MTA3OC90ZXh0cmVnaW9uOjViYmU5OGFkYWQwZTQ4M2VhMTE0YzQyNmJkOWUwNDhjXzE2NDkyNjc0NDE2ODM_1f720098-413b-4184-9b0d-dcc083ebdb84">89</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="idc34b4f0b824400cb3e06c112446fd78_I20220331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNC0xLTEtMS04MTA3OC90ZXh0cmVnaW9uOjViYmU5OGFkYWQwZTQ4M2VhMTE0YzQyNmJkOWUwNDhjXzI3NDg3NzkwNjk0NzM_df41c27a-8be9-4a76-afd6-6108f0c36160">100</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa6c770a5e4e43219c664f8eeaebc92b_I20220331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNC0yLTEtMS04MTA4MC90ZXh0cmVnaW9uOmMzYzcyMDAxZGQyNTQzNTRhYjBjZGRmMzEwOTkxMzQ0XzI3NDg3NzkwNjk0NTA_f621a23b-df7f-4771-a959-3f4a432c6de1">91</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifeca827be1174ca8b3b26a2dd3170414_I20211231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMi0xLTEtMS03MzI1My90ZXh0cmVnaW9uOjUyYjVhYWQ5ZDdjYTRlNWJhMjI0MWI4Y2I2MTQ1Mjk1XzI3NDg3NzkwNjk0NTE_210fd7dc-6734-4f08-8930-315215149d25">89</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i4c6e00071bb14c0f9134687f14d184c0_I20211231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMi0xLTEtMS03MzI1My90ZXh0cmVnaW9uOjUyYjVhYWQ5ZDdjYTRlNWJhMjI0MWI4Y2I2MTQ1Mjk1XzI3NDg3NzkwNjk0NTU_a06df4bd-66c5-42b7-bec1-a1d801b405b0">100</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40f7d8e61c394c11942ca3d90870ce76_I20211231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMi0yLTEtMS03MzI1My90ZXh0cmVnaW9uOmQ0MGEzNmJlOGMxYzRjM2RhOTE4ZWYwODI5MTZiYTcwXzI3NDg3NzkwNjk0NDQ_22cd617e-882f-4a62-a3a0-f377e022ebfd">90</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment for royalties by indication</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36a5db71b7bc44afa79f34197c0d50c0_I20220331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0xLTEtMS04MTA3OC90ZXh0cmVnaW9uOjhhOTdiMzJiNzRjNDQ3YjM5NDlmMWQ2MzEzNGY2ZTk5XzI3NDg3NzkwNjk0NTg_1139f260-ebf0-4997-a8bf-8e3e9c1797b3">56</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i3b7bbcb6f78a486c9aaaf2cc66ad620a_I20220331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0xLTEtMS04MTA3OC90ZXh0cmVnaW9uOjhhOTdiMzJiNzRjNDQ3YjM5NDlmMWQ2MzEzNGY2ZTk5XzI3NDg3NzkwNjk0NjY_34203fed-736d-478f-9829-5ad6abaa8128">100</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a58f36c0a0f455fb16aee3fddf5e537_I20220331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0yLTEtMS04MTA4MC90ZXh0cmVnaW9uOjZiMTY3ZWQzNGFiYjRkNDdiMTA0MzIyMDkyZTJlNGZjXzI3NDg3NzkwNjk0NTA_9cccc2a8-86e2-48fe-9f89-53bbf7e6c0f0">96</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c4ab8ef49f6437ea3dc95bf05981bfc_I20211231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0xLTEtMS03MzI1My90ZXh0cmVnaW9uOjM0NmYyMzM1ZDVmNDRhYWU5ZGJiNzc3ZDA4MTVlMTEzXzI3NDg3NzkwNjk0NDQ_7949dad9-89a4-41ee-b66a-7fc7207216bb">56</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i088dd727214a49e5bdaa60f93779a823_I20211231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0xLTEtMS03MzI1My90ZXh0cmVnaW9uOjM0NmYyMzM1ZDVmNDRhYWU5ZGJiNzc3ZDA4MTVlMTEzXzI3NDg3NzkwNjk0NTA_04ada94e-64b7-459a-a5dd-adeb4f6ea353">100</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3155754d608b4eb491cdd36b45bcc5de_I20211231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfMy0yLTEtMS03MzI1My90ZXh0cmVnaW9uOjMzNzFjODljMzFkYjQ3NGI5MTdlYjI1N2E0ZmI2OTcxXzI3NDg3NzkwNjk0NDQ_af625595-0582-4b93-a179-0e2dd45ed242">96</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86308a2e6f2a4ecfba5255d3af29d432_I20220331" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNy0xLTEtMS04MTA3OC90ZXh0cmVnaW9uOjk3YTdiZDUxZjg2ZjQ5NGJiZjY4YmZkZmVhOGEzMDhlXzI3NDg3NzkwNjk0NjI_3b0ced0f-8f99-4445-907a-3c0d71be910e">2022</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="id9678c4caaf349ba8006f44b404b1b82_I20220331" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNy0xLTEtMS04MTA3OC90ZXh0cmVnaW9uOjk3YTdiZDUxZjg2ZjQ5NGJiZjY4YmZkZmVhOGEzMDhlXzI3NDg3NzkwNjk0NzI_69b5d90e-c630-43e4-b77f-dbe9fdc99247">2034</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d2bc0b8db334803be5cea99172bad7f_I20220331" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNy0yLTEtMS04MTA4MC90ZXh0cmVnaW9uOjc2MzFmNTcxMzBkZTQyZjE4NmQ5MmEwNjk4ODM5MGM1XzI3NDg3NzkwNjk0NTA_6fba84dd-6dc2-4522-a73d-12e386424d43">2027</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdc8ba9e255b47fbb82c3c726dd8508a_I20211231" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0xLTEtMS03MzI1My90ZXh0cmVnaW9uOmU2OTRhY2VkY2VhOTQyMTc5YTIyZDVjNDA4ZTk1ZmMyXzI3NDg3NzkwNjk0NDQ_5fc5885d-234b-4571-8b62-077908990d07">2022</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="i1455f288cfc245b69c8e6fa1ee29a92c_I20211231" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0xLTEtMS03MzI1My90ZXh0cmVnaW9uOmU2OTRhY2VkY2VhOTQyMTc5YTIyZDVjNDA4ZTk1ZmMyXzI3NDg3NzkwNjk0NTE_7c73872c-d194-4650-b82e-07c88cc47f6f">2034</ix:nonFraction> </span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i653e387441bf474ba40509d89d957072_I20211231" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOjlkZmVkOTU3OGIxNzQ1ZDJhMTJjNGJiNDY3N2UxODkzL3RhYmxlcmFuZ2U6OWRmZWQ5NTc4YjE3NDVkMmExMmM0YmI0Njc3ZTE4OTNfNS0yLTEtMS03MzI1Mw_1e8fbd73-3e85-44c5-8cfb-b0e0822a4975">2027</ix:nonFraction></span></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMTQ_721db4ae-4305-482d-b373-ec8b16aa1b8a" footnoteRole="http://www.xbrl.org/2003/role/footnote">(a) Unobservable inputs were weighted by the relative fair value of the contingent consideration liabilities.</ix:footnote></span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMDY_84d7cab9-93ac-4fc8-a39f-7622c4e8652b" footnoteRole="http://www.xbrl.org/2003/role/footnote"><ix:continuation id="i59f9e4eefcf5436d81aa9f8e3489dad0">(b) Excluding approved indications, the estimated probability of payment ranged from <ix:nonFraction unitRef="number" contextRef="i01d4a0312e1a42c1bbb49eebf6fb2dbc_I20211231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjc0ODc3OTA5NTI1Mg_0f1e56d2-f43a-4f83-bd88-7a819ad1ed4f"><ix:nonFraction unitRef="number" contextRef="ib6f0399851154ccb8d747ab261a55ff7_I20220331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjc0ODc3OTA5NTI1Mg_2255b661-58b9-448c-a8da-5793bd88bc4d">56</ix:nonFraction></ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i5e22014612a6456496ade50c3c0e598b_I20220331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjc0ODc3OTA5NTI1OA_5d256177-b7e1-4915-a8f0-e491dbb9f298"><ix:nonFraction unitRef="number" contextRef="i6150f60c782f4bbe93e9e862b343af55_I20211231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMjc0ODc3OTA5NTI1OA_6cae88be-9805-4211-99eb-5aa8a24bbdff">89</ix:nonFraction></ix:nonFraction>% at March 31, 2022 and December 31, 2021.</ix:continuation> </ix:footnote></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been <ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="INF" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNzkyNw_23556952-0e2b-4c08-99c0-2f6b33baa242"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="INF" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNzkyNw_a1ddc400-ce0f-422f-8b58-502ad0d49b57"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="INF" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNzkyNw_af6a8924-aea1-477c-aff9-2976d067f7e6"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="INF" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfNzkyNw_cd407c3f-3b97-4b47-80da-3d25ae11fcb2">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> transfers of assets or liabilities into or out of Level 3 of the fair value hierarchy. <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIwOTA_100b962c-957a-43d3-a551-059f15431102" continuedAt="i2e62e9d6612049bf966586cbe30b8cc6" escape="true">The following table presents the changes in fair value of total contingent consideration liabilities which are measured using Level 3 inputs:</ix:nonNumeric></span><ix:continuation id="i2e62e9d6612049bf966586cbe30b8cc6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmNhMDVlMjFjZjQ3ZjQ4YTk4YmY2YzcwMWQwNTk5NmI5L3RhYmxlcmFuZ2U6Y2EwNWUyMWNmNDdmNDhhOThiZjZjNzAxZDA1OTk2YjlfMi0yLTEtMS03MzI1Mw_fce6ad73-5c38-4177-9519-e43dde40a9f1">14,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6accb844205d4e909ea7d6f406d2b865_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmNhMDVlMjFjZjQ3ZjQ4YTk4YmY2YzcwMWQwNTk5NmI5L3RhYmxlcmFuZ2U6Y2EwNWUyMWNmNDdmNDhhOThiZjZjNzAxZDA1OTk2YjlfMi00LTEtMS03MzI1Mw_382bb798-b551-4fda-96c6-4742e882011a">12,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmNhMDVlMjFjZjQ3ZjQ4YTk4YmY2YzcwMWQwNTk5NmI5L3RhYmxlcmFuZ2U6Y2EwNWUyMWNmNDdmNDhhOThiZjZjNzAxZDA1OTk2YjlfNC0yLTEtMS03MzI1Mw_69b0b4be-0d5c-4446-bbee-159e6cd2147d">748</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmNhMDVlMjFjZjQ3ZjQ4YTk4YmY2YzcwMWQwNTk5NmI5L3RhYmxlcmFuZ2U6Y2EwNWUyMWNmNDdmNDhhOThiZjZjNzAxZDA1OTk2YjlfNC00LTEtMS03MzI1Mw_402c8bb3-37d5-4303-ad01-b5d357d25499">343</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmNhMDVlMjFjZjQ3ZjQ4YTk4YmY2YzcwMWQwNTk5NmI5L3RhYmxlcmFuZ2U6Y2EwNWUyMWNmNDdmNDhhOThiZjZjNzAxZDA1OTk2YjlfNS0yLTEtMS03MzI1Mw_ddd6632d-52b8-4685-8f09-71053e6937ec">321</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmNhMDVlMjFjZjQ3ZjQ4YTk4YmY2YzcwMWQwNTk5NmI5L3RhYmxlcmFuZ2U6Y2EwNWUyMWNmNDdmNDhhOThiZjZjNzAxZDA1OTk2YjlfNS00LTEtMS03MzI1Mw_507e5aca-753b-4eca-8887-24c735a1ffc0">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmNhMDVlMjFjZjQ3ZjQ4YTk4YmY2YzcwMWQwNTk5NmI5L3RhYmxlcmFuZ2U6Y2EwNWUyMWNmNDdmNDhhOThiZjZjNzAxZDA1OTk2YjlfNi0yLTEtMS03MzI1Mw_fb7fd865-7fc9-4ae9-9f22-c448c227954e">13,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf70c299b6747128fa4a148bd06c306_I20210331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmNhMDVlMjFjZjQ3ZjQ4YTk4YmY2YzcwMWQwNTk5NmI5L3RhYmxlcmFuZ2U6Y2EwNWUyMWNmNDdmNDhhOThiZjZjNzAxZDA1OTk2YjlfNi00LTEtMS03MzI1Mw_9a4f4f93-61f5-4419-9bfc-48b8555f4253">12,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value recognized in net earnings is recorded in other income, net in the condensed consolidated statements of earnings. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain financial instruments are carried at historical cost or some basis other than fair value. <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTIxMDM_910c352f-0926-4622-bb36-74058eab4e5c" continuedAt="ibcb25eeb717e4fc882fb7f8abc22200b" escape="true">The book values, approximate fair values and bases used to measure the approximate fair values of certain financial instruments as of March 31, 2022 are shown in the table below:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ibcb25eeb717e4fc882fb7f8abc22200b" continuedAt="i9a43199d8d074513b383ff5d2afdb7a3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis&#160;of&#160;fair&#160;value&#160;measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Book value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;prices in&#160;active markets for identical assets <br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant other&#160;<br/>observable inputs <br/>(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant unobservable inputs <br/>(Level&#160;3)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044a3d7ac50441e494f6a05e1c9a61b5_I20220331" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfNi0xLTEtMS03MzI1Mw_ec6557c6-4e00-49e1-81e3-3d8e78bb9032">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42be951e40b4522978f85dbcf5c6c5f_I20220331" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfNi0yLTEtMS03MzI1Mw_26abb2c2-8d6f-4b23-8f78-5884b5ada290">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077c77a1980b4f8fb626087d04f359c2_I20220331" decimals="-6" name="us-gaap:ShorttermDebtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfNi00LTEtMS03MzI1Mw_4edc8536-dbfc-4d47-a360-c1dbf775b231">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c0cf7b896574cd48467e517534d6c7e_I20220331" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfNi02LTEtMS03MzI1Mw_84a5019b-fda2-49c4-beae-82c72713fb14">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1f25b805ee48a38221900a8f4ec23b_I20220331" decimals="-6" name="us-gaap:ShorttermDebtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfNi04LTEtMS03MzI1Mw_a93b2245-d4ce-46ff-92d2-ffef3954ffae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt and finance lease obligations, excluding fair value hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044a3d7ac50441e494f6a05e1c9a61b5_I20220331" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfNy0xLTEtMS03MzI1Mw_84476e5c-8d7c-4829-abc2-5b2abefad4cb">9,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42be951e40b4522978f85dbcf5c6c5f_I20220331" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfNy0yLTEtMS03MzI1Mw_2d05748d-9d90-4bda-a163-b79dd691ac53">9,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a0fb1ead0c4427aa4a771f260c12ddb_I20220331" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfNy00LTEtMS03MzI1Mw_8e5f56b3-b846-4db2-81a8-d0a46ca894f6">8,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c0cf7b896574cd48467e517534d6c7e_I20220331" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfNy02LTEtMS03MzI1Mw_d39416d2-d5dc-4a4e-b778-e83d341839a4">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1f25b805ee48a38221900a8f4ec23b_I20220331" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfNy04LTEtMS03MzI1Mw_385b0e1d-dd16-4a9e-a97f-0c11faa81e4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations, excluding fair value hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044a3d7ac50441e494f6a05e1c9a61b5_I20220331" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfOC0xLTEtMS03MzI1Mw_18332905-2e8b-4488-8522-4f92e26c2e06">63,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42be951e40b4522978f85dbcf5c6c5f_I20220331" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfOC0yLTEtMS03MzI1Mw_98dc593e-30d3-42f3-87ad-743d1255ce0d">65,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a0fb1ead0c4427aa4a771f260c12ddb_I20220331" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfOC00LTEtMS03MzI1Mw_580f34ac-5a65-413f-a94c-e98086ef8be0">64,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c0cf7b896574cd48467e517534d6c7e_I20220331" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfOC02LTEtMS03MzI1Mw_e1d8151d-5ef5-46a2-812c-76cc2306d387">876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1f25b805ee48a38221900a8f4ec23b_I20220331" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfOC04LTEtMS03MzI1Mw_3a014d2e-8f45-461e-ad3d-30d5e202d284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044a3d7ac50441e494f6a05e1c9a61b5_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfOS0xLTEtMS03MzI1Mw_b5ec4535-03a9-44c8-ba5c-213b706d3a7f">73,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42be951e40b4522978f85dbcf5c6c5f_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfOS0yLTEtMS03MzI1Mw_3ce24172-3512-436b-8cd2-6a96844f948d">75,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a0fb1ead0c4427aa4a771f260c12ddb_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfOS00LTEtMS03MzI1Mw_d9559910-c28d-4090-b849-0bc02256f3cd">73,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c0cf7b896574cd48467e517534d6c7e_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfOS02LTEtMS03MzI1Mw_77c5a49d-c00e-411e-8308-9e31bed78efa">1,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1f25b805ee48a38221900a8f4ec23b_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmYxZTNmOGY0YTdhNjRjYzE4YThmODA4OTQwYzFmNjQ1L3RhYmxlcmFuZ2U6ZjFlM2Y4ZjRhN2E2NGNjMThhOGY4MDg5NDBjMWY2NDVfOS04LTEtMS03MzI1Mw_17815096-4c3e-4b4f-a2ae-32b2837f3ff2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">14</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i653d992abe1a41be812978532a3d9c4e"><div style="margin-bottom:8pt;margin-top:8pt"><ix:continuation id="i9a43199d8d074513b383ff5d2afdb7a3"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The book values, approximate fair values and bases used to measure the approximate fair values of certain financial instruments as of December 31, 2021 are shown in the table below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis&#160;of&#160;fair&#160;value&#160;measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Book value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;prices in&#160;active markets for identical assets <br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant other&#160;<br/>observable inputs <br/>(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant unobservable inputs <br/>(Level&#160;3)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6c49899324342418b3c03ecab096e69_I20211231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfNi0xLTEtMS03MzI1Mw_3ea8bba2-220c-4c8f-bc45-6f40036305aa">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93bb319518438dacf0fb870fcabe09_I20211231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfNi0yLTEtMS03MzI1Mw_10165b74-d3be-402f-a798-ab22fec74d61">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3079fe6a94b4043bd136bd42880f7e2_I20211231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfNi00LTEtMS03MzI1Mw_8401bdd8-e6ba-4ae3-9d19-14252e1f0720">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaafb386815a84014b6e79d88e23df483_I20211231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfNi02LTEtMS03MzI1Mw_bd649abc-9610-4bba-9fed-c1e33c4212c6">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i683f0aac0c634dfca6b9b368ab20372a_I20211231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfNi04LTEtMS03MzI1Mw_7a2ee053-2092-4357-a168-b009f2343221">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt and finance lease obligations, excluding fair value hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6c49899324342418b3c03ecab096e69_I20211231" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfNy0xLTEtMS03MzI1Mw_e863d395-3e03-4939-a8e1-09b7bb71d98f">12,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93bb319518438dacf0fb870fcabe09_I20211231" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfNy0yLTEtMS03MzI1Mw_911f0c63-673b-462a-86de-546bafb39438">11,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb19f61a177a44cc83608f369fc35200_I20211231" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfNy00LTEtMS03MzI1Mw_d1d82fd7-5546-4daa-ac7c-a28e80662c0c">11,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaafb386815a84014b6e79d88e23df483_I20211231" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfNy02LTEtMS03MzI1Mw_88a73813-5a00-4e32-860a-e73188283410">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i683f0aac0c634dfca6b9b368ab20372a_I20211231" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfNy04LTEtMS03MzI1Mw_c55c3667-d87c-4374-841f-4f7722190513">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations, excluding fair value hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6c49899324342418b3c03ecab096e69_I20211231" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfOC0xLTEtMS03MzI1Mw_d50e863c-3edb-4679-88a8-de32e17f85b8">64,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93bb319518438dacf0fb870fcabe09_I20211231" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfOC0yLTEtMS03MzI1Mw_d846bc2b-8e9a-415e-b09d-c68a7c1c3bad">71,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb19f61a177a44cc83608f369fc35200_I20211231" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfOC00LTEtMS03MzI1Mw_6974b90c-2316-4faf-b7e7-0ee6b474cb5f">70,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaafb386815a84014b6e79d88e23df483_I20211231" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfOC02LTEtMS03MzI1Mw_560b71b5-1de2-46ef-838e-38343a0ffe61">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i683f0aac0c634dfca6b9b368ab20372a_I20211231" decimals="-6" name="abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfOC04LTEtMS03MzI1Mw_f1294b3a-c59f-4daa-9318-5ab545c32267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6c49899324342418b3c03ecab096e69_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfOS0xLTEtMS03MzI1Mw_4971d2e4-0359-4820-9b6f-90e7b818b0cd">76,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93bb319518438dacf0fb870fcabe09_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfOS0yLTEtMS03MzI1Mw_9bcba3f5-2edd-4014-9ece-72d663988109">83,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb19f61a177a44cc83608f369fc35200_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfOS00LTEtMS03MzI1Mw_185d839a-d1b3-46bc-9ba8-30f36fcc66f2">82,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaafb386815a84014b6e79d88e23df483_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfOS02LTEtMS03MzI1Mw_6afbfdbc-88a5-49b6-80d2-4204a334b10c">1,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i683f0aac0c634dfca6b9b368ab20372a_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RhYmxlOmIyNzFmMmM3NTZjNTQxZjM5YmY1YjNlMTg4YjJkNWNjL3RhYmxlcmFuZ2U6YjI3MWYyYzc1NmM1NDFmMzliZjViM2UxODhiMmQ1Y2NfOS04LTEtMS03MzI1Mw_0f30e809-712e-4355-9e87-d25d1a5a6634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie also holds investments in equity securities that do not have readily determinable fair values. The company records these investments at cost and remeasures them to fair value based on certain observable price changes or impairment events as they occur. The carrying amount of these investments was $<ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfOTA3MQ_f68f08ac-ad79-4287-a6bd-9521dd11fbdb">147</ix:nonFraction> million as of March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i3ee167f36562471dab7b2f232caad9ae_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfOTA4Nw_b215e944-2c71-4796-a771-f3f906066a22">149</ix:nonFraction> million as of December 31, 2021. No significant cumulative upward or downward adjustments have been recorded for these investments as of March 31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of total net accounts receivable, <ix:nonFraction unitRef="wholesaler" contextRef="i95aad88173d14db798e85a935c24c68b_D20220101-20220331" decimals="INF" name="abbv:NumberOfPrincipalUSCustomers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfOTI2NQ_a5b25310-07b4-411f-b9e4-032274334647">three</ix:nonFraction> U.S. wholesalers accounted for <ix:nonFraction unitRef="number" contextRef="i6a1415a76d304bdd903790a631d4b562_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfOTI5OQ_5d33445e-e46f-4316-87d7-532b0571ebd9">74</ix:nonFraction>% as of March 31, 2022 and <ix:nonFraction unitRef="number" contextRef="ie5fd10e4797b4759b2ad9ee884eb18fb_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfOTMxNQ_c0a1db7f-bd06-4c2a-97c4-0af505732cb6">75</ix:nonFraction>% as of December 31, 2021, and substantially all of AbbVie&#8217;s pharmaceutical product net revenues in the United States were to these <ix:nonFraction unitRef="wholesaler" contextRef="i95aad88173d14db798e85a935c24c68b_D20220101-20220331" decimals="INF" name="abbv:NumberOfPrincipalUSCustomers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfOTQxMA_a5b25310-07b4-411f-b9e4-032274334647">three</ix:nonFraction> wholesalers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humira (adalimumab) is AbbVie&#8217;s single largest product and accounted for approximately <ix:nonFraction unitRef="number" contextRef="idb70f3e9a3064175beb5a4288f9555cf_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfOTUxMw_7808ce34-b29f-4709-83ae-46e43eff3a3e">35</ix:nonFraction>% of AbbVie&#8217;s total net revenues for the three months ended March 31, 2022 and <ix:nonFraction unitRef="number" contextRef="i598f780a95a34397b93cc33d29482fbf_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfOTU2Mg_917b7ce7-3452-49c4-b914-ec1d6eddfdd6">37</ix:nonFraction>% for the three months ended March 31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt and Credit Facilities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the company repaid $<ix:nonFraction unitRef="usd" contextRef="if319dff6fb6d4c9b9e70b7590afec644_D20220101-20220131" decimals="-8" sign="-" name="us-gaap:ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMzg0ODI5MDcyMjAyMg_9f655c38-f9e0-4c0f-9e6c-171b85fe79ba">2.9</ix:nonFraction> billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="id24046754e794d98901ac09a9a57728a_I20220131" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTA5OTUxMTY1OTY4NQ_61f8e13e-05d8-4793-a527-3482e9abff51">3.45</ix:nonFraction>% senior notes that were scheduled to mature in March 2022. This repayment was made by exercising, under the terms of the notes, 60-day early redemption at 100% of the principal amount.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the company refinanced its $<ix:nonFraction unitRef="usd" contextRef="ia646a389a6944ee39075a400a0260d9f_I20220228" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTA5OTUxMTY1NTY5Mw_6c281ecd-4bfb-4950-bd00-cd6d64125b93">2.0</ix:nonFraction> billion floating rate <ix:nonNumeric contextRef="iedf4aed6ce494fb0b76f1715e4bc5fdb_D20220201-20220228" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTY0OTI2NzQ2OTUwOQ_f2dce082-cda0-4d85-94ff-78e1b132304f">five-year</ix:nonNumeric> term loan. As part of the refinancing, the company repaid the existing $<ix:nonFraction unitRef="usd" contextRef="iedf4aed6ce494fb0b76f1715e4bc5fdb_D20220201-20220228" decimals="-8" sign="-" name="us-gaap:ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTY0OTI2NzQ2OTU3NA_e8717d41-5c5a-4d99-bf5d-eacfa9e70753">2.0</ix:nonFraction> billion term loan due May 2025 and borrowed $<ix:nonFraction unitRef="usd" contextRef="i5d290b478df340cb86cfefef5344e881_I20220228" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183MC9mcmFnOjNkYjc4MTIwZTI1NDQ0ZDQ4Y2UyNGJkMTMzZDUxZTYwL3RleHRyZWdpb246M2RiNzgxMjBlMjU0NDRkNDhjZTI0YmQxMzNkNTFlNjBfMTY0OTI2NzQ2OTU1OA_20253348-c9b2-427e-9cf5-c90c19f3ad85">2.0</ix:nonFraction> billion under a new term loan at a lower floating rate. All other significant terms of the loan, including the maturity date, remained unchanged after the refinancing.</span></div></ix:continuation><div id="ic89f06320f9c4f57b19c511822f36cac_76"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 9</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:PostemploymentBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RleHRyZWdpb246MzBmOWVmMjk3MGRjNDk3NTg5NjZjNDNkZTM1OTc3OWZfMjQ0_edc7fb5f-7c2d-4e7a-943b-743e976a2431" continuedAt="i7cd35ce7cf8d45b791b836a8a6536a1e" escape="true"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Post-Employment Benefits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RleHRyZWdpb246MzBmOWVmMjk3MGRjNDk3NTg5NjZjNDNkZTM1OTc3OWZfMjQ3_73bb8d3f-d8a6-4688-ba7c-901f4fd7ebae" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes net periodic benefit cost relating to the company&#8217;s defined benefit and other post-employment plans:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined <br/>benefit&#160;plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;post- <br/>employment&#160;plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5efb5d06f0c4acd9a7f96ddd5917965_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfMy01LTEtMS03MzI1Mw_488dd1c4-fcac-44dd-9935-5adc427c4f1c">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3cf0076169046e2a8a90c274b32e1a5_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfMy03LTEtMS03MzI1Mw_0d51ac4d-cc5a-4fd9-b15b-deee1d9ffb74">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f119ab76784686b6ca0d67fd748f1b_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfMy05LTEtMS03MzI1Mw_97b56fd3-7f4e-42ba-b83e-2e5267ecc0be">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336829d47f964430a3f3ec676b1093ab_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfMy0xMS0xLTEtNzMyNTM_671f4df8-a67d-4a87-859e-ca84e423df81">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5efb5d06f0c4acd9a7f96ddd5917965_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNC01LTEtMS03MzI1Mw_c7e579ce-a731-45b7-821b-14318b84178b">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3cf0076169046e2a8a90c274b32e1a5_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNC03LTEtMS03MzI1Mw_5ad2697c-86f1-4d42-9ce3-85e0c4a77b4e">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f119ab76784686b6ca0d67fd748f1b_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNC05LTEtMS03MzI1Mw_afbe2674-a3cf-4625-ae85-c20dff5f616e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336829d47f964430a3f3ec676b1093ab_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNC0xMS0xLTEtNzMyNTM_e70d36eb-a7a4-4b49-b853-38bc644b8f0f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5efb5d06f0c4acd9a7f96ddd5917965_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNS01LTEtMS03MzI1Mw_2fcf2d22-9d64-4cc2-8281-d38e9e8b987e">180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3cf0076169046e2a8a90c274b32e1a5_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNS03LTEtMS03MzI1Mw_e0c3c265-1736-4ae4-bf59-d05b0658672a">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f119ab76784686b6ca0d67fd748f1b_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNS05LTEtMS03MzI1Mw_caafee07-dbd1-41cd-9da1-781266df324c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336829d47f964430a3f3ec676b1093ab_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNS0xMS0xLTEtNzMyNTM_043cdd3a-76b0-4390-a35a-aec8d8795b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost (credit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5efb5d06f0c4acd9a7f96ddd5917965_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNi01LTEtMS03MzI1Mw_d07abbcd-738d-4ed6-b400-345e7a982614">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3cf0076169046e2a8a90c274b32e1a5_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNi03LTEtMS03MzI1Mw_5868af74-f1ca-48b9-9f3d-e2fa478c0796">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8f119ab76784686b6ca0d67fd748f1b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNi05LTEtMS03MzI1Mw_4663028c-2c6b-4ecc-a7eb-7991a7c1d27a">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336829d47f964430a3f3ec676b1093ab_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNi0xMS0xLTEtNzMyNTM_2bea99c9-92fa-40a1-80ad-30d6361b6993">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5efb5d06f0c4acd9a7f96ddd5917965_D20220101-20220331" decimals="-6" sign="-" name="abbv:DefinedBenefitPlanAmortizationOfActuarialGainLossPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNy01LTEtMS03MzI1Mw_342d4792-b1f1-4dbd-a881-a75475c86b6d">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3cf0076169046e2a8a90c274b32e1a5_D20210101-20210331" decimals="-6" sign="-" name="abbv:DefinedBenefitPlanAmortizationOfActuarialGainLossPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNy03LTEtMS03MzI1Mw_c3665630-32e5-45b0-b7c4-7c9484eab28b">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f119ab76784686b6ca0d67fd748f1b_D20220101-20220331" decimals="-6" sign="-" name="abbv:DefinedBenefitPlanAmortizationOfActuarialGainLossPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNy05LTEtMS03MzI1Mw_3e8f75c8-4cf7-4175-8c23-da7997a30086">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336829d47f964430a3f3ec676b1093ab_D20210101-20210331" decimals="-6" sign="-" name="abbv:DefinedBenefitPlanAmortizationOfActuarialGainLossPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfNy0xMS0xLTEtNzMyNTM_b3b361d6-a2b6-404a-909b-5bea4958777e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5efb5d06f0c4acd9a7f96ddd5917965_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfOC01LTEtMS03MzI1Mw_07c564b2-7ddc-44b8-92c4-825f960211b0">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3cf0076169046e2a8a90c274b32e1a5_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfOC03LTEtMS03MzI1Mw_9e68bcf6-f68d-4a67-a76c-c1106de49f54">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f119ab76784686b6ca0d67fd748f1b_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfOC05LTEtMS03MzI1Mw_f658938d-68ec-4d89-996a-138a1197afbc">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336829d47f964430a3f3ec676b1093ab_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY183Ni9mcmFnOjMwZjllZjI5NzBkYzQ5NzU4OTY2YzQzZGUzNTk3NzlmL3RhYmxlOmJlOTk0Mzk2NWM2NTRmYTk4YTA2MjRkZGI2YWM5NzNjL3RhYmxlcmFuZ2U6YmU5OTQzOTY1YzY1NGZhOThhMDYyNGRkYjZhYzk3M2NfOC0xMS0xLTEtNzMyNTM_29570d0a-0a66-4254-a97d-fc4de62ab605">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7cd35ce7cf8d45b791b836a8a6536a1e">The components of net periodic benefit cost other than service cost are included in other income, net in the condensed consolidated statements of earnings.</ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">15</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_82"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 10 <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMzAwMQ_647a1771-735b-4506-b0a5-95143bbe25de" continuedAt="ib646fc8b0806444aa881f041d36654b0" escape="true">Equity</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="ib646fc8b0806444aa881f041d36654b0" continuedAt="i20fa6a6b29fe432293dc90c233bfe75b">Stock-Based Compensation</ix:continuation></span></div><ix:continuation id="i20fa6a6b29fe432293dc90c233bfe75b" continuedAt="i622cdc1d751040dbafda97df89408140"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, stockholders of the company approved the AbbVie Amended and Restated 2013 Incentive Stock Program (the Amended Plan), which amends and restates the AbbVie 2013 Incentive Stock Program. <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjk2NA_a4a4e6a0-1a26-45a7-b9ca-c51c1678f893" continuedAt="i364b730502e54296aa4a668d6128e057" escape="true">Stock-based compensation expense is principally related to awards issued pursuant to the AbbVie 2013 Incentive Stock Program and the Amended Plan and is summarized as follows:</ix:nonNumeric></span><ix:continuation id="i364b730502e54296aa4a668d6128e057"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79841cf14ea346c48bdbc856f1e4b860_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfMi02LTEtMS03MzI1Mw_ccc8a0d7-a255-46c0-8c21-d5db2870edb9">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88ba3758b6c416da9c9db84a7ca5778_D20210101-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfMi04LTEtMS03MzI1Mw_ba1cba0d-4db2-4283-b027-b53e699209af">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26f9a43336ae4b0da381254b468ae09c_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfMy02LTEtMS03MzI1Mw_9610329e-e7c6-4798-ac02-a7cf98b279bc">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7badfe6657634d348d22e9be1faa35ea_D20210101-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfMy04LTEtMS03MzI1Mw_4fd7e9ba-9f06-4efd-8570-14b16a0e1486">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54988d2c4f2f40c2933727e2b8be27ff_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfNC02LTEtMS03MzI1Mw_3f68270d-d044-4237-ad67-9bdf82e3a6ab">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3001aef538c54c44b5812a99e4845adc_D20210101-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfNC04LTEtMS03MzI1Mw_6a259d62-9ef1-4062-b2b4-18fa1d446484">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax compensation expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfNS02LTEtMS03MzI1Mw_4bc27963-ae21-4d83-8e86-bc3433f1ba29">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfNS04LTEtMS03MzI1Mw_caeb63a6-cd2f-467b-874d-cd9fac28b578">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfNi02LTEtMS03MzI1Mw_566a1e70-5b8f-4390-b16c-dce120b72695">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfNi04LTEtMS03MzI1Mw_7f959620-ef5d-404f-8384-9131c6b1871c">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax compensation expense</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfNy02LTEtMS03MzI1Mw_d1151ec7-62c5-4366-b468-5d2de4e9488a">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjI2YWRhNTY0NjUzMTRhZGQ5MGY2MGEyZDBiOTUwMDNjL3RhYmxlcmFuZ2U6MjZhZGE1NjQ2NTMxNGFkZDkwZjYwYTJkMGI5NTAwM2NfNy04LTEtMS03MzI1Mw_7cce9d1b-6a90-4c2a-9b9a-bcceccdf42a2">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2022, primarily in connection with the company's annual grant, AbbVie granted <ix:nonFraction unitRef="shares" contextRef="i8391b17f0e1049f9be08ea7161a2487c_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfNjM5_6cfa84db-b077-4a76-8c35-be6a353a7a19">0.9</ix:nonFraction>&#160;million stock options with a weighted-average grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8391b17f0e1049f9be08ea7161a2487c_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfNzA1_a2be6f5d-6ea0-401b-aec1-8630750af893">22.83</ix:nonFraction>. As of March 31, 2022, $<ix:nonFraction unitRef="usd" contextRef="icbf3ce65514c443c8ef37159d35d4a69_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfNzE5_edcb99ef-15e6-4953-8a25-7705b333973d">15</ix:nonFraction> million of unrecognized compensation cost related to stock options is expected to be recognized as expense over approximately the next <ix:nonNumeric contextRef="i8391b17f0e1049f9be08ea7161a2487c_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfODQ5_0c6c36dc-7142-4841-8116-fd5a2deb3a98">two years</ix:nonNumeric>.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RSUs and Performance Shares</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2022, primarily in connection with the company's annual grant, AbbVie granted <ix:nonFraction unitRef="shares" contextRef="i5e56837ed6bd423c89d802b44906df17_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfOTY4_661e766a-c6fa-4471-8ad1-b29ece80f8c5">5.6</ix:nonFraction>&#160;million RSUs and performance shares with a weighted-average grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic438b74601344b28a5a621e09638dfa5_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMTA0OA_552814b6-7048-48c5-a599-f21a0017f810">145.54</ix:nonFraction>. As of March 31, 2022, $<ix:nonFraction unitRef="usd" contextRef="ic438b74601344b28a5a621e09638dfa5_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMTA2Mg_f51142f9-bd0c-490f-b39e-73842ea982b2">955</ix:nonFraction>&#160;million of unrecognized compensation cost related to RSUs and performance shares is expected to be recognized as expense over approximately the next <ix:nonNumeric contextRef="i5e56837ed6bd423c89d802b44906df17_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMTIwNg_4b07e495-1675-49f4-bc7b-f808ec978f71">two years</ix:nonNumeric>.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends</span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfDividendsPayableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjk3Nw_a29c418f-3295-451c-80f6-28f821617c97" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes quarterly cash dividends declared during 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend Per Share</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date Declared</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend Per Share</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2d2926;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02/17/22</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2d2926;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">05/16/22</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bcd77a684aa4ecf8e6a62f0794f8418_D20220217-20220217" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjYxYWM2YTAwZTZhMzRhMWE5MGNlM2NlZWQ2YzFmYjM5L3RhYmxlcmFuZ2U6NjFhYzZhMDBlNmEzNGExYTkwY2UzY2VlZDZjMWZiMzlfMi00LTEtMS03MzI1Mw_4f25a377-5652-41bc-b521-14c47d6f1df9">1.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2d2926;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/29/21</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2d2926;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02/15/22</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e438a1448d44f418e9b8f452ccf2783_D20211029-20211029" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjYxYWM2YTAwZTZhMzRhMWE5MGNlM2NlZWQ2YzFmYjM5L3RhYmxlcmFuZ2U6NjFhYzZhMDBlNmEzNGExYTkwY2UzY2VlZDZjMWZiMzlfMi0xMC0xLTEtNzMyNTM_b7f3d94c-d607-427b-a2d2-dce7341ade81">1.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2d2926;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/10/21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2d2926;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/15/21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2670f469a2ac4a459ccecfc909f364ee_D20210910-20210910" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjYxYWM2YTAwZTZhMzRhMWE5MGNlM2NlZWQ2YzFmYjM5L3RhYmxlcmFuZ2U6NjFhYzZhMDBlNmEzNGExYTkwY2UzY2VlZDZjMWZiMzlfMy0xMC0xLTEtNzMyNTM_a8f02438-c7e2-467d-ab5c-412ecffb35a9">1.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2d2926;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">06/17/21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2d2926;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">08/16/21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i72db19201e77427a944de55507b7fe80_D20210617-20210617" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjYxYWM2YTAwZTZhMzRhMWE5MGNlM2NlZWQ2YzFmYjM5L3RhYmxlcmFuZ2U6NjFhYzZhMDBlNmEzNGExYTkwY2UzY2VlZDZjMWZiMzlfNC0xMC0xLTEtNzMyNTM_9ca16ffc-57cc-49bd-9836-56032288399d">1.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2d2926;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02/18/21</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2d2926;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">05/14/21</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i300fb3fc7b084fe1ae13da9f57c82d71_D20210218-20210218" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjYxYWM2YTAwZTZhMzRhMWE5MGNlM2NlZWQ2YzFmYjM5L3RhYmxlcmFuZ2U6NjFhYzZhMDBlNmEzNGExYTkwY2UzY2VlZDZjMWZiMzlfNS0xMC0xLTEtNzMyNTM_00b22f3e-6b11-46ad-a647-6b77aee89359">1.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's stock repurchase authorization permits purchases of AbbVie shares from time to time in open-market or private transactions at management's discretion. The program has no time limit and can be discontinued at any time. Shares repurchased under this program are recorded at acquisition cost, including related expenses, and are available for general corporate purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie repurchased <ix:nonFraction unitRef="shares" contextRef="ib694cd894894414da5c46138d815dd90_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMTczNQ_179d288c-4c4b-4176-8afd-d7c1676d3c39">8</ix:nonFraction>&#160;million shares for $<ix:nonFraction unitRef="usd" contextRef="ib694cd894894414da5c46138d815dd90_D20220101-20220331" decimals="-8" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMTc0OQ_ace58bd0-32f9-4b38-9b4a-feb688038a57">1.1</ix:nonFraction>&#160;billion during the three months ended March 31, 2022 and <ix:nonFraction unitRef="shares" contextRef="i6bcc50f777fb4122a035380de5a8418a_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMTc3MA_472345c8-7d01-49d7-9aff-40e3e35ceb0e">5</ix:nonFraction>&#160;million shares for $<ix:nonFraction unitRef="usd" contextRef="i6bcc50f777fb4122a035380de5a8418a_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMTc4NA_c73e7f8e-8391-46a6-aed4-3648918de159">550</ix:nonFraction>&#160;million during the three months ended March 31, 2021. AbbVie's remaining stock repurchase authorization was approximately $<ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMTg3MA_114f1288-7ee2-4d45-8e0e-35269d11d62a">1.4</ix:nonFraction>&#160;billion as of March 31, 2022.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">16</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i622cdc1d751040dbafda97df89408140" continuedAt="i8e2925967be2463eaf328135ee6b9ab3"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss </span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjk2MQ_21423e4f-a9b1-4c84-bfca-b2a59f1c6fb0" continuedAt="i65d6407736b0414488df938c58a3eb97" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in each component of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency <br/>translation adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net investment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">hedging activities</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">and post-employment <br/>benefits</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flow hedging <br/>activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30d113b6de524e999e45640992e7d5f9_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMS0xLTEtMS03MzI1Mw_77f70682-aa47-4061-b81c-c1e5cc33936d">570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic307ce6fcfdb4b95a357b18194e6695a_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMS0zLTEtMS03MzI1Mw_ed9efadd-0b70-4c28-a654-3ba3fdffec44">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4482ed129142548aa3b7aba9e6e05f_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMS01LTEtMS03MzI1Mw_87a60b0f-b93c-46cf-b77a-d210f3b60ade">2,546</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b80412b07c14765b60765c6863daf16_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMS05LTEtMS03MzI1Mw_fd66df94-3e37-4172-870b-7d694403bb60">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i305d5315aa3249959cf54167f51117a7_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMS0xMS0xLTEtNzMyNTM_3a7f76fd-01d7-4286-bce0-85eaa3e36fb7">2,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ef7519873594295b569d2ed9d013d3b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMi0xLTEtMS03MzI1Mw_f8b1b970-28c1-417a-a13c-accc19b34ed4">231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5c66dc788a1430581c272b0c716b06a_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMi0zLTEtMS03MzI1Mw_0c196775-8afa-4e06-abd0-8ac9707cf0a9">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19158d14e728497cbede5b260b0904be_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMi01LTEtMS03MzI1Mw_4a1d6403-b50c-424e-a577-1329c647cf59">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i222f710050af4ecca660d0fd445ff9ef_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMi05LTEtMS03MzI1Mw_69274530-2b25-41b5-97d3-90492c5cfa64">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6c2e6b413dd4c95ae4cc6fd40f6a699_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMi0xMS0xLTEtNzMyNTM_f3bb716e-6c7d-4a47-a30b-e74377f40787">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses (gains) reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ef7519873594295b569d2ed9d013d3b_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMy0xLTEtMS03MzI1Mw_1298a307-bcbc-447e-837b-437f76c494b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5c66dc788a1430581c272b0c716b06a_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMy0zLTEtMS03MzI1Mw_f48164ac-7cd6-43fb-a521-ccce6d9a8f91">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19158d14e728497cbede5b260b0904be_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMy01LTEtMS03MzI1Mw_8b74cff2-1213-4912-a7bf-6b146f8edcb1">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i222f710050af4ecca660d0fd445ff9ef_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMy05LTEtMS03MzI1Mw_dff79d81-9f2f-4fa0-8852-ca8568d86d3d">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c2e6b413dd4c95ae4cc6fd40f6a699_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfMy0xMS0xLTEtNzMyNTM_0d3dccb7-f5f7-44a2-b76a-5495135363eb">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ef7519873594295b569d2ed9d013d3b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfNC0xLTEtMS03MzI1Mw_298f64df-bbe7-4d83-94c3-58d32b8d3753">231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5c66dc788a1430581c272b0c716b06a_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfNC0zLTEtMS03MzI1Mw_c5a2f653-636f-4547-9735-558b206f4855">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19158d14e728497cbede5b260b0904be_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfNC01LTEtMS03MzI1Mw_36f93c7f-07c3-4763-a333-e296a396fef9">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i222f710050af4ecca660d0fd445ff9ef_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfNC05LTEtMS03MzI1Mw_9347fb8c-cdfe-4372-aec8-e495ca7ef79c">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6c2e6b413dd4c95ae4cc6fd40f6a699_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfNC0xMS0xLTEtNzMyNTM_59ef415f-bb77-4dde-aec0-3ce5e3ee7249">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38cbefbb7640470d8912c518f4d612c4_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfNS0xLTEtMS03MzI1Mw_a2a27db3-fbc3-462c-a009-15a092e1779a">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0749feb42e4416b8b7650f417a1131_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfNS0zLTEtMS03MzI1Mw_403a9201-0f5c-4205-aaec-a91ada04e201">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a8127b3ac3548c3890da55bf63f1701_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfNS01LTEtMS03MzI1Mw_b8a6180b-1cd5-4b51-a6f7-95aa62fc8592">2,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice36e374d1fe41cd885017f660510ca7_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfNS05LTEtMS03MzI1Mw_92804cbc-58b0-4c67-a080-522492b6e035">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00bc0c90f91f4af0a5a3a88ab5477eaa_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOmZkZjc0Mzg2OGM4ZTQ5MjVhZjM0OWFiODhkNjEyMzY1L3RhYmxlcmFuZ2U6ZmRmNzQzODY4YzhlNDkyNWFmMzQ5YWI4OGQ2MTIzNjVfNS0xMS0xLTEtNzMyNTM_67f164da-e354-4460-bc13-a1dbc7015a90">2,984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive loss for the three months ended March 31, 2022 included foreign currency translation adjustments totaling a loss of $<ix:nonFraction unitRef="usd" contextRef="i7ef7519873594295b569d2ed9d013d3b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjA2MQ_96e17760-55c4-44a9-8b63-0e567a6341da">231</ix:nonFraction> million and the offsetting impact of net investment hedging activities totaling a gain of $<ix:nonFraction unitRef="usd" contextRef="ib5c66dc788a1430581c272b0c716b06a_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjE0NA_20b09ab5-2c30-4c26-9dc1-3c6796bbc789">130</ix:nonFraction> million, which were principally due to the impact of the weakening of the Euro on the translation of the company&#8217;s Euro-denominated assets.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:continuation id="i65d6407736b0414488df938c58a3eb97"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in each component of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency <br/>translation adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net investment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">hedging activities</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension&#160;<br/>and post-employment <br/>benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flow hedging <br/>activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba4be4766064887868cd838db3129a4_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMS0xLTEtMS03MzI1Mw_fe7eb643-5c2e-48ff-b0d7-910749fc9116">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13ba96e9d518432f846efbdefd0568c1_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMS0zLTEtMS03MzI1Mw_3b9c3c4c-629d-480e-a9bc-cb6e7730c1a9">790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfa61ba6e74c4671b7c09c21de67bea5_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMS01LTEtMS03MzI1Mw_8b1d9b67-75fc-4706-ac89-05607b6fe060">3,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f7baaa43f94988beb4cab455519ed9_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMS05LTEtMS03MzI1Mw_9e210a6b-a8d7-4be0-bc23-ed4c54775cc6">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ef17bd343cf45f4a0064de2b7b25559_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMS0xMS0xLTEtNzMyNTM_a8bb977e-b28c-4f5b-bd9a-89e070581d08">3,117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fde8fe6a5d44d7083e9b20d383298c0_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMi0xLTEtMS03MzI1Mw_5091bf29-43bd-431d-a704-7fb9db81eccd">677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f16ffe755c541c08daeb711d76a9eed_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMi0zLTEtMS03MzI1Mw_5ecb2c41-ded5-47c1-9456-044ed82eed49">377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1455b44d7b4ad7ae2afb21e3bdb861_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMi01LTEtMS03MzI1Mw_720bf9b4-2c7c-4781-a199-6f2a90a3017d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacecdda3bbc54ee1b9906ba01da77d2e_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMi05LTEtMS03MzI1Mw_171d1ad6-70f3-410b-a34f-f64b2ae56119">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0d08aebc5e649d9a475213ebb8a10ef_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMi0xMS0xLTEtNzMyNTM_f855eef1-8a36-4cf1-80be-dcabedf16dd4">241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses (gains) reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fde8fe6a5d44d7083e9b20d383298c0_D20210101-20210331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMy0xLTEtMS03MzI1Mw_61d391f1-9d0c-4152-97d2-7f8b158571d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f16ffe755c541c08daeb711d76a9eed_D20210101-20210331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMy0zLTEtMS03MzI1Mw_c55f480c-7b37-493b-bbd0-d437c39d8f64">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1455b44d7b4ad7ae2afb21e3bdb861_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMy01LTEtMS03MzI1Mw_235ef38a-f6ab-43fc-a4c1-c2fe8af5ebb3">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacecdda3bbc54ee1b9906ba01da77d2e_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMy05LTEtMS03MzI1Mw_a2b03e6b-bf89-4c9e-b4b4-d852b838f644">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d08aebc5e649d9a475213ebb8a10ef_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfMy0xMS0xLTEtNzMyNTM_0e1bda45-a5a4-42c8-9cbb-929eefa3a23e">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fde8fe6a5d44d7083e9b20d383298c0_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfNC0xLTEtMS03MzI1Mw_e14401c9-dfa9-476c-add1-c1dc16d322af">677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f16ffe755c541c08daeb711d76a9eed_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfNC0zLTEtMS03MzI1Mw_769e6d0e-35c3-4ef5-b0df-64cf7115895c">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1455b44d7b4ad7ae2afb21e3bdb861_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfNC01LTEtMS03MzI1Mw_24867c57-01fa-4dbe-883f-fc6689a9ebf3">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacecdda3bbc54ee1b9906ba01da77d2e_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfNC05LTEtMS03MzI1Mw_447e3161-da5c-40fa-9de3-8e0cbc174251">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0d08aebc5e649d9a475213ebb8a10ef_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfNC0xMS0xLTEtNzMyNTM_eaf61c04-c54d-4a68-9187-d327530dadb2">178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32fccc997a0749b1bb81108be62eb6e8_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfNS0xLTEtMS03MzI1Mw_f0c16c0e-7b6e-4610-949b-0f71ce370d2e">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i157ad54cc34c4b9e9f5f62ce15e5c956_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfNS0zLTEtMS03MzI1Mw_3a67128c-4e2c-48c8-81f2-2c6e5d5f69f3">416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcc473aa8ebe448e985aa0a29dcd7e8c_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfNS01LTEtMS03MzI1Mw_5120133a-9fb5-43e1-9cbc-40d924229cf5">2,988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ce7636b82d0488790d551ca1286a964_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfNS05LTEtMS03MzI1Mw_97434751-500e-4eec-939f-7edc8464e0d7">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe0c4dc2984f481b92d6852e941b91b9_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjM4YTZkNTA4OWI5NzQ0N2ZhOWE1M2U1YzViMzdmNzRkL3RhYmxlcmFuZ2U6MzhhNmQ1MDg5Yjk3NDQ3ZmE5YTUzZTVjNWIzN2Y3NGRfNS0xMS0xLTEtNzMyNTM_a663df18-efbd-4f3f-973a-ce8748b0af62">3,295</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive loss for the three months ended March 31, 2021 included foreign currency translation adjustments totaling a loss of $<ix:nonFraction unitRef="usd" contextRef="i4fde8fe6a5d44d7083e9b20d383298c0_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjQ1Mw_414d4f41-8327-43fc-bdef-4a32becbc3fc">677</ix:nonFraction> million and the offsetting impact of net investment hedging activities totaling a gain of $<ix:nonFraction unitRef="usd" contextRef="i6f16ffe755c541c08daeb711d76a9eed_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjUzNg_a7a98ad9-a4a8-4ce8-bb67-aa673c880201">374</ix:nonFraction>&#160;million, which were principally due to the impact of the weakening of the Euro on the translation of the company&#8217;s Euro-denominated assets.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">17</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i8e2925967be2463eaf328135ee6b9ab3"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjk2OQ_f08f215e-185f-43d3-935f-b5ad69422b48" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the impact on AbbVie&#8217;s condensed consolidated statements of earnings for significant amounts reclassified out of each component of accumulated other comprehensive loss:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.927%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions) (brackets&#160;denote&#160;gains)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedging activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on derivative amount excluded from effectiveness testing</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28e53bf29aba4d48b3d569bcdcfec9ec_D20220101-20220331" decimals="-6" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMy01LTEtMS03MzI1Mw_dcbb1f13-4991-4b76-b758-f7b88b8d660e">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i156ab7fa7ed04946b0d67a6660158361_D20210101-20210331" decimals="-6" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMy03LTEtMS03MzI1Mw_a9d9e243-873f-4eef-b19e-5939933a8100">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e53bf29aba4d48b3d569bcdcfec9ec_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfNC01LTEtMS03MzI1Mw_5f0e1514-67fc-4d20-8b08-68e5c6f4d4f1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i156ab7fa7ed04946b0d67a6660158361_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfNC03LTEtMS03MzI1Mw_77ebe8da-9685-4ffa-8526-61d7c89d48b8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28e53bf29aba4d48b3d569bcdcfec9ec_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfNS01LTEtMS03MzI1Mw_ec404f7b-1deb-4c78-884b-51df5958ad4e">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i156ab7fa7ed04946b0d67a6660158361_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfNS03LTEtMS03MzI1Mw_7044b95b-6116-4e47-a277-d51285f3fb47">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and post-employment benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial losses and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19158d14e728497cbede5b260b0904be_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfNy01LTEtMS03MzI1Mw_5de29469-8128-4032-a9fe-d194d6935866">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1455b44d7b4ad7ae2afb21e3bdb861_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfNy03LTEtMS03MzI1Mw_e0b01168-ad34-434d-9854-14c860bb3278">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19158d14e728497cbede5b260b0904be_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfOC01LTEtMS03MzI1Mw_112200b5-9640-4d81-9fee-7db12d22b8a8">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab1455b44d7b4ad7ae2afb21e3bdb861_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfOC03LTEtMS03MzI1Mw_8f879815-e499-4e80-ade5-9e40fe45bc45">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19158d14e728497cbede5b260b0904be_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfOS01LTEtMS03MzI1Mw_9dd51b1c-5977-4e4e-8c01-6970958c10cf">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1455b44d7b4ad7ae2afb21e3bdb861_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfOS03LTEtMS03MzI1Mw_d6e3f0b4-65bf-4b59-ba85-79044bab00a6">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedging activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses (gains) on foreign currency forward exchange contracts</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i115d67da01e8464594d5f3097915285d_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTEtNS0xLTEtNzMyNTM_c3509005-a607-426a-a140-90bfa6a40cdb">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2a39cd4e914c2baf4e3f7f78e0e037_D20210101-20210331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTEtNy0xLTEtNzMyNTM_da5e13a0-ba04-43e2-9ccc-697be415ecf8">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on treasury rate lock agreements</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia93484cb8e084701be386a098217dd41_D20220101-20220331" decimals="-6" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTItNS0xLTEtNzMyNTM_5e757465-320d-4d59-890d-c8493a2521aa">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac58012cb8394749b3da275880c656bf_D20210101-20210331" decimals="-6" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTItNy0xLTEtNzMyNTM_d33aba04-37d9-4799-8851-d1a29a61115b">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses on interest rate swap contracts</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f8aa0c8a5684d66952c25dc6e509fe7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTMtNS0xLTEtNzMyNTM_f5d8bf1d-c1fd-4481-bde9-f036b794d7e1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5ce39b3335d40a193f5da7859d3e742_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTMtNy0xLTEtNzMyNTM_9dfa7b53-a718-428a-84f0-a2b6048d47ca">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c8e4e34cdc418dadb3f7f36b8d5041_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTQtNS0xLTEtNzMyNTM_d872b70e-3b25-442d-9a78-73c7d69c6ba0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2761b85b027474db273e8bb0d34f65a_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTQtNy0xLTEtNzMyNTM_5319d78c-a45b-46c7-b368-9e3013b38f0a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18c8e4e34cdc418dadb3f7f36b8d5041_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTUtNS0xLTEtNzMyNTM_ddf6dd7e-9a94-469b-b583-bf68b1b57af7">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2761b85b027474db273e8bb0d34f65a_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RhYmxlOjRmODNjNjgzYzY2YjRhOTFhMWVlZmZhZDk3YTA5YjBiL3RhYmxlcmFuZ2U6NGY4M2M2ODNjNjZiNGE5MWExZWVmZmFkOTdhMDliMGJfMTUtNy0xLTEtNzMyNTM_b0b11797-29bf-4771-bf25-60dd8128fc4f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjk5NQ_4f394a68-56b5-40ba-85ee-31ba8f0a7a22" footnoteRole="http://www.xbrl.org/2003/role/footnote">(a)&#160;Amounts are included in interest expense, net (see Note 8)</ix:footnote>.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMzAwOA_4e00e857-6c03-4577-bf53-0941bd05ee5f" footnoteRole="http://www.xbrl.org/2003/role/footnote">(b)&#160;Amounts are included in the computation of net periodic benefit cost (see Note 9).</ix:footnote></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184Mi9mcmFnOmY4Yjk1N2UzNWRmODRmZTI4MzcwZDJiYWYyMGVhMmI2L3RleHRyZWdpb246ZjhiOTU3ZTM1ZGY4NGZlMjgzNzBkMmJhZjIwZWEyYjZfMjk2Ng_339b42bb-9e96-46ac-89bc-283f924a8cbd" footnoteRole="http://www.xbrl.org/2003/role/footnote">(c) Amounts are included in cost of products sold (see Note 8).</ix:footnote></span></div></ix:nonNumeric></ix:continuation><div id="ic89f06320f9c4f57b19c511822f36cac_88"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 11 <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184OC9mcmFnOmE2MWIyMDgyNjQ5MjQ5ZmU5NGEzNDljMzJhYzEyODA4L3RleHRyZWdpb246YTYxYjIwODI2NDkyNDlmZTk0YTM0OWMzMmFjMTI4MDhfODc2_3cffd7dd-37dd-4a84-81ee-af324be0a3e4" continuedAt="i99cb4b156f08419297b1ad867c8d43ab" escape="true">Income Taxes </ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i99cb4b156f08419297b1ad867c8d43ab" continuedAt="i7886cf96252c48d2bd72bf4c5d7cd808">The effective tax rate was <ix:nonFraction unitRef="number" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184OC9mcmFnOmE2MWIyMDgyNjQ5MjQ5ZmU5NGEzNDljMzJhYzEyODA4L3RleHRyZWdpb246YTYxYjIwODI2NDkyNDlmZTk0YTM0OWMzMmFjMTI4MDhfMzg_95480677-3953-4786-aa98-e1c16c06b125"><ix:nonFraction unitRef="number" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184OC9mcmFnOmE2MWIyMDgyNjQ5MjQ5ZmU5NGEzNDljMzJhYzEyODA4L3RleHRyZWdpb246YTYxYjIwODI2NDkyNDlmZTk0YTM0OWMzMmFjMTI4MDhfMzg_a5d928bc-8853-4106-a13d-3adbe2389638">9</ix:nonFraction></ix:nonFraction>% for the three months ended March 31, 2022 compared to <ix:nonFraction unitRef="number" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184OC9mcmFnOmE2MWIyMDgyNjQ5MjQ5ZmU5NGEzNDljMzJhYzEyODA4L3RleHRyZWdpb246YTYxYjIwODI2NDkyNDlmZTk0YTM0OWMzMmFjMTI4MDhfNjQ_40a93071-68a4-4386-9aa8-1a8d760378c3"><ix:nonFraction unitRef="number" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184OC9mcmFnOmE2MWIyMDgyNjQ5MjQ5ZmU5NGEzNDljMzJhYzEyODA4L3RleHRyZWdpb246YTYxYjIwODI2NDkyNDlmZTk0YTM0OWMzMmFjMTI4MDhfNjQ_980de54f-ec99-47f6-ba90-1fb0e3b4ece4">8</ix:nonFraction></ix:nonFraction>% for the three months ended March 31, 2021. The effective tax rate in each period differed from the U.S. statutory tax rate of <ix:nonFraction unitRef="number" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184OC9mcmFnOmE2MWIyMDgyNjQ5MjQ5ZmU5NGEzNDljMzJhYzEyODA4L3RleHRyZWdpb246YTYxYjIwODI2NDkyNDlmZTk0YTM0OWMzMmFjMTI4MDhfMTYy_342774af-a098-4993-a192-a5e468b13e30"><ix:nonFraction unitRef="number" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184OC9mcmFnOmE2MWIyMDgyNjQ5MjQ5ZmU5NGEzNDljMzJhYzEyODA4L3RleHRyZWdpb246YTYxYjIwODI2NDkyNDlmZTk0YTM0OWMzMmFjMTI4MDhfMTYy_9d4d592b-3622-4fbb-a18d-cdc5cfadda06">21</ix:nonFraction></ix:nonFraction>% principally due to the impact of foreign operations which reflects the impact of lower income tax rates in locations outside the United States, tax incentives in Puerto Rico and other foreign tax jurisdictions, business development activities and accretion on contingent consideration. The increase in the effective tax rate for the three months ended March 31, 2022 over the prior year was primarily due to differences in the company&#8217;s jurisdictional mix of earnings.</ix:continuation></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7886cf96252c48d2bd72bf4c5d7cd808">Due to the potential for resolution of federal, state and foreign examinations and the expiration of various statutes of limitations, it is reasonably possible that the company&#8217;s gross unrecognized tax benefits balance may change within the next 12 months by up to $<ix:nonFraction unitRef="usd" contextRef="i8b2b4b8b78f645bdb160863ef2a3fb7a_I20220331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY184OC9mcmFnOmE2MWIyMDgyNjQ5MjQ5ZmU5NGEzNDljMzJhYzEyODA4L3RleHRyZWdpb246YTYxYjIwODI2NDkyNDlmZTk0YTM0OWMzMmFjMTI4MDhfODcz_24d67e30-c249-4f72-827e-f53b4c88b925">244</ix:nonFraction>&#160;million.</ix:continuation></span></div><div id="ic89f06320f9c4f57b19c511822f36cac_94"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 12 <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfMTU5MDQ_4c0ad276-1c33-4e3a-a63b-75138bffbe09" continuedAt="idf820d4f97b4411cb498861b357bced4" escape="true">Legal Proceedings and Contingencies </ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idf820d4f97b4411cb498861b357bced4" continuedAt="i2eaa16948fae4a78bd89cb9451ab982c">AbbVie is subject to contingencies, such as various claims, legal proceedings and investigations regarding product liability, intellectual property, commercial, securities and other matters that arise in the normal course of business. The most significant matters are described below. Loss contingency provisions are recorded for probable losses at management&#8217;s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount within a probable range is recorded. For litigation matters discussed below for which a loss is probable or reasonably possible, the company is unable to estimate the possible loss or range of loss, if any, beyond the amounts accrued. Initiation of new legal proceedings or a change in the status of existing proceedings may result in a change in the estimated loss accrued by AbbVie. While it is not feasible to predict the outcome of all proceedings and exposures with certainty, management believes that their ultimate disposition should not have a material adverse effect on AbbVie&#8217;s consolidated financial position, results of operations or cash flows.</ix:continuation></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2eaa16948fae4a78bd89cb9451ab982c" continuedAt="i827b9fe08da94ce28fcd2c03aa46d243">Subject to certain exceptions specified in the separation agreement by and between Abbott and AbbVie, AbbVie assumed the liability for, and control of, all pending and threatened legal matters related to its business, including liabilities for any claims or legal proceedings related to products that had been part of its business, but were discontinued prior to the distribution, as well as assumed or retained liabilities, and will indemnify Abbott for any liability arising out of or resulting from such assumed legal matters.</ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">18</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i827b9fe08da94ce28fcd2c03aa46d243" continuedAt="i495db9e670144528b0827551455b795c"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lawsuits are pending against AbbVie and others generally alleging that the 2005 patent litigation settlement involving Niaspan entered into between Kos Pharmaceuticals, Inc. (a company acquired by Abbott in 2006 and presently a subsidiary of AbbVie) and a generic company violates federal and state antitrust laws and state unfair and deceptive trade practices and unjust enrichment laws. Plaintiffs generally seek monetary damages and/or injunctive relief and attorneys' fees. The lawsuits pending in federal court consist of <ix:nonFraction unitRef="lawsuit" contextRef="idfd179fad6a84747bceee1f796370db1_D20220101-20220331" decimals="INF" name="abbv:LossContingencyIndividualPlaintiffLawsuitsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfMjAzMw_5787628e-6f07-4264-aa30-ad6b14497e72">four</ix:nonFraction> individual plaintiff lawsuits and <ix:nonFraction unitRef="class_action" contextRef="idfd179fad6a84747bceee1f796370db1_D20220101-20220331" decimals="INF" name="abbv:LossContingencyPurportedClassActionsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfMjA3MA_45995349-1a0a-47ca-8a77-5d7f5df40e8c">two</ix:nonFraction> consolidated purported class actions: <ix:nonFraction unitRef="direct_purchaser" contextRef="idfd179fad6a84747bceee1f796370db1_D20220101-20220331" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfMjExMQ_33823b0e-1fc4-4c5c-a470-3d12bd22c315">one</ix:nonFraction> brought by Niaspan direct purchasers and <ix:nonFraction unitRef="end_payor_purchaser" contextRef="idfd179fad6a84747bceee1f796370db1_D20220101-20220331" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfMjE1NQ_f45633de-1c5d-4a3f-8084-0ef38c826c91">one</ix:nonFraction> brought by Niaspan end-payors. The cases are pending in the United States District Court for the Eastern District of Pennsylvania for coordinated or consolidated pre-trial proceedings under the MDL Rules as&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Niaspan Antitrust Litigation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, MDL No.&#160;2460. In August 2019, the court certified a class of direct purchasers of Niaspan. In June 2020 and August 2021, the court denied the end-payors' motion to certify a class. In October 2016, the Orange County, California District Attorney&#8217;s Office filed a lawsuit on behalf of the State of California regarding the Niaspan patent litigation settlement in Orange County Superior Court, asserting a claim under the unfair competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys&#8217; fees. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott acquired in February 2010 and now known as AbbVie Products LLC) with <ix:nonFraction unitRef="company" contextRef="ie9849c3641274f60b03fcb8763315cdc_D20190801-20190831" decimals="INF" name="abbv:LossContingencyNumberOfGenericCompaniesAsCounterpartyOfLitigationRelatedAgreementsViolatedCertainLaws" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfNDY2NQ_aa25e41b-bf53-4a5a-a31b-8dc09404aab6">three</ix:nonFraction> generic companies violated federal antitrust law, and also alleging that 2011 patent litigation by Abbott with two generic companies regarding AndroGel was sham litigation and the settlements of those litigations violated federal antitrust law. In May 2020, Perrigo Company and related entities filed a lawsuit against AbbVie and others, alleging that Abbott&#8217;s 2011 AndroGel patent lawsuit filed against Perrigo was sham litigation. In September 2021, the United States District Court for the District of New Jersey granted AbbVie's motion for judgment on the pleadings in the Perrigo lawsuit, dismissing it with prejudice. Perrigo has appealed the dismissal.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between March and May 2019, <ix:nonFraction unitRef="company" contextRef="i2876ad381a314d1492fed65c7ba60831_D20190301-20190531" decimals="INF" name="abbv:PutativeClassActionLawsuitIndividualNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfNTMyOA_458b4390-3a4a-4239-a538-cf697171a444">12</ix:nonFraction> putative class action lawsuits were filed in the United States District Court for the Northern District of Illinois by indirect Humira purchasers, alleging that AbbVie&#8217;s settlements with biosimilar manufacturers and AbbVie&#8217;s Humira patent portfolio violated state and federal antitrust laws. The court consolidated these lawsuits as </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Humira (Adalimumab) Antitrust Litigation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In June 2020, the court dismissed the consolidated litigation with prejudice. The plaintiffs have appealed the dismissal.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lawsuits are pending against Forest Laboratories, LLC, an AbbVie subsidiary, and others generally alleging that 2009 and 2010 patent litigation settlements involving Namenda entered into between Forest and generic companies and other conduct by Forest involving Namenda, violated state antitrust, unfair and deceptive trade practices, and unjust enrichment laws. Plaintiffs generally seek monetary damages, injunctive relief and attorneys&#8217; fees. The lawsuits, purported class actions filed by indirect purchasers of Namenda, are consolidated as </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Namenda Indirect Purchaser Antitrust Litigation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States District Court for the Southern District of New York.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lawsuits are pending against Allergan Inc., an Allergan subsidiary, generally alleging that Allergan&#8217;s petitioning to the U.S. Patent Office and Food and Drug Administration and other conduct by Allergan involving Restasis violated federal and state antitrust laws and state unfair and deceptive trade practices and unjust enrichment laws. Plaintiffs generally seek monetary damages, injunctive relief and attorneys&#8217; fees. The lawsuits, certified as a class action filed on behalf of indirect purchasers of Restasis, are consolidated for pre-trial purposes in the United States District Court for the Eastern District of New York under the MDL Rules as In re: Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation, MDL No. 2819. In May 2021, the parties reached an agreement to settle this matter that is subject to final court approval.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lawsuits are pending against Forest Laboratories, LLC and others generally alleging that 2012 and 2013 patent litigation settlements involving Bystolic with <ix:nonFraction unitRef="company" contextRef="i061f6899a2e64d8b9f6710d2ffdaa440_D20220101-20220331" decimals="INF" name="abbv:LossContingencyNumberOfGenericCompaniesAsCounterpartyOfLitigationRelatedAgreementsViolatedCertainLaws" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfNzQ2Mg_4ba8e633-fc58-4bcc-8ee8-5bfffb5d90cc">six</ix:nonFraction> generic manufacturers violated federal and state antitrust laws and state unfair and deceptive trade practices and unjust enrichment laws. Plaintiffs generally seek monetary damages, injunctive relief and attorneys&#8217; fees. The lawsuits, purported class actions filed on behalf of direct and indirect purchasers of Bystolic, are consolidated as </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Bystolic Antitrust Litigation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States District Court for the Southern District of New York.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Proceedings</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lawsuits are pending against Allergan and several other manufacturers generally alleging that they improperly promoted and sold prescription opioid products. Approximately <ix:nonFraction unitRef="claim" contextRef="i1b950ca2895a442093c6358346b89e00_I20220331" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfODExNQ_3c84c455-296a-473b-8bf5-dee1996e950f">3,146</ix:nonFraction> matters are pending against Allergan. The federal court cases are consolidated for pre-trial purposes in the United States District Court for the Northern District of Ohio under the MDL rules as In re: National Prescription Opiate Litigation, MDL No. 2804. Approximately <ix:nonFraction unitRef="claim" contextRef="i0d6b8a8607154239bab327083f4f2a16_I20220331" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfODM4OQ_51a4d9ca-a094-49b5-ba2c-ed7909e16509">257</ix:nonFraction> matters are pending in various state courts. The plaintiffs in these cases, which include states, counties, cities, other municipal entities, Native American tribes, union trust funds and other third-party </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">19</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i495db9e670144528b0827551455b795c" continuedAt="i41165d3a0cd74222a4ac32e425b3ca37"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payors, private hospitals and personal injury claimants, generally seek compensatory and punitive damages. In March 2022, Allergan reached settlements with the States of Florida and Rhode Island and their political subdivisions. Allergan previously reached settlements with other plaintiffs.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the New Mexico Attorney General filed a lawsuit, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of New Mexico ex rel. Balderas v. AbbVie Inc., et al.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in New Mexico District Court for Santa Fe County against AbbVie and other companies alleging their marketing of AndroGel violated New Mexico&#8217;s Unfair Practices Act. In October 2020, the state added a claim under the New Mexico False Advertising Act.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder and Securities Litigation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, a lawsuit, Elliott Associates, L.P., et al. v. AbbVie Inc., was filed by <ix:nonFraction unitRef="investment_fund" contextRef="i5c041511930545c890fb52c2cac408df_D20160601-20160630" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfOTIxMg_4b9a294a-6bd8-4bec-bd5e-925e4d42bbbf">five</ix:nonFraction> investment funds against AbbVie in the Cook County, Illinois Circuit Court alleging that AbbVie made misrepresentations and omissions in connection with its proposed transaction with Shire. Similar lawsuits were filed between July 2017 and October 2019 against AbbVie and in some instances its chief executive officer in the same court by additional investment funds. The court granted motions dismissing the claims of <ix:nonFraction unitRef="investment_fund" contextRef="id8b1a9f1c7674ab7b5a46fc570730aa0_D20220201-20220228" decimals="INF" name="us-gaap:LossContingencyClaimsDismissedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfOTYzNA_d11b56cf-06d2-463c-b4f6-23ef529e8f4c">three</ix:nonFraction> investment-fund plaintiffs, which they appealed. One appeal was dismissed with prejudice in August 2021. In the other two appeals, the Illinois Appellate Court affirmed the dismissal of one in March 2021 and affirmed the dismissal of the other in February 2022. <ix:nonFraction unitRef="investment_fund" contextRef="ie49c8cbd1c924c69b51d6bd1f5088886_D20220101-20220131" decimals="INF" name="us-gaap:LossContingencyClaimsDismissedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185NC9mcmFnOjFhYjlkNGQwNzA2ODQwMWZiODdhNzE3NWE3NGE5ZDBkL3RleHRyZWdpb246MWFiOWQ0ZDA3MDY4NDAxZmI4N2E3MTc1YTc0YTlkMGRfOTc2MA_80e278f6-e0da-4ec5-bd0f-3f6921e4c321">One</ix:nonFraction> of these plaintiffs refiled its lawsuit in the New York Supreme Court for the County of New York, where it was dismissed in November 2020, and that dismissal was affirmed by the Supreme Court of New York, Appellate Division, in January 2022. In September 2021, the Illinois court granted AbbVie's motion for summary judgment against all remaining plaintiffs on all the remaining claims, dismissing them with prejudice. Those plaintiffs have appealed the dismissals.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, a federal securities lawsuit, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Holwill v. AbbVie Inc., et al</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., was filed in the United States District Court for the Northern District of Illinois against AbbVie, its chief executive officer and former chief financial officer, alleging that reasons stated for Humira sales growth in financial filings between 2013 and 2018 were misleading because they omitted alleged misconduct in connection with Humira patient and reimbursement support services and other services and items of value that allegedly induced Humira prescriptions. In September 2021, the court granted plaintiffs' motion to certify a class.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lawsuits are pending against Allergan and certain of its current and former officers alleging they made misrepresentations and omissions regarding Allergan's textured breast implants. The lawsuits, which were filed by Allergan shareholders, have been consolidated in the United States District Court for the Southern District of New York as </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Allergan plc Securities Litigation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The plaintiffs generally seek compensatory damages and attorneys&#8217; fees. In September 2019, the court partially granted Allergan's motion to dismiss. In September 2021, the court granted plaintiffs' motion to certify a class.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability and General Litigation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, a qui tam lawsuit, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Silbersher v. Allergan Inc., et al.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the United States District Court for the Northern District of California against several Allergan entities and others, alleging that their conduct before the U.S. Patent Office resulted in false claims for payment being made to federal and state healthcare payors for Namenda XR and Namzaric. The plaintiff-relator seeks damages and attorneys' fees under the federal False Claims Act and state law analogues. The federal government and state governments declined to intervene in the lawsuit.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property Litigation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie Inc. and AbbVie Biotechnology Ltd are seeking to enforce their patent rights relating to adalimumab (a drug AbbVie sells under the trademark Humira). In April 2021 and May 2021, cases were filed in the United States District Court for the Northern District of Illinois against Alvotech hf. AbbVie alleges defendant&#8217;s proposed biosimilar adalimumab product infringes certain AbbVie patents and seeks declaratory and injunctive relief. In August 2021, the court denied Defendant&#8217;s motion to dismiss on jurisdictional grounds in the first case; a motion in the second case remains pending. The court has set a trial on a subset of patents for August 2022. The court order provides that Alvotech will stay off the market until that decision. Litigation on the remaining patents is stayed. In October 2021, the May 2021 declaratory judgment action filed by Alvotech hf. and its U.S. subsidiary Alvotech USA, Inc. in the United States Eastern District of Virginia was transferred to the Northern District of Illinois and subsequently dismissed. In March 2022, the parties settled the case and it was dismissed without prejudice.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmacyclics LLC, a wholly owned subsidiary of AbbVie, is seeking to enforce its patent rights relating to ibrutinib tablets (a drug Pharmacyclics sells under the trademark Imbruvica). Cases were filed in the United States District Court for the District of Delaware in March 2019 against Alvogen Pine Brook LLC and Natco Pharma Ltd.. In August 2021, the court issued a decision holding all asserted patents infringed and valid. The judgment precludes Defendants from obtaining regulatory approval and launching until the last patent expires in 2036. On August 30, 2021, Defendants appealed. Janssen Biotech, Inc. which is in a global collaboration with Pharmacyclics concerning the development and marketing of Imbruvica, is the co-plaintiff in these suits.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">20</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i41165d3a0cd74222a4ac32e425b3ca37">Allergan USA, Inc., Allergan Sales, LLC, and Forest Laboratories Holdings Limited, wholly owned subsidiaries of AbbVie, are seeking to enforce patent rights relating to cariprazine (a drug sold under the trademark Vraylar). Litigation was filed in the United States District Court for the District of Delaware in December 2019 against Sun Pharmaceutical Industries Limited and Sun Pharma Global FZE; Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.; and Zydus Pharmaceuticals (USA), Inc. and Cadila Healthcare Limited. Allergan alleges defendants' proposed generic cariprazine products infringe certain patents and seeks declaratory and injunctive relief. Gedeon Richter Plc, Inc. which is in a global collaboration with Allergan concerning the development and marketing of Vraylar, is the co-plaintiff in this suit.</ix:continuation> </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">21</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_97"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 13 <ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RleHRyZWdpb246YWRmOWQwNjFjMDQxNDdhMmE4Y2FhYTcxYzA4NDk4YzFfMTIyNQ_a01029c1-acb2-4324-80fb-b0d9f3987bc5" continuedAt="if12cf0c76d664bb1a83d9efa0003a9ba" escape="true">Segment Information</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if12cf0c76d664bb1a83d9efa0003a9ba" continuedAt="i2986d4963bdf425f863e072a76ea81de">AbbVie operates as a single global business segment dedicated to the research and development, manufacturing, commercialization and sale of innovative medicines and therapies. This operating structure enables the Chief Executive Officer, as chief operating decision maker (CODM), to allocate resources and assess business performance on a global basis in order to achieve established long-term strategic goals. Consistent with this structure, a global research and development and supply chain organization is responsible for the discovery, manufacturing and supply of products. Commercial efforts that coordinate the marketing, sales and distribution of these products are organized by geographic region or therapeutic area. All of these activities are supported by a global corporate administrative staff. The determination of a single business segment is consistent with the consolidated financial information regularly reviewed by the CODM for purposes of assessing performance, allocating resources and planning and forecasting future periods.</ix:continuation></span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:continuation id="i2986d4963bdf425f863e072a76ea81de" continuedAt="id92fcc4540ea400ca8883e907a2ad7f4"><ix:nonNumeric contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RleHRyZWdpb246YWRmOWQwNjFjMDQxNDdhMmE4Y2FhYTcxYzA4NDk4YzFfMTIzMw_32c51bec-a861-4071-b236-e1875aa43e34" continuedAt="icf9070a14c6d4669b7d61d74fb251f20" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details AbbVie&#8217;s worldwide net revenues:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.429%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Immunology</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Humira</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d814e2470641b7adca70c8dfd22826_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNC02LTEtMS03MzI1Mw_36c3bfe8-9650-4555-9459-63295132e331">3,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d8cd18e85b4007971cea988abe2864_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNC04LTEtMS03MzI1Mw_929fc5c8-0534-4b8b-938e-bdd8245084e9">3,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86efe50966f24c74849d1de4249000b9_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNS02LTEtMS03MzI1Mw_2a24f481-424e-47e5-9c1b-e3ca9cea3416">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf1053eda3554c3bb53ea7f9f667809a_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNS04LTEtMS03MzI1Mw_85cb3600-69f7-4b65-9e45-70a17d0c09d7">960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8620bf3edb45e497398d57317e67ab_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNi02LTEtMS03MzI1Mw_54002b94-0bd4-4aeb-9b69-56bcf8c8c78f">4,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i151f76a6bb394b0e8dc33fbdabffeef4_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNi04LTEtMS03MzI1Mw_2641a9b0-3ef3-4582-9bae-12c3a244bd2b">4,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skyrizi</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9dcf0e2a5bc4237a3420a8ed35591ab_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNy02LTEtMS03MzI1Mw_162044ff-fbc3-4ad8-b7f6-a72ff98ab7ab">781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a121fb3a1a74d08bb6b193989e4706a_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNy04LTEtMS03MzI1Mw_ddf85b60-4824-4dfb-be36-190594c6950e">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7e3bfd63234b9987cf846478a441fd_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfOC02LTEtMS03MzI1Mw_6499a3b2-7c7c-4ece-8fc6-d9e76d451169">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8267ed584474c71a1ee8dbc54f58ef8_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfOC04LTEtMS03MzI1Mw_518c16b0-8dd8-4197-a15c-326ac85ac06c">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f415caa04a941a3b6c40335ad6d10f0_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfOS02LTEtMS03MzI1Mw_03042188-9aeb-4ba4-bc81-1b45d1cf0ea2">940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1c4e6bb026457da1f4cdf7df42c5f6_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfOS04LTEtMS03MzI1Mw_5aa32436-4793-4e6b-8872-70789931b376">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rinvoq</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38c669542ad4085a09a271f057f90d9_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTAtNi0xLTEtNzMyNTM_c4d69af5-a829-45a7-9540-b27d486d3df4">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0dfe507ba24433988668a7d003a378c_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTAtOC0xLTEtNzMyNTM_f27b2299-fe4b-4669-ac44-b44a59de50bf">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89a047a7f15451fae62f0586e4244bb_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTEtNi0xLTEtNzMyNTM_e13db72e-fb4c-4316-b7a8-a4afbbabbf72">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4d1ef4d3c3472f8587646493588ca3_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTEtOC0xLTEtNzMyNTM_639016e5-e8f9-4c7b-885b-092f8deeeb6d">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06547d54c7744ec59245e1aabe7bb4a9_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTItNi0xLTEtNzMyNTM_405092bf-3acd-4a29-ad37-567816952ead">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68fecb4ba92b444e8e7c4082e3cacd88_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTItOC0xLTEtNzMyNTM_1da59748-41ab-49d1-b504-3de25de1a323">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hematologic Oncology</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Imbruvica</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c7fad38a034510aef4faf293e98042_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTQtNi0xLTEtNzMyNTM_ee3ab9a4-ad1c-4adc-992a-83b79bd7611d">874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2609235fb4a14a5fa8a9ae2ce41de85d_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTQtOC0xLTEtNzMyNTM_6b42358a-937a-498b-9a59-fc2c81ec2c1b">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaboration revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83dd8a4923b14d1e9444794bdc3c9fa3_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTUtNi0xLTEtNzMyNTM_066cbcc0-a381-4005-99e6-9245e4d8a1ad">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839ac535845b43fe8878c6e026ae540d_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTUtOC0xLTEtNzMyNTM_5a601b29-a36d-4b4f-9ebd-27ebc94578fd">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88dc4f478b445c989df2931bf4129de_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTYtNi0xLTEtNzMyNTM_0025c39e-a490-4bde-a247-823399e5217d">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8b31104dd4f4b588d5964c0a59fc7d9_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTYtOC0xLTEtNzMyNTM_8bf4e65c-57ef-47f6-b085-265597b287be">1,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Venclexta</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa0a5001dda54d03b17d99d99907ef72_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTctNi0xLTEtNzMyNTM_7bc08d4b-265a-45ec-999a-5880b7d81bc9">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc2f01f0a3bc4965baed776f9c1ee2ee_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTctOC0xLTEtNzMyNTM_60fce076-6160-4caf-87cc-e0583981aac1">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd7e7447fe34c6287942f568429ef69_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTgtNi0xLTEtNzMyNTM_32389218-f067-4d6e-a580-742b7701a81a">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffd103eaea8d4b81b307a47031308a2b_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTgtOC0xLTEtNzMyNTM_6b3d5f2e-fb4b-4d4b-b2b6-bf0adce3fbeb">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia21887679ab4450e9854e11b52987fd2_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTktNi0xLTEtNzMyNTM_e7070f5d-8298-426c-9d71-7210a2f9e5fe">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca3b9d904a042d1be012441bfbfbbbc_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMTktOC0xLTEtNzMyNTM_8dcef4d7-85d6-46b0-8db0-3b79fae3a350">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aesthetics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Botox Cosmetic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i646b3499eac046a9a4d0c7b552528647_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjEtNi0xLTEtNzMyNTM_73866265-4668-400d-a67d-f7f3f75076e2">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d51184fb925493e90b9ff271b8ba444_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjEtOC0xLTEtNzMyNTM_1ebd005b-4dfe-469b-b721-7756e7b20115">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf374b782644e749678d1f567eb3bc1_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjItNi0xLTEtNzMyNTM_c264426a-4684-4437-8182-33f8b7d452dd">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231632e602304cbcbf663af9260ff447_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjItOC0xLTEtNzMyNTM_442eaa2a-5bc1-4dfc-89fe-02ca33986c62">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d97cd1c204d47a0894f071baccfb3dc_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjMtNi0xLTEtNzMyNTM_62291a29-fb33-4ea7-9dd3-9a1782f9abc2">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i485c4f314f4d4d4887041a01bca64c2b_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjMtOC0xLTEtNzMyNTM_fb739af8-6bba-45c1-8b11-01922c4a9043">477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Juvederm Collection</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81395f4f3fa48e8826d79041d865c17_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjQtNi0xLTEtNzMyNTM_14e65d96-5742-4a2e-9353-b4dc242e06fc">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5523e96c483e4a5a83a81a78cfdec571_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjQtOC0xLTEtNzMyNTM_35fd73b2-36b4-4489-927b-418983fb98ba">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2bf9f5d90ff4778afcba822173f993c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjUtNi0xLTEtNzMyNTM_2d73675f-a4dc-4226-92b4-c014f5b1900f">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ccf536e0504054b9c01fbb9c17051f_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjUtOC0xLTEtNzMyNTM_2529bfca-3120-4f0e-8b45-d5f9b3f0c389">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68379647466f42ac98da932e0ae7ba56_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjYtNi0xLTEtNzMyNTM_ac4d593e-86fa-43a0-824d-f1199478a40b">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9a74c5d27b427db7df5b72e0ef9e71_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjYtOC0xLTEtNzMyNTM_78ed5b47-b125-4b62-9a16-7f43e4acb843">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9886797304fd44789c0dae1792702122_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjctNi0xLTEtNzMyNTM_ab5f4c59-9bf0-4231-9769-bf405f746840">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1192611baa7144ae9f6aa9bd6469b73f_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjctOC0xLTEtNzMyNTM_d1918ce4-e532-4150-b5d2-77cb324c8e5e">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f45042ba49947aea027157aa3e5005e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjgtNi0xLTEtNzMyNTM_b7b6576c-986f-4b54-a6da-7f46e2c52930">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6297715bc8540428f641904958468e5_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjgtOC0xLTEtNzMyNTM_5b3719aa-af83-4077-bb5e-beb520b9439c">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274365a0958a49bb88080cb48c332ccd_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjktNi0xLTEtNzMyNTM_5041ce48-e13f-47ff-90fa-c05b5c89533c">323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aeec465d3b44d6d836a7f5d22f41e34_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMjktOC0xLTEtNzMyNTM_d9223227-4083-4a32-9f50-44d714b8568d">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Neuroscience</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Botox Therapeutic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic117a05f0ad047458c3dfdf3d563d985_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzEtNi0xLTEtNzMyNTM_a14980a4-664b-4ea1-a6f0-365e6cae2a01">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0aa0c6e5e8e4e86be8c148b66aedbb6_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzEtOC0xLTEtNzMyNTM_627bf828-6065-419e-8192-900c0845bbd6">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f1b5410e4a4e8fb9abfa2219b13d78_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzItNi0xLTEtNzMyNTM_04926e6a-3715-4def-95f4-9f31abf1cac3">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic78f3e2ee61c499ba7cc0746a2385d47_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzItOC0xLTEtNzMyNTM_99f3b4f7-3e67-4b53-88c6-c3ffa1e86380">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdbacd087ccb4b378166217f2e6bac38_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzMtNi0xLTEtNzMyNTM_aae2e661-b438-44c1-9018-01ab05c80024">614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2b0f54b6f66490ea61e7105a06bbd5f_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzMtOC0xLTEtNzMyNTM_e4a24f30-3a05-4de4-940b-12f67c67fb37">532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vraylar</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff614778cc44cd498c6a9c8964075c2_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzQtNi0xLTEtNzMyNTM_c1fed9b7-0dc1-4f1d-b68a-abcd334da6f1">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f19775fa7fb4454916890a2d18f7368_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzQtOC0xLTEtNzMyNTM_150c33ab-756c-4e02-a022-484ec30d7166">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duodopa</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3125d8c421f84befbfdc8c98d0f12733_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzctNi0xLTEtNzMyNTM_29b75ffb-0381-4970-a9d0-3ada4ae3b464">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c196d5476444949e789bed861f1aa6_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzctOC0xLTEtNzMyNTM_ee6fffc4-865e-4ab0-9b8e-12f2347b64d8">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d5f22d6d24942c5974fd185d2251f6a_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzgtNi0xLTEtNzMyNTM_f566b25d-a465-4361-af44-536ea448062c">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf4bed28ef04a34be1be2775ace098f_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzgtOC0xLTEtNzMyNTM_4039c928-f5df-4024-8572-a3d4c85a5449">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia72f22aa56674f6ea95b38deaf7d7ef0_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzktNi0xLTEtNzMyNTM_15774689-14f0-46bb-88e3-bf539fcf6d8a">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i639f02ea2ac340d384b27444a35f86c5_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfMzktOC0xLTEtNzMyNTM_17afb34f-3f1b-43ab-9e86-ee9c63a5b746">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ubrelvy</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f9dd7d8685493e9094a8411dc69ba7_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDAtNi0xLTEtNzMyNTM_9e617e15-55ae-4d59-9a31-03d29b13479c">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb5cc0c791ad4deb82c1071bb2540517_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDAtOC0xLTEtNzMyNTM_66a757f9-b648-4d7c-a0a2-8538d53f748d">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qulipta</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d3e94281d14e1ead6013f512d2ba56_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDMtNi0xLTEtODE2Njk_d7c0345b-c90d-419b-8d78-c1ffe16d4ba8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18fd6150a38a4e9b9bd77ea967639212_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDMtOC0xLTEtODE2ODI_7783c6ab-c9ef-4120-86b6-49000195aeef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512cec6652ce4f19be4c4e4462feb4e8_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDMtNi0xLTEtNzMyNTM_cb7d8987-e142-45dd-8a58-885b5bb0ff44">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4fe39a35de44ecaa3535608505ded0_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDMtOC0xLTEtNzMyNTM_da5c2922-dbcc-49f2-a7f1-d1a771183af7">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeabc0e9b646406e88ddb1c5e1f12518_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDQtNi0xLTEtNzMyNTM_e8788858-d899-4db6-aaec-d06cb7ac880c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia12ead842eee42f59b1937c152fb8415_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDQtOC0xLTEtNzMyNTM_d48e3d62-74d7-439f-b248-e3573767dac6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia67b003e0c9d489a93fc432063b0605d_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDUtNi0xLTEtNzMyNTM_c43e30b9-49b5-46cb-8317-dce2c66c88e2">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a38522757a47f08bcaaed26cc95890_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDUtOC0xLTEtNzMyNTM_06e48134-5cae-4127-9f2a-bf7e134c4e92">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">22</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:continuation id="id92fcc4540ea400ca8883e907a2ad7f4"><ix:continuation id="icf9070a14c6d4669b7d61d74fb251f20"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.429%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eye Care</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lumigan/Ganfort</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0b09878f9324ebc81010863a7bb2312_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDctNi0xLTEtNzMyNTM_d2318318-93b2-43da-a67c-dff3909d51a6">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67b43137ee1c4af9956280587d60c83c_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDctOC0xLTEtNzMyNTM_5743eadd-4e20-403e-9863-6ff734eed9ca">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae85b406a18e40d7b2917cf2e17d0b83_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDgtNi0xLTEtNzMyNTM_8813f64c-9195-4893-8b43-b66f1fabd378">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i741797da087c4ef6a3b16e0b40c35175_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDgtOC0xLTEtNzMyNTM_ead8daed-e9d7-493f-af54-6132cade79db">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34cab53f8594ff4979a946f5a3fc1f9_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDktNi0xLTEtNzMyNTM_05fa9027-d0cd-4cac-af3b-f71ef87e9cca">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd48264009438ca440c693ab0cf2f1_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNDktOC0xLTEtNzMyNTM_7c681d77-ec0a-41bd-aae3-fcd868aedb4c">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Alphagan/Combigan</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc8282031784d8caeb6a4ef809f2f50_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTAtNi0xLTEtNzMyNTM_55d46e55-341d-43cf-a116-89b43801efcd">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a85e57b458b4094a0c62505b2a9799e_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTAtOC0xLTEtNzMyNTM_7bab5c73-9f23-4dc2-9bbf-92388fa89089">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50fb763a0f1c482a9572f571170e440e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTEtNi0xLTEtNzMyNTM_3ea334ee-965e-4608-b89a-4f1eb2db06a3">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93307eafe6504d879af164c82b04eda8_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTEtOC0xLTEtNzMyNTM_1d61a0e4-921f-41f1-9ad6-5ae9811519ca">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia46e3aeb263045cfbb0acf95c88c121b_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTItNi0xLTEtNzMyNTM_16ef93fd-37c7-4688-9bdb-1a5f802b9c45">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a77a42b923942bfaff4dc08627c3225_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTItOC0xLTEtNzMyNTM_d1625484-50ed-43f3-be25-826a15d39bc7">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restasis</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief85b551045345879ed1be64c67a8b4b_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTMtNi0xLTEtNzMyNTM_53bc52e2-bd4c-4837-ba9c-3c40f70acda8">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf3d5f2dfb344e59a6c9efc465d8f5b_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTMtOC0xLTEtNzMyNTM_23e2c35f-3db4-4444-90a4-c3e8cb22efd3">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic62a015e1747449791ed3c131fc6f351_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTQtNi0xLTEtNzMyNTM_9a0403a8-91a7-4128-8b45-263a93987573">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bf8ded17cba43f7b08f7d24f7aed016_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTQtOC0xLTEtNzMyNTM_af7af429-cb8e-49fa-8159-b65ded5dbcd7">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2c9be5775d49e7af0a83f0b14fce7f_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTUtNi0xLTEtNzMyNTM_c60990e1-a2a2-4a02-9c3d-490abd0c4f47">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ddf6b053a5d4cf1b48234a1c15b6c1a_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTUtOC0xLTEtNzMyNTM_6cd9ac42-65ad-4642-a7e3-480dc3c682e2">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Eye Care</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882c0ed4b6454d5db18fd823a31bcb88_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTYtNi0xLTEtNzMyNTM_5e161b08-de8e-48dd-bd01-d3e88e3e176b">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf25850c2d1c4ceb840ecd9bfee2891c_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTYtOC0xLTEtNzMyNTM_9c030a35-13fd-41e3-ab84-efff01f8f235">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife17341a39044007bd37eb3dcabab9af_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTctNi0xLTEtNzMyNTM_e39d9814-9d7e-4d3f-b4f6-bce26ad8cdb3">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i379b152b16b1407985df7a9d9e3ad633_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTctOC0xLTEtNzMyNTM_df937c43-3c35-433e-894d-b3729743f666">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df2de6a1db84a14bc36698e3dbcbf51_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTgtNi0xLTEtNzMyNTM_b4fd3319-97ce-4b03-807b-e3e658087392">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58a92b2ecc5f4aaf9d8351f86caf7be5_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNTgtOC0xLTEtNzMyNTM_be3abe21-d3be-4f9a-9602-efac9c5f0c15">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Key Products</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mavyret</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e933b76f7264c7cb306a5779cb4d526_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzAtNi0xLTEtNzMyNTM_9152e379-0fc6-4fad-a615-1c6f4467f1e7">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9bf38d011cc4cfd9351b1938594689b_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzAtOC0xLTEtNzMyNTM_a54130ef-ff84-4355-8b13-997edee68873">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e746d238af04e0fba57b391911704b6_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzEtNi0xLTEtNzMyNTM_d3f56cb5-c2bb-4377-ab28-cec53bc7ca50">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59295dec623542dba93f26a4df9b7bf3_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzEtOC0xLTEtNzMyNTM_91db4c7b-8ed1-47f2-af88-8c71ffcac031">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieefe0806b5ac487fb58df139e942b4bf_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzItNi0xLTEtNzMyNTM_137adc64-b240-4cbb-b982-d47ea1150d79">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic251b48766744736852af8a750fb5fa6_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzItOC0xLTEtNzMyNTM_fa85162e-f767-4553-9b1c-6f8bf43889a0">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Creon</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife9748feec04436daefd70ed8fde5035_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzMtNi0xLTEtNzMyNTM_7a044198-cc03-4d41-a23a-b44a9e180167">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ca6bfcb2a742d2a419a770b28a65e2_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzMtOC0xLTEtNzMyNTM_3a9b6290-3743-46e7-b69d-aca39a7363c7">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Linzess/Constella</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2ecf09fad83434f8b75838cf1459dde_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzctNi0xLTEtNzMyNTM_d91db237-6306-41d3-9027-5189db05b88c">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6fb7ab9f9404aa4800b094182ef46f5_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzctOC0xLTEtNzMyNTM_4a4787fe-8450-41e4-b2d5-92da5688cefa">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9915235f3a844da69814226e5774c2d7_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzgtNi0xLTEtNzMyNTM_0d3b281e-ab0d-45ea-ad80-489e3c75f266">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4538d383a2c14cac819e3ce9bc8a27c4_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzgtOC0xLTEtNzMyNTM_e6536072-3b68-4589-857b-80abc79eac26">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i531f3349e8c348c39ad330ddd7567561_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzktNi0xLTEtNzMyNTM_27bd77ea-9059-44c3-8a2a-6c60a60af0ca">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a8b6f17bd484927bdf4246fdc7d2e83_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfNzktOC0xLTEtNzMyNTM_7ac3f90c-6936-448e-bf10-77b7a0ad14e7">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092297541dd04ee2b04cfdcfbb71eef1_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfODQtNi0xLTEtNzMyNTM_0abc59f1-4597-4d34-8a52-4eafb5624a34">1,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143c59ef117840e5b84f10e564ee91c4_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfODQtOC0xLTEtNzMyNTM_3f9e4b9b-f703-4708-be83-79598895c460">1,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f690357b3411ab045058c62c6b838_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfODUtNi0xLTEtNzMyNTM_3560e8c6-d560-4bf8-9af0-4748f93abd1e">13,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f1d797ff34ad09ebb8518ec09bdf3_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4OWYwNjMyMGY5YzRmNTdiMTljNTExODIyZjM2Y2FjL3NlYzpjODlmMDYzMjBmOWM0ZjU3YjE5YzUxMTgyMmYzNmNhY185Ny9mcmFnOmFkZjlkMDYxYzA0MTQ3YTJhOGNhYWE3MWMwODQ5OGMxL3RhYmxlOjI4MzRmNmMzNjNhMzRiYTliMWU4Yzg2MWMyZjk0OTliL3RhYmxlcmFuZ2U6MjgzNGY2YzM2M2EzNGJhOWIxZThjODYxYzJmOTQ5OWJfODUtOC0xLTEtNzMyNTM_b38b4100-48f5-49fb-81ff-dac7d1620595">13,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">23</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_103"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion and analysis of the financial condition of AbbVie Inc. (AbbVie or the company) as of March 31, 2022 and December 31, 2021 and the results of operations for the three months ended March 31, 2022 and 2021. This commentary should be read in conjunction with the Condensed Consolidated Financial Statements and accompanying notes appearing in Item 1, &#8220;Financial Statements and Supplementary Data.&#8221;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OVERVIEW</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie is a global, diversified research-based biopharmaceutical company positioned for success with a comprehensive product portfolio that has leadership positions across immunology, oncology, aesthetics, neuroscience and eye care. AbbVie uses its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world&#8217;s most complex and serious diseases.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie's products are generally sold worldwide directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies and independent retailers from AbbVie-owned distribution centers and public warehouses. Certain products (including aesthetic products and devices) are also sold directly to physicians and other licensed healthcare providers. In the United States, AbbVie distributes pharmaceutical products principally through independent wholesale distributors, with some sales directly to retailers, pharmacies, patients or other customers. Outside the United States, AbbVie sells products primarily to customers or through distributors, depending on the market served. Certain products are co-marketed or co-promoted with other companies. AbbVie has approximately 50,000 employees. AbbVie operates as a single global business segment.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Strategic Objectives</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie's mission is to discover and develop innovative medicines and products that solve serious health issues today and address the medical challenges of tomorrow while achieving top-tier financial performance through outstanding execution. AbbVie intends to continue to advance its mission in a number of ways, including: (i) maximizing the benefits of a diversified revenue base with multiple long-term growth drivers; (ii)&#160;growing revenues by leveraging AbbVie's commercial strength and international infrastructure across therapeutic areas and ensuring strong commercial execution of new product launches; (iii)&#160;continuing to invest in and expand its pipeline in support of opportunities in immunology, oncology, aesthetics, neuroscience and eye care as well as continued investment in key on-market products; (iv)&#160;expanding operating margins; and (v)&#160;returning cash to shareholders via a strong and growing dividend while also reducing debt. In addition, AbbVie anticipates several regulatory submissions and data readouts from key clinical trials in the next 12 months.</span></div><div id="ic89f06320f9c4f57b19c511822f36cac_106"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Results</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's financial performance for the three months ended March 31, 2022 included delivering worldwide net revenues of $13.5&#160;billion, operating earnings of $4.7&#160;billion, diluted earnings per share of $2.51 and cash flows from operations of $4.9&#160;billion. Worldwide net revenues grew by 4% on a reported basis and 5% on a constant currency basis, reflecting growth across its immunology, neuroscience and aesthetics portfolios.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share was $2.51 for the three months ended March 31, 2022 and included the following after-tax costs:            (i) $1.6&#160;billion related to the amortization of intangible assets; (ii) $148 million for charges related to litigation matters; (iii) $145 million&#160;for acquired IPR&amp;D and milestones; and (iv) $121&#160;million of acquisition and integration expenses. These costs were partially offset by an after-tax benefit of $746&#160;million related to the change in fair value of contingent consideration liabilities. Additionally, financial results reflected continued funding to support all stages of AbbVie&#8217;s pipeline assets and continued investment in AbbVie&#8217;s on-market brands.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the closing of the Allergan acquisition, AbbVie implemented an integration plan designed to reduce costs, integrate and optimize the combined organization. The integration plan is expected to realize approximately $2.5 billion of annual cost synergies in 2022. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To achieve these integration objectives, AbbVie expects to incur total cumulative charges of approximately $2 billion through 2022. These costs consist of severance and employee benefit costs (cash severance, non-cash severance, including accelerated equity award compensation expense, retention and other termination benefits) and other integration expenses.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">24</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Global Events</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Russia/Ukraine</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the military conflict between Russia and Ukraine, the United States and other North Atlantic Treaty Organization member states, as well as certain non-member states, announced targeted economic sanctions and export controls on Russia and Belarus. These include restrictions on the export and transfer of products containing certain toxins, including Botox, to Russia and Belarus. With the exception of Botox, AbbVie is not prohibited to continue the sale of essential pharmaceutical products to help ensure patients receive an uninterrupted supply of their medicines. In March 2022, AbbVie announced the suspension of operations for all aesthetics products in Russia. In April 2022, AbbVie also announced that all profits from the sales of essential medicines in Russia will be donated to support direct humanitarian relief efforts in Ukraine. While the company&#8217;s operations in Russia, Belarus and Ukraine are not significant, if the conflict escalates and results in broader economic and political concerns, AbbVie&#8217;s business could be adversely impacted. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of the Coronavirus Disease 2019 (COVID-19)</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the ongoing public health crisis posed by COVID-19, AbbVie continues to focus on ensuring the safety of employees. Throughout the pandemic, AbbVie has followed health and safety guidance from state and local health authorities and implemented safety measures for those employees who are returning to the workplace. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie also continues to closely manage manufacturing and supply chain resources around the world to help ensure that patients continue to receive an uninterrupted supply of their medicines. Clinical trial sites are being monitored locally to protect the safety of study participants, staff and employees. While the impact of COVID-19 on AbbVie's operations to date has not been material, AbbVie continues to experience lower new patient starts in certain products and markets. AbbVie expects this matter could continue to negatively impact its results of operations throughout the duration of the pandemic. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which COVID-19 may impact AbbVie's financial condition and results of operations remains uncertain and is dependent on numerous evolving factors, including the measures being taken by authorities to mitigate against the spread of COVID-19, the emergence of new variants and the availability and successful administration of effective vaccines.</span></div><div id="ic89f06320f9c4f57b19c511822f36cac_109"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and innovation are the cornerstones of AbbVie&#8217;s business as a global biopharmaceutical company. AbbVie&#8217;s long-term success depends to a great extent on its ability to continue to discover and develop innovative products and acquire or collaborate on compounds currently in development by other biotechnology or pharmaceutical companies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie&#8217;s pipeline currently includes approximately 90 compounds, devices or indications in development individually or under collaboration or license agreements and is focused on such important specialties as immunology, oncology, aesthetics, neuroscience and eye care. Of these programs, more than 50 are in mid- and late-stage development. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sections summarize transitions of significant programs from mid-stage development to late-stage development as well as developments in significant late-stage and registration programs. AbbVie expects multiple mid-stage programs to transition into late-stage programs in the next 12 months.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Programs and Developments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Immunology</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Skyrizi</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In January 2022, A</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bbVie announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi for the treatment of adults with active psoriatic arthritis (PsA). </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In February 2022, AbbVie announced that the FDA has extended the Prescription Drug User Fee Act action date by three months for Skyrizi for the treatment of moderate to severe Crohn&#8217;s disease in patients 16 years.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rinvoq</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In January 2022, Abb</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vie announced its submission of a supplemental New Drug Application (sNDA) to the FDA and a marketing authorization application (MAA) to the European Medicines Agency (EMA) for Rinvoq for the treatment of adults with active nr-axSpA with objective signs of inflammation who have responded inadequately to nonsteroidal anti-inflammatory drugs.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">25</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In January 2022, Ab</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bVie announced that the FDA approved Rinvoq for the treatment of moderate to severe atopic dermatitis (AD) in adults and children 12 years of age and older whose disease did not respond to previous treatment and is not well controlled with other pills or injections, including biologic medicines, or when use of other pills or injections is not recommended.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In February 2022, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie was notified that the European Commission (EC) is requesting the EMA to assess safety concerns associated with JAK inhibitor products authorized in inflammatory diseases and to evaluate the impact of these events on their benefit-risk balance. The assessment covers all JAK inhibitors approved for use in inflammatory diseases. The request is for an opinion from the EMA by September 30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In February 2022, AbbVie announced top-line results from its second Phase 3 induction study, U-Excel, for Rinvoq in patients with moderate to severe Crohn&#8217;s disease who had an inadequate response or were intolerant to conventional or biologic therapy met the primary and most key secondary endpoints.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In March 2022, AbbVie announced that the FDA approved Rinvoq for the treatment of adults with moderately to severely active ulcerative colitis who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">In April 2022, AbbVie announced that the FDA approved Rinvoq for the treatment of adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more TNF blockers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oncology</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Teliso-V</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In January 2022, AbbVie announced that the FDA granted Breakthrough Therapy Designation to investigational telisotuzumab vedotin (Teliso-V) for the treatment of patients with advanced/metastatic epidermal growth factor receptor wild type, nonsquamous non-small cell lung cancer with high levels of c-Met overexpression whose disease has progressed on or after platinum-based therapy.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Imbruvica</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In February 2022, AbbVie submitted an sNDA to the FDA for Imbruvica for the treatment of pediatric and adolescent patients one year and older with chronic graft versus host disease after failure of one or more lines of systemic therapy.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Epcoritamab</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In March 2022, Genmab A/S (Genmab) announced that FDA granted orphan-drug designation to the investigational medicine, epcoritamab (DuoBody-CD3xCD20), for the treatment of follicular lymphoma. Genmab and AbbVie are co-developing epcoritamab and will share commercial responsibilities in the U.S. and Japan, with AbbVie responsible for further global commercialization.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">In April 2022, AbbVie and Genmab announced positive topline results from the first cohort of the EPCORE NHL-1 phase 1/2 clinical trial evaluating epcoritamab (DuoBody-CD3xCD20) in patients with relapsed/refractory large B-cell lymphoma (LBCL) who received at least two prior lines of systemic therapy. Based on the topline results, the companies will engage global regulatory authorities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aesthetics</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Juvederm Collection</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In February 2022, AbbVie announced that the FDA approved JUVEDERM VOLBELLA XC for improvement of infraorbital hollows in adults over the age of 21.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">BoNTE</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In March 2022, AbbVie initiated three Phase 3 clinical trials to evaluate the efficacy and safety of BoNTE (AGN-151586) for the treatment of glabellar lines.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">26</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Neuroscience</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vraylar</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In February 2022, AbbVie submitted an sNDA to the FDA for Vraylar for the adjunctive treatment of major depressive disorder in patients who are receiving ongoing antidepressant therapy.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Qulipta</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">In March 2022, AbbVie announced results from the Phase 3 PROGRESS trial for Qulipta in the preventive treatment of chronic migraine in adults met the primary endpoint and resulted in significant improvements in all secondary endpoints after adjustment for multiple comparisons.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eye Care</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vuity</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">In April 2022, AbbVie announced that the Phase 3 VIRGO trial evaluating the safety and efficacy of investigational twice-daily administration of Vuity 1.25% in adults with presbyopia met its primary efficacy endpoint. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a more comprehensive discussion of AbbVie&#8217;s products and pipeline, see the company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2021.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">27</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_112"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div id="ic89f06320f9c4f57b19c511822f36cac_115"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenues</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparisons presented at constant currency rates reflect comparative local currency net revenues at the prior year&#8217;s foreign exchange rates. This measure provides information on the change in net revenues assuming that foreign currency exchange rates had not changed between the prior and current periods. AbbVie believes that the non-GAAP measure of change in net revenues at constant currency rates, when used in conjunction with the GAAP measure of change in net revenues at actual currency rates, may provide a more complete understanding of the company&#8217;s operations and can facilitate analysis of the company&#8217;s results of operations, particularly in evaluating performance from one period to another.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.321%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;change</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At&#160;actual <br/>currency&#160;rates</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At&#160;constant <br/>currency rates</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in&#160;millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net revenues</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">28</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details AbbVie&#8217;s worldwide net revenues:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.098%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At&#160;actual <br/>currency rates</span></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At&#160;constant <br/>currency rates</span></td></tr><tr style="height:14pt"><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in&#160;millions)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Immunology</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Humira</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Skyrizi</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rinvoq</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&gt;100.0 %</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&gt;100.0 %</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hematologic Oncology</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Imbruvica</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Collaboration revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,268&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Venclexta</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Botox Cosmetic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Juvederm Collection</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Botox Therapeutic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vraylar</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Duodopa</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ubrelvy</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Qulipta</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/m</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">29</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.098%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At&#160;actual <br/>currency rates</span></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At&#160;constant <br/>currency rates</span></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in&#160;millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eye Care</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lumigan/Ganfort</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alphagan/Combigan</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restasis</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Eye Care</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Key Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mavyret</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Creon</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Linzess/Constella</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,538&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,010&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">n/m &#8211; Not meaningful</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis of AbbVie&#8217;s net revenues by product is presented on a constant currency basis.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Humira sales decreased by 2% for the three months ended March 31, 2022 primarily driven by direct biosimilar competition in certain international markets, partially offset by market growth across therapeutic categories. In the United States, Humira sales increased by 2% for the three months ended March 31, 2022 primarily driven by market growth across all indications. This increase was partially offset by slightly lower market share following corresponding market share gains of Skyrizi and Rinvoq. Internationally, Humira revenues decreased by 18% for the three months ended March 31, 2022 primarily driven by direct biosimilar competition in certain international markets.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for Skyrizi increased by 66% for the three months ended March 31, 2022 primarily driven by continued strong volume and market share uptake since launch as a treatment for plaque psoriasis as well as market growth. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for Rinvoq increased by 57% for the three months ended March 31, 2022 primarily driven by continued strong volume and market share uptake since launch for the treatment of moderate to severe rheumatoid arthritis as well as market growth. Net revenues for the three months ended March 31, 2022 were also favorably impacted by recent regulatory approvals and expansion of Rinvoq for the treatment of psoriatic arthritis, atopic dermatitis and ankylosing spondylitis in certain international markets.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for Imbruvica represent product revenues in the United States and collaboration revenues outside of the United States related to AbbVie&#8217;s 50% share of Imbruvica profit. AbbVie's global Imbruvica revenues decreased by 7% for the three months ended March 31, 2022 as a result of lower new patient starts due to the COVID-19 pandemic and share loss in the United States, partially offset by increased collaboration revenues.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for Venclexta increased by 21% for the three months ended March 31, 2022 primarily due to continued expansion of Venclexta for the treatment of patients with first-line chronic lymphocytic leukemia (CLL), relapsed/refractory CLL and first-line acute myeloid leukemia.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for Botox Cosmetic used in facial aesthetics increased by 37% for the three months ended March 31, 2022 due to increased consumer demand and penetration rates driven by targeted brand investment. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">30</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for Juvederm Collection (including Juvederm Ultra XC, Juvederm Voluma XC and other Juvederm products) used in facial aesthetics increased by 31% for the three months ended March 31, 2022 due to increased consumer demand and penetration rates driven by targeted brand investment.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for Botox Therapeutic used primarily in neuroscience and urology therapeutic areas increased by 17% for the three months ended March 31, 2022 due to market growth, higher market share and strong market recovery from the COVID-19 pandemic.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for Vraylar for the treatment of schizophrenia, bipolar I disorder and bipolar depression increased by 23% for the three months ended March 31, 2022 due to higher market share and market growth.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for Ubrelvy for the acute treatment of migraine with or without aura in adults increased by 70% for the three months ended March 31, 2022 primarily due to increased market share uptake since launch.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for Mavyret decreased by 5% for the three months ended March 31, 2022 driven by the continued disruption of global HCV markets due to the COVID-19 pandemic.</span></div><div id="ic89f06320f9c4f57b19c511822f36cac_118"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Margin </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,486</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,797</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">as a % of net revenues</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin as a percentage of net revenues increased for the three months ended March 31, 2022 compared to the prior year. Gross margin percentage for the three months ended March 31, 2022 was favorably impacted by changes in product mix and lower amortization of intangible assets associated with the Allergan acquisition. </span></div><div id="ic89f06320f9c4f57b19c511822f36cac_121"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General and Administrative</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,127</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">as a % of net revenues</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses as a percentage of net revenues increased for the three months ended March 31, 2022 compared to the prior year. SG&amp;A expense percentage for the three months ended March 31, 2022 was unfavorably impacted by litigation reserve charges of $184 million as well as increased brand investment and product launch expenses, partially offset by leverage from revenue growth and increased synergies realized. </span></div><div id="ic89f06320f9c4f57b19c511822f36cac_124"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development and Acquired IPR&amp;D and Milestones</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">as a % of net revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D and milestones</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses as a percentage of net revenues decreased for the three months ended March 31, 2022 compared to the prior year. R&amp;D expense percentage was favorably impacted by the purchase of a priority review voucher from a third party in the first quarter of 2021, increased scale of the combined company and synergies realized as well as lower integration costs related to the acquisition of Allergan.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D and milestones expense represents upfront and subsequent development milestone payments incurred prior to regulatory approval to acquire rights to in-process R&amp;D projects through R&amp;D collaborations, licensing arrangements or other asset acquisitions. Acquired IPR&amp;D and milestones expense in the three months ended March 31, 2022 included a charge of $130 million as a result of acquiring Syndesi Therapeutics SA and its portfolio of novel modulators of the synaptic vesicle protein 2A (SV2A), including its lead molecule SDI-118, which is being evaluated to target nerve terminals to enhance synaptic efficiency. There were no individually significant transactions during the three months ended March 31, 2021.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">31</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_127"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Non-Operating Expenses (Income)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(776)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net decreased for the three months ended March 31, 2022 compared to the prior year primarily due to lower average debt balance due to deleveraging.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net included a benefit related to changes in fair value of contingent consideration liabilities of $748&#160;million for the three months ended March 31, 2022 and $343&#160;million for the three months ended March 31, 2021. The fair value of contingent consideration liabilities is impacted by the passage of time and multiple other inputs, including the probability of success of achieving regulatory/commercial milestones, discount rates, the estimated amount of future sales of the acquired products and other market-based factors. For the three months ended March 31, 2022 and 2021, the change in fair value was driven by higher discount rates partially offset by the passage of time. </span></div><div id="ic89f06320f9c4f57b19c511822f36cac_133"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate was 9% for the three months ended March 31, 2022 compared to 8% for the three months ended March 31, 2021. The effective tax rate in each period differed from the U.S. statutory tax rate of 21% principally due to the impact of foreign operations which reflects the impact of lower income tax rates in locations outside the United States, tax incentives in Puerto Rico and other foreign tax jurisdictions, business development activities and accretion on contingent consideration. The increase in the effective tax rate for the three months ended March 31, 2022 over the prior year was primarily due to differences in the company&#8217;s jurisdictional mix of earnings.</span></div><div id="ic89f06320f9c4f57b19c511822f36cac_136"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL POSITION, LIQUIDITY AND CAPITAL RESOURCES</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows provided by (used in):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,972)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,174)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows for the three months ended March 31, 2022 were flat compared to the prior year primarily due to improved results of operations resulting from revenue growth, offset by the timing of working capital cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing cash flows for the three months ended March 31, 2022 included payments made for net purchases of investment securities totaling $1.4&#160;billion, acquisitions and investments of $185&#160;million and capital expenditures of $162&#160;million. Investing cash flows for the three months ended March 31, 2021 included payments made for acquisitions and investments of $198 million, capital expenditures of $188 million and net purchases of investment securities totaling $5&#160;million. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows for the three months ended March 31, 2022 included an early repayment of $2.9 billion aggregate principal amount of the company&#8217;s 3.45% senior notes. Additionally, financing cash flows included repayment of a $2.0 billion floating rate term loan due May 2025 and issuance of a new $2.0 billion floating rate term loan as part of the term loan refinancing in February 2022. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows also included cash dividend payments of $2.5 billion for the three months ended March 31, 2022 and $2.3 billion for the three months ended March 31, 2021. The increase in cash dividend payments was primarily driven by the increase in the quarterly dividend rate. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">32</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;17, 2022, the company announced that its board of directors declared a quarterly cash dividend of $1.41 per share for stockholders of record at the close of business on April&#160;15, 2022, payable on May&#160;16, 2022. The timing, declaration, amount of and payment of any dividends by AbbVie in the future is within the discretion of its board of directors and will depend upon many factors, including AbbVie&#8217;s financial condition, earnings, capital requirements of its operating subsidiaries, covenants associated with certain of AbbVie&#8217;s debt service obligations, legal requirements, regulatory constraints, industry practice, ability to access capital markets and other factors deemed relevant by its board of directors. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's stock repurchase authorization permits purchases of AbbVie shares from time to time in open-market or private transactions at management's discretion. The program has no time limit and can be discontinued at any time. AbbVie repurchased 8&#160;million shares for $1.1&#160;billion during the three months ended March 31, 2022 and 5&#160;million shares for $550&#160;million during the three months ended March 31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie monitors economic conditions, the creditworthiness of customers and government regulations and funding, both domestically and abroad. AbbVie regularly communicates with its customers regarding the status of receivable balances, including their payment plans and obtains positive confirmation of the validity of the receivables. AbbVie establishes an allowance for credit losses equal to the estimate of future losses over the contractual life of outstanding accounts receivable. AbbVie may also utilize factoring arrangements to mitigate credit risk, although the receivables included in such arrangements have historically not been a significant amount of total outstanding receivables.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facility, Access to Capital and Credit Ratings</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facility</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie currently has a $4.0 billion five-year revolving credit facility that matures in August 2024. This credit facility enables the company to borrow funds on an unsecured basis at variable interest rates and contains various covenants. At March 31, 2022, the company was in compliance with all covenants, and commitment fees under the credit facility were insignificant. No amounts were outstanding under the company's credit facility as of March 31, 2022 and December 31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Access to Capital</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company intends to fund short-term and long-term financial obligations as they mature through cash on hand, future cash flows from operations or has the ability to issue additional debt. The company&#8217;s ability to generate cash flows from operations, issue debt or enter into financing arrangements on acceptable terms could be adversely affected if there is a material decline in the demand for the company&#8217;s products or in the solvency of its customers or suppliers, deterioration in the company&#8217;s key financial ratios or credit ratings or other material unfavorable changes in business conditions. At the current time, the company believes it has sufficient financial flexibility to issue debt, enter into other financing arrangements and attract long-term capital on acceptable terms to support the company&#8217;s growth objectives.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Ratings</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, Moody&#8217;s Investors Service (Moody&#8217;s) affirmed its Baa2 senior unsecured long-term rating and the Prime-2 short-term rating. At the same time, Moody&#8217;s revised the outlook to positive from stable. Unfavorable changes to the ratings may have an adverse impact on future financing arrangements; however, they would not affect the company&#8217;s ability to draw on its credit facility and would not result in an acceleration of scheduled maturities of any of the company&#8217;s outstanding debt.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the company&#8217;s significant accounting policies is included in Note 2, &#8220;Summary of Significant Accounting Policies&#8221; in AbbVie's Annual Report on Form&#160;10-K for the year ended December 31, 2021. There have been no significant changes in the company&#8217;s application of its critical accounting policies during the three months ended March 31, 2022.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">33</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some statements in this quarterly report on Form&#160;10-Q may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.&#160;The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;project,&#8221; and similar expressions, among others, generally identify forward-looking statements.&#160;AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.&#160;Such risks and uncertainties include, but are not limited to, failure to realize the expected benefits from AbbVie's acquisition of Allergan, failure to promptly and effectively integrate Allergan's businesses, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry and the impact of public health outbreaks, epidemics or pandemics, such as COVID-19.&#160;Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie&#8217;s operations is set forth in Item 1A, &#8220;Risk Factors,&#8221; in AbbVie&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2021, which has been filed with the Securities and Exchange Commission.&#160;AbbVie notes these factors for investors as permitted by the Private Securities Litigation Reform Act of 1995. AbbVie undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.</span></div><div id="ic89f06320f9c4f57b19c511822f36cac_139"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the company's market risk, see Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" in AbbVie's Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div id="ic89f06320f9c4f57b19c511822f36cac_142"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DISCLOSURE CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Chief Executive Officer, Richard A. Gonzalez, and the Chief Financial Officer, Robert A. Michael, evaluated the effectiveness of AbbVie&#8217;s disclosure controls and procedures as of the end of the period covered by this report, and concluded that AbbVie&#8217;s disclosure controls and procedures were effective to ensure that information AbbVie is required to disclose in the reports that it files or submits with the Securities and Exchange Commission under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules&#160;and forms, and to ensure that information required to be disclosed by AbbVie in the reports that it files or submits under the Exchange Act is accumulated and communicated to AbbVie&#8217;s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There were no changes in AbbVie&#8217;s internal control over financial reporting (as defined in Rule&#160;13a-15(f)&#160;under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, AbbVie&#8217;s internal control over financial reporting during the quarter ended March 31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitations on Effectiveness of Controls.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AbbVie&#8217;s management, including its Chief Executive Officer and its Chief Financial Officer, do not expect that AbbVie&#8217;s disclosure controls or internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">34</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_145"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART&#160;II. OTHER INFORMATION</span></div><div id="ic89f06320f9c4f57b19c511822f36cac_148"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to legal proceedings is provided in Note 12 to the Condensed Consolidated Financial Statements and is incorporated by reference herein.</span></div><div id="ic89f06320f9c4f57b19c511822f36cac_154"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)&#160;Total <br/>Number&#160;of <br/>Shares&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(or Units) <br/>Purchased</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)&#160;Average <br/>Price&#160;Paid <br/>per&#160;Share <br/>(or&#160;Unit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)&#160;Total&#160;Number <br/>of&#160;Shares&#160;(or <br/>Units)&#160;Purchased <br/>as&#160;Part&#160;of&#160;Publicly <br/>Announced&#160;Plans <br/>or&#160;Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)&#160;Maximum <br/>Number&#160;(or <br/>Approximate <br/>Dollar&#160;Value)&#160;of <br/>Shares&#160;(or&#160;Units) <br/>that&#160;May&#160;Yet&#160;Be <br/>Purchased&#160;Under <br/>the&#160;Plans&#160;or <br/>Programs</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022 - January 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$135.74</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,523,316,993</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2022 - February 28, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,653,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$146.18</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,652,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,550,785,350</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022 - March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$149.88</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,393,714,917</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,702,838&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$146.69</span></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,700,791&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,393,714,917</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.92pt">In addition to AbbVie shares repurchased on the open market under a publicly announced program, if any, these shares also included the shares purchased on the open market for the benefit of participants in the AbbVie Employee Stock Purchase Plan &#8211; 715 in January; 692 in February; and 640 in March.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These shares do not include the shares surrendered to AbbVie to satisfy minimum tax withholding obligations in connection with the vesting or exercise of stock-based awards.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">35</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_157"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:3pt;margin-top:12pt"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits 32.1 and 32.2 are furnished herewith and should not be deemed to be &#8220;filed&#8221; under the Securities Exchange Act of 1934.</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:11.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex101.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex101.htm">Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex102.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex102.htm">Form of AbbVie Inc. Performance Share Award Agreement*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex103.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="abbv-20220331xex103.htm">Form of AbbVie Inc. Non-Employee Director RSU Agreement (US)</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="abbv-20220331xex103.htm">*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex104.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="abbv-20220331xex104.htm">Form of AbbVie Inc. Non-Qualified Stock Option Agreement</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="abbv-20220331xex104.htm">*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex105.htm">10.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex105.htm">Form of AbbVie Inc. Retention RSU Agreement &#8211; Ratable Vesting*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex106.htm">10.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="abbv-20220331xex106.htm">Form of AbbVie Inc. Retention RSU Agreement &#8211; Cliff Vesting with Dividend Equivalent Accrual</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="abbv-20220331xex106.htm">*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex311.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex311.htm">Certification of Chief Executive Officer Required by Rule&#160;13a-14(a)&#160;(17 CFR 240.13a-14(a)).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex312.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex312.htm">Certification of Chief Financial Officer Required by Rule&#160;13a-14(a)&#160;(17 CFR 240.13a-14(a)).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex321.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex321.htm">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex322.htm">32.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="abbv-20220331xex322.htm">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial statements and notes from the AbbVie Inc. Quarterly Report on Form&#160;10-Q for the quarter ended March 31, 2022, filed on May&#160;6, 2022, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i)&#160;Condensed Consolidated Statements of Earnings; (ii)&#160;Condensed Consolidated Statements of Comprehensive Income; (iii)&#160;Condensed Consolidated Balance Sheets; (iv) Condensed Consolidated Statements of Equity; (v)&#160;Condensed Consolidated Statements of Cash Flows; and (vi)&#160;the Notes to Condensed Consolidated Financial Statements.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (the cover page from the AbbVie Inc. Quarterly Report on Form 10-Q formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Denotes management contract or compensatory plan or arrangement required to be filed as an exhibit hereto.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">36</span></div></td></tr></table></div></div></div><div id="ic89f06320f9c4f57b19c511822f36cac_160"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:center"><span style="color:#444867;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.539%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABBVIE INC.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert A. Michael</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert A. Michael</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-6.75pt;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice Chairman, Finance and Commercial Operations and</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-6.75pt;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: May&#160;6, 2022</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">2022 Form 10-Q</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> | </span><img src="abbv-20220331_g2.gif" alt="abbv-20220331_g2.gif" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">37</span></div></td></tr></table></div></div></div></body></html>
